KHS1
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0A2R8Y4L2 | S95 | Sugiyama | HNRNPA1L3 HNRNPA1P48 | RPHKVDGRVVEPKRAVSREDsQRPDAHLTVKKIFVGGIKED |
| A5A3E0 | T789 | Sugiyama | POTEF A26C1B | YPMEHGIITNWDDMEKIWHHtFyNELRVAPEEHPVLLTEAT |
| A5A3E0 | T949 | Sugiyama | POTEF A26C1B | TVAsSSSLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| O00303 | T119 | Sugiyama | EIF3F EIF3S5 | LASIVDSYERRNEGAARVIGtLLGtVDKHSVEVTNCFSVPH |
| O00303 | T123 | Sugiyama | EIF3F EIF3S5 | VDSYERRNEGAARVIGtLLGtVDKHSVEVTNCFSVPHNEsE |
| O00541 | S282 | Sugiyama | PES1 | EGTyALDSESCMEKLAALsAsLARVVVPATEEEAEVDEFPt |
| O14556 | T301 | Sugiyama | GAPDHS GAPD2 GAPDH2 GAPDS HSD-35 HSD35 | ASTGAAKAVTKVIPELKGKLtGMAFRVPTPDVSVVDLTCRL |
| O14744 | T80 | Sugiyama | PRMT5 HRMT1L5 IBP72 JBP1 SKB1 | KNRPGPQTRSDLLLSGRDWNtLIVGKLSPWIRPDSKVEKIR |
| O14908 | T238 | Sugiyama | GIPC1 C19orf3 GIPC RGS19IP1 | FDMISQRsAGGRPGsGPQLGtGRGtLRLRsRGPAtVEDLPs |
| O14908 | T242 | Sugiyama | GIPC1 C19orf3 GIPC RGS19IP1 | SQRsAGGRPGsGPQLGtGRGtLRLRsRGPAtVEDLPsAFEE |
| O15067 | S1053 | Sugiyama | PFAS KIAA0361 | RGLRERMGPSYCLPPTFPKAsVPREPGGPsPRVAILREEGS |
| O15067 | T591 | Sugiyama | PFAS KIAA0361 | NRDFLTHVSARERCPACFVGtITGDRRIVLVDDRECPVRRN |
| O15143 | S323 | Sugiyama | ARPC1B ARC41 | QNLDKKAssEGGtAAGAGLDsLHKNsVsQIsVLsGGKAKCS |
| O15212 | T107 | Sugiyama | PFDN6 HKE2 PFD6 | IKRYESQLRDLERQsEQQREtLAQLQQEFQRAQAAKAGAPG |
| O15371 | T49 | Sugiyama | EIF3D EIF3S7 | PyQPFsKGDRLGKVADWtGAtyQDKRYTNKYSSQFGGGSQY |
| O43390 | T137 | Sugiyama | HNRNPR HNRPR | ESTKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVYS |
| O43399 | T146 | Sugiyama | TPD52L2 | yKKTQETLsQAGQKtsAALstVGsAIsRKLGDMRNsAtFKs |
| O43707 | S507 | Sugiyama | ACTN4 | DsHNVNtRCQKICDQWDALGsLtHsRREALEKTEKQLEAID |
| O43707 | T443 | Sugiyama | ACTN4 | sIHEAWtDGKEAMLKHRDyEtAtLsDIKALIRKHEAFEsDL |
| O43707 | T445 | Sugiyama | ACTN4 | HEAWtDGKEAMLKHRDyEtAtLsDIKALIRKHEAFEsDLAA |
| O43707 | Y441 | Sugiyama | ACTN4 | KAsIHEAWtDGKEAMLKHRDyEtAtLsDIKALIRKHEAFEs |
| O43852 | T89 | Sugiyama | CALU | sKERLGKIVSKIDGDKDGFVtVDELKDWIKFAQKRWIyEDV |
| O60506 | T134 | Sugiyama | SYNCRIP HNRPQ NSAP1 | DSSKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVYS |
| O75390 | T335 | Sugiyama | CS | LQKEVGKDVSDEKLRDYIWNtLNSGRVVPGyGHAVLRKTDP |
| O75475 | Y18 | Sugiyama | PSIP1 DFS70 LEDGF PSIP2 | ___MTRDFKPGDLIFAKMKGyPHWPARVDEVPDGAVKPPTN |
| O75821 | T240 | Sugiyama | EIF3G EIF3S4 | DGAsRRGESMQPNRRADDNAtIRVtNLSEDTRETDLQELFR |
| O75821 | T27 | Sugiyama | EIF3G EIF3S4 | DsKPsWADQVEEEGEDDKCVtsELLKGIPLAtGDtsPEPEL |
| O94776 | S433 | Sugiyama | MTA2 MTA1L1 PID | ATRGtTEPHSRGHLsRPEAQsLsPyttsANRAKLLAKNRQt |
| O95218 | T50 | Sugiyama | ZRANB2 ZIS ZNF265 | SCNRCGREKTTEAKMMKAGGtEIGKtLAEKSRGLFsANDWQ |
| O95218 | T55 | Sugiyama | ZRANB2 ZIS ZNF265 | GREKTTEAKMMKAGGtEIGKtLAEKSRGLFsANDWQCKTCs |
| O95347 | S664 | Sugiyama | SMC2 CAPE SMC2L1 PRO0324 | RIMTRTVtLGGDVFDPHGtLsGGARSQAASILTKFQELKDV |
| O95347 | T651 | Sugiyama | SMC2 CAPE SMC2L1 PRO0324 | DNMDNAKKVAFDKRIMTRTVtLGGDVFDPHGtLsGGARSQA |
| O95347 | T662 | Sugiyama | SMC2 CAPE SMC2L1 PRO0324 | DKRIMTRTVtLGGDVFDPHGtLsGGARSQAASILTKFQELK |
| O95678 | S162 | Sugiyama | KRT75 K6HF KB18 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| O95757 | S579 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | SAVSDKQDRLNQTLKKGKVKsIDLPIQssLCRQLGQDLLNs |
| O95757 | S586 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | DRLNQTLKKGKVKsIDLPIQssLCRQLGQDLLNsyIENEGK |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P00338 | S167 | Sugiyama | LDHA PIG19 | AWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVHPLSCHG |
| P00338 | S319 | Sugiyama | LDHA PIG19 | GISDLVKVTLtsEEEARLKKsADtLWGIQKELQF_______ |
| P00338 | S69 | Sugiyama | LDHA PIG19 | ALVDVIEDKLKGEMMDLQHGsLFLRTPKIVSGKDyNVTANs |
| P00338 | T275 | Sugiyama | LDHA PIG19 | SVADLAESIMKNLRRVHPVstMIKGLYGIKDDVFLSVPCIL |
| P00338 | T322 | Sugiyama | LDHA PIG19 | DLVKVTLtsEEEARLKKsADtLWGIQKELQF__________ |
| P00492 | S92 | Sugiyama | HPRT1 HPRT | YKFFADLLDYIKALNRNSDRsIPMtVDFIRLKsYCNDQsTG |
| P00492 | T96 | Sugiyama | HPRT1 HPRT | ADLLDYIKALNRNSDRsIPMtVDFIRLKsYCNDQsTGDIKV |
| P00558 | S390 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | IIGGGDtAtCCAKWNtEDKVsHVstGGGAsLELLEGKVLPG |
| P00558 | S399 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | CCAKWNtEDKVsHVstGGGAsLELLEGKVLPGVDALsNI__ |
| P00558 | T168 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | EAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGF |
| P00558 | T369 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | ARGTKALMDEVVKAtsRGCItIIGGGDtAtCCAKWNtEDKV |
| P00558 | T376 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | MDEVVKAtsRGCItIIGGGDtAtCCAKWNtEDKVsHVstGG |
| P00558 | Y161 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | KAEPAKIEAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNL |
| P02538 | S176 | Sugiyama | KRT6A K6A KRT6D | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWT |
| P04040 | T361 | Sugiyama | CAT | PGIEASPDKMLQGRLFAyPDtHRHRLGPNyLHIPVNCPyRA |
| P04075 | S336 | Sugiyama | ALDOA ALDA | GKKENLKAAQEEYVKRALANsLACQGKytPsGQAGAAAsEs |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | T119 | Sugiyama | ALDOA ALDA | KsKGGVVGIKVDKGVVPLAGtNGEtttQGLDGLsERCAQYK |
| P04075 | T124 | Sugiyama | ALDOA ALDA | VVGIKVDKGVVPLAGtNGEtttQGLDGLsERCAQYKKDGAD |
| P04075 | T37 | Sugiyama | ALDOA ALDA | sDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRR |
| P04080 | S83 | Sugiyama | CSTB CST6 STFB | DFVHLRVFQsLPHENKPLtLsNyQTNKAKHDELtyF_____ |
| P04080 | T81 | Sugiyama | CSTB CST6 STFB | DEDFVHLRVFQsLPHENKPLtLsNyQTNKAKHDELtyF___ |
| P04080 | Y85 | Sugiyama | CSTB CST6 STFB | VHLRVFQsLPHENKPLtLsNyQTNKAKHDELtyF_______ |
| P04083 | S173 | Sugiyama | ANXA1 ANX1 LPC1 | NRVYREELKRDLAKDItsDtsGDFRNALLsLAKGDRsEDFG |
| P04083 | S182 | Sugiyama | ANXA1 ANX1 LPC1 | RDLAKDItsDtsGDFRNALLsLAKGDRsEDFGVNEDLADsD |
| P04259 | S176 | Sugiyama | KRT6B K6B KRTL1 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04406 | T229 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | AstGAAKAVGKVIPELNGKLtGMAFRVPtANVsVVDLtCRL |
| P04406 | T237 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | VGKVIPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDD |
| P04406 | T246 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKVVKQAS |
| P04792 | T91 | Sugiyama | HSPB1 HSP27 HSP28 | PAYsRALsRQLssGVsEIRHtADRWRVsLDVNHFAPDELtV |
| P05187 | T181 | Sugiyama | ALPP PLAP | AGKSVGVVTTTRVQHAsPAGtyAHtVNRNWysDADVPASAR |
| P05187 | T185 | Sugiyama | ALPP PLAP | VGVVTTTRVQHAsPAGtyAHtVNRNWysDADVPASARQEGC |
| P05455 | S325 | Sugiyama | SSB | VLEGEVEKEALKKIIEDQQEsLNKWKSKGRRFKGKGKGNKA |
| P05455 | T120 | Sugiyama | SSB | VTDEyKNDVKNRsVYIKGFPtDAtLDDIKEWLEDKGQVLNI |
| P05455 | T123 | Sugiyama | SSB | EyKNDVKNRsVYIKGFPtDAtLDDIKEWLEDKGQVLNIQMR |
| P05455 | T302 | Sugiyama | SSB | ALGKAKDANNGNLQLRNKEVtWEVLEGEVEKEALKKIIEDQ |
| P05783 | S399 | Sugiyama | KRT18 CYK18 PIG46 | TYRRLLEDGEDFNLGDALDssNsMQtIQKtTTRRIVDGKVV |
| P05783 | T404 | Sugiyama | KRT18 CYK18 PIG46 | LEDGEDFNLGDALDssNsMQtIQKtTTRRIVDGKVVsETND |
| P05787 | S104 | Sugiyama | KRT8 CYK8 | IQAVRTQEKEQIKTLNNKFAsFIDKVRFLEQQNKMLETKWS |
| P05787 | S291 | Sugiyama | KRT8 CYK8 | ANRsRAEAEsMyQIKyEELQsLAGKHGDDLRRTKTEISEMN |
| P05787 | S330 | Sugiyama | KRT8 CYK8 | MNRNISRLQAEIEGLKGQRAsLEAAIADAEQRGELAIKDAN |
| P06733 | S353 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | NEKsCNCLLLKVNQIGsVTEsLQACKLAQANGWGVMVsHRs |
| P06733 | T19 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | __MSILKIHAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGA |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P06733 | T26 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | IHAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGAstGIyEA |
| P06733 | T41 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | EVDLFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKG |
| P06733 | T55 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | VPsGAstGIyEALELRDNDKtRYMGKGVSKAVEHINKtIAP |
| P06733 | T72 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | NDKtRYMGKGVSKAVEHINKtIAPALVsKKLNVtEQEKIDK |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07195 | S168 | Sugiyama | LDHB | TWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIHPSSCHG |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07195 | T276 | Sugiyama | LDHB | SVADLIESMLKNLSRIHPVStMVKGMYGIENEVFLSLPCIL |
| P07195 | T302 | Sugiyama | LDHB | YGIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsAD |
| P07195 | T323 | Sugiyama | LDHB | sVINQKLKDDEVAQLKKsADtLWDIQKDLKDL_________ |
| P07205 | S390 | Sugiyama | PGK2 PGKB | VIGGGDTATCCAKWNtEDKVsHVstGGGAsLELLEGKILPG |
| P07205 | S399 | Sugiyama | PGK2 PGKB | CCAKWNtEDKVsHVstGGGAsLELLEGKILPGVEALSNM__ |
| P07205 | T168 | Sugiyama | PGK2 PGKB | EAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNLPHKASGF |
| P07205 | Y161 | Sugiyama | PGK2 PGKB | KAEPDKIEAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNL |
| P07237 | T117 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | RGyPtIKFFRNGDTASPKEytAGREADDIVNWLKKRTGPAA |
| P07237 | T413 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | YAPWCGHCKQLAPIWDKLGEtyKDHENIVIAKMDstANEVE |
| P07437 | S115 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | sGAGNNWAKGHytEGAELVDsVLDVVRKEAESCDCLQGFQL |
| P07437 | T107 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | PDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKEAESC |
| P07437 | T312 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | QVFDAKNMMAACDPRHGRyLtVAAVFRGRMsMKEVDEQMLN |
| P07437 | T72 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | NEAtGGKyVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVF |
| P07737 | T65 | Sugiyama | PFN1 | PAEVGVLVGKDRssFyVNGLtLGGQKCsVIRDsLLQDGEFs |
| P07814 | T1506 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | LCELQPGAKCVCGKNPAKyytLFGRsy______________ |
| P07814 | T707 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | VsPysCKEAPCVLIyIPDGHtKEMPTSGSKEKTKVEATKNE |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P07864 | S167 | Sugiyama | LDHC LDH3 LDHX | VWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVHPTSCHG |
| P07900 | S165 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | AEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGEPMGRGTK |
| P07900 | S169 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | TVITKHNDDEQyAWEssAGGsFtVRTDTGEPMGRGTKVILH |
| P07900 | S476 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | RKKLsELLRyytsAsGDEMVsLKDYCTRMKENQKHIyyItG |
| P07900 | S505 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | KENQKHIyyItGETKDQVANsAFVERLRKHGLEVIyMIEPI |
| P07900 | S52 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LIINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDs |
| P07900 | S63 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IFLRELIsNssDALDKIRyEsLtDPsKLDsGKELHINLIPN |
| P07900 | T171 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | ITKHNDDEQyAWEssAGGsFtVRTDTGEPMGRGTKVILHLK |
| P07900 | T317 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | WtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHFSVEGQLEF |
| P07900 | T467 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LGIHEDsQNRKKLsELLRyytsAsGDEMVsLKDYCTRMKEN |
| P07900 | T624 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | yGWTANMERIMKAQALRDNstMGyMAAKKHLEINPDHsIIE |
| P07900 | T645 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | MGyMAAKKHLEINPDHsIIEtLRQKAEADKNDKSVKDLVIL |
| P07900 | T65 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LRELIsNssDALDKIRyEsLtDPsKLDsGKELHINLIPNKQ |
| P07900 | T88 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | sKLDsGKELHINLIPNKQDRtLtIVDtGIGMTKADLINNLG |
| P07900 | T90 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LDsGKELHINLIPNKQDRtLtIVDtGIGMTKADLINNLGtI |
| P07900 | T94 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | KELHINLIPNKQDRtLtIVDtGIGMTKADLINNLGtIAKSG |
| P07900 | Y465 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IKLGIHEDsQNRKKLsELLRyytsAsGDEMVsLKDYCTRMK |
| P08195 | S134 | Sugiyama | SLC3A2 MDU1 | ELNELEPEKQPMNAAsGAAMsLAGAEKNGLVKIKVAEDEAE |
| P08238 | S160 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | AEKVVVITKHNDDEQyAWEssAGGsFtVRADHGEPIGRGTK |
| P08238 | S164 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | VVITKHNDDEQyAWEssAGGsFtVRADHGEPIGRGTKVILH |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | S468 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | RRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItG |
| P08238 | S58 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IFLRELIsNAsDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| P08238 | T166 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | ITKHNDDEQyAWEssAGGsFtVRADHGEPIGRGTKVILHLK |
| P08238 | T309 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | WtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHFSVEGQLEF |
| P08238 | T60 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LRELIsNAsDALDKIRyEsLtDPsKLDsGKELKIDIIPNPQ |
| P08238 | T616 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | yGWTANMERIMKAQALRDNstMGyMMAKKHLEINPDHPIVE |
| P08238 | T637 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MGyMMAKKHLEINPDHPIVEtLRQKAEADKNDKAVKDLVVL |
| P08238 | T83 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | sKLDsGKELKIDIIPNPQERtLtLVDtGIGMtKADLINNLG |
| P08238 | T85 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LDsGKELKIDIIPNPQERtLtLVDtGIGMtKADLINNLGtI |
| P08238 | T89 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KELKIDIIPNPQERtLtLVDtGIGMtKADLINNLGtIAKSG |
| P08238 | Y457 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LKLGIHEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMK |
| P08729 | S104 | Sugiyama | KRT7 SCL | LQRVRQEESEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWT |
| P08758 | S37 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | ERADAEtLRKAMKGLGtDEEsILtLLtsRsNAQRQEISAAF |
| P08758 | T111 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | yDAyELKHALKGAGTNEKVLtEIIAsRtPEELRAIKQVyEE |
| P08758 | T40 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | DAEtLRKAMKGLGtDEEsILtLLtsRsNAQRQEISAAFKTL |
| P08758 | T43 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | tLRKAMKGLGtDEEsILtLLtsRsNAQRQEISAAFKTLFGR |
| P08758 | T8 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | _____________MAQVLRGtVtDFPGFDERADAEtLRKAM |
| P09211 | T62 | Sugiyama | GSTP1 FAEES3 GST3 | GsLKASCLyGQLPKFQDGDLtLyQsNtILRHLGRTLGLYGK |
| P09211 | T68 | Sugiyama | GSTP1 FAEES3 GST3 | CLyGQLPKFQDGDLtLyQsNtILRHLGRTLGLYGKDQQEAA |
| P09211 | Y64 | Sugiyama | GSTP1 FAEES3 GST3 | LKASCLyGQLPKFQDGDLtLyQsNtILRHLGRTLGLYGKDQ |
| P09382 | T58 | Sugiyama | LGALS1 | DsNNLCLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVF |
| P09417 | S163 | Sugiyama | QDPR DHPR SDR33C1 | GTPGMIGYGMAKGAVHQLCQsLAGKNSGMPPGAAAIAVLPV |
| P09429 | S35 | Sugiyama | HMGB1 HMG1 | syAFFVQtCREEHKKKHPDAsVNFsEFsKKCsERWKtMsAK |
| P09651 | S365 | Sugiyama | HNRNPA1 HNRPA1 | GQyFAKPRNQGGyGGssssssyGsGRRF_____________ |
| P09651 | S368 | Sugiyama | HNRNPA1 HNRPA1 | FAKPRNQGGyGGssssssyGsGRRF________________ |
| P09651 | S95 | Sugiyama | HNRNPA1 HNRPA1 | RPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| P09651 | Y366 | Sugiyama | HNRNPA1 HNRPA1 | QyFAKPRNQGGyGGssssssyGsGRRF______________ |
| P09874 | S185 | Sugiyama | PARP1 ADPRT PPOL | KNREELGFRPEYsAsQLKGFsLLAtEDKEALKKQLPGVKSE |
| P09923 | T178 | Sugiyama | ALPI | AGKSVGVVTTTRVQHAsPAGtyAHtVNRNWysDADMPASAR |
| P09923 | T182 | Sugiyama | ALPI | VGVVTTTRVQHAsPAGtyAHtVNRNWysDADMPASARQEGC |
| P0CG38 | T789 | Sugiyama | POTEI | YPMEHGIITNWDDMEKIWHHtFyNELRVAPEEHPILLTEAP |
| P0CG39 | T752 | Sugiyama | POTEJ | YPMEHGIITNWDDMEKIWHHtFyNELRVAPEEHPILLTEAP |
| P0DPH7 | T334 | Sugiyama | TUBA3C TUBA2 | ACCMLYRGDVVPKDVNAAIAtIKtKRTIQFVDWCPTGFKVG |
| P0DPH7 | T41 | Sugiyama | TUBA3C TUBA2 | WELYCLEHGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKH |
| P10412 | S36 | Sugiyama | H1-4 H1F4 HIST1H1E | EKtPVKKKARKsAGAAKRKAsGPPVsELItKAVAASKERsG |
| P10412 | S55 | Sugiyama | H1-4 H1F4 HIST1H1E | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P10412 | S58 | Sugiyama | H1-4 H1F4 HIST1H1E | PPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEKNNS |
| P10515 | S98 | Sugiyama | DLAT DLTA | LGSPGRRYYSLPPHQKVPLPsLsPtMQAGtIARWEKKEGDK |
| P10515 | T102 | Sugiyama | DLAT DLTA | GRRYYSLPPHQKVPLPsLsPtMQAGtIARWEKKEGDKINEG |
| P10515 | T107 | Sugiyama | DLAT DLTA | SLPPHQKVPLPsLsPtMQAGtIARWEKKEGDKINEGDLIAE |
| P10809 | S488 | Sugiyama | HSPD1 HSP60 | IKRTLKIPAMtIAKNAGVEGsLIVEKIMQSSsEVGYDAMAG |
| P10809 | T173 | Sugiyama | HSPD1 HSP60 | AELKKQsKPVttPEEIAQVAtIsANGDKEIGNIIsDAMKKV |
| P10809 | T206 | Sugiyama | HSPD1 HSP60 | IsDAMKKVGRKGVITVKDGKtLNDELEIIEGMKFDRGyIsP |
| P10809 | T231 | Sugiyama | HSPD1 HSP60 | LEIIEGMKFDRGyIsPyFINtsKGQKCEFQDAyVLLsEKKI |
| P10809 | Y223 | Sugiyama | HSPD1 HSP60 | DGKtLNDELEIIEGMKFDRGyIsPyFINtsKGQKCEFQDAy |
| P11142 | S340 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | ALRDAKLDKsQIHDIVLVGGstRIPKIQKLLQDFFNGKELN |
| P11142 | S432 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VLIKRNtTIPTKQtQtFttysDNQPGVLIQVyEGERAMTKD |
| P11142 | T138 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | EVSSMVLTKMKEIAEAyLGKtVTNAVVtVPAyFNDsQRQAt |
| P11142 | T145 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | TKMKEIAEAyLGKtVTNAVVtVPAyFNDsQRQAtKDAGtIA |
| P11142 | T163 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VVtVPAyFNDsQRQAtKDAGtIAGLNVLRIINEPtAAAIAy |
| P11142 | T226 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVNHFIAEFK |
| P11142 | T45 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPtN |
| P11142 | T586 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DKQKILDKCNEIINWLDKNQtAEKEEFEHQQKELEKVCNPI |
| P11142 | T66 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQsD |
| P11586 | S129 | Sugiyama | MTHFD1 MTHFC MTHFD | INTEEVINAIAPEKDVDGLtsINAGKLARGDLNDCFIPCtP |
| P11586 | T128 | Sugiyama | MTHFD1 MTHFC MTHFD | SINTEEVINAIAPEKDVDGLtsINAGKLARGDLNDCFIPCt |
| P11940 | T191 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | GRFKSRKEREAELGARAKEFtNVyIKNFGEDMDDERLKDLF |
| P11940 | T319 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | KNLDDGIDDERLRKEFsPFGtItsAKVMMEGGRSKGFGFVC |
| P11940 | T379 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | AtKPLyVALAQRKEERQAHLtNQyMQRMASVRAVPNPVINP |
| P11940 | T71 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | sLGyAyVNFQQPADAERALDtMNFDVIKGKPVRIMWSQRDP |
| P12035 | S211 | Sugiyama | KRT3 | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWN |
| P12268 | S416 | Sugiyama | IMPDH2 IMPD2 | APGEYFFSDGIRLKKyRGMGsLDAMDKHLssQNRyFsEADK |
| P12268 | S508 | Sugiyama | IMPDH2 IMPD2 | LKFEKRtssAQVEGGVHsLHsyEKRLF______________ |
| P12268 | Y509 | Sugiyama | IMPDH2 IMPD2 | KFEKRtssAQVEGGVHsLHsyEKRLF_______________ |
| P12270 | T1039 | Sugiyama | TPR | QDDKRRAIESMEQQLSELKKtLSSVQNEVQEALQRASTALS |
| P12277 | T327 | Sugiyama | CKB CKBB | KFsEVLKRLRLQKRGtGGVDtAAVGGVFDVsNADRLGFSEV |
| P12814 | T490 | Sugiyama | ACTN1 | PsVNARCQKICDQWDNLGALtQKRREALERTEKLLETIDQL |
| P12956 | T302 | Sugiyama | XRCC6 G22P1 | KPPPIKLYRETNEPVKTKTRtFNtstGGLLLPsDtKRSQIY |
| P12956 | T305 | Sugiyama | XRCC6 G22P1 | PIKLYRETNEPVKTKTRtFNtstGGLLLPsDtKRSQIYGSR |
| P13639 | S418 | Sugiyama | EEF2 EF2 | ISKMVPTSDKGRFyAFGRVFsGLVsTGLKVRIMGPNytPGK |
| P13639 | S422 | Sugiyama | EEF2 EF2 | VPTSDKGRFyAFGRVFsGLVsTGLKVRIMGPNytPGKKEDL |
| P13639 | T34 | Sugiyama | EEF2 EF2 | DKKANIRNMsVIAHVDHGKStLtDsLVCKAGIIAsARAGEt |
| P13639 | T484 | Sugiyama | EEF2 EF2 | VPCGNIVGLVGVDQFLVKtGtIttFEHAHNMRVMKFsVsPV |
| P13639 | T5 | Sugiyama | EEF2 EF2 | ________________MVNFtVDQIRAIMDKKANIRNMsVI |
| P13647 | S181 | Sugiyama | KRT5 | IQRVRTEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P13667 | T238 | Sugiyama | PDIA4 ERP70 ERP72 | KAAKELSKRSPPIPLAKVDAtAETDLAKRFDVsGyPTLKIF |
| P13667 | T380 | Sugiyama | PDIA4 ERP70 ERP72 | PEKFQSKYEPRSHMMDVQGstQDsAIKDFVLKyALPLVGHR |
| P13796 | T174 | Sugiyama | LCP1 PLS2 | FNAVGDGIVLCKMINLSVPDtIDERTINKKKLTPFTIQENL |
| P13797 | T177 | Sugiyama | PLS3 | FKAVGDGIVLCKMINLSVPDtIDERAINKKKLTPFIIQENL |
| P13929 | T19 | Sugiyama | ENO3 | __MAMQKIFAREILDsRGNPtVEVDLHtAKGRFRAAVPsGA |
| P13929 | T26 | Sugiyama | ENO3 | IFAREILDsRGNPtVEVDLHtAKGRFRAAVPsGAstGIyEA |
| P14314 | S126 | Sugiyama | PRKCSH G19P1 | yNsGVICENtCKEKGRKEREsLQQMAEVtREGFRLKKILIE |
| P14314 | S478 | Sugiyama | PRKCSH G19P1 | DKFSAMKyEQGtGCWQGPNRstTVRLLCGKEtMVtStTEPS |
| P14314 | T469 | Sugiyama | PRKCSH G19P1 | WGsWIGPDHDKFSAMKyEQGtGCWQGPNRstTVRLLCGKEt |
| P14618 | S202 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | SLQVKQKGADFLVtEVENGGsLGsKKGVNLPGAAVDLPAVs |
| P14618 | S205 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | VKQKGADFLVtEVENGGsLGsKKGVNLPGAAVDLPAVsEKD |
| P14618 | T45 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | TFLEHMCRLDIDsPPItARNtGIICtIGPAsRsVEtLKEMI |
| P14618 | T50 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | MCRLDIDsPPItARNtGIICtIGPAsRsVEtLKEMIKsGMN |
| P14618 | T80 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | tLKEMIKsGMNVARLNFsHGtHEyHAEtIKNVRtAtEsFAs |
| P14618 | T87 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | sGMNVARLNFsHGtHEyHAEtIKNVRtAtEsFAsDPILyRP |
| P14625 | S514 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | LGVIEDHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEK |
| P14625 | S523 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | RtRLAKLLRFQssHHPtDItsLDQyVERMKEKQDKIyFMAG |
| P14625 | T150 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | EELTVKIKCDKEKNLLHVtDtGVGMtREELVKNLGTIAKsG |
| P14625 | T171 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | GVGMtREELVKNLGTIAKsGtsEFLNKMTEAQEDGQSTSEL |
| P14625 | T450 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | LNFVKGVVDsDDLPLNVsREtLQQHKLLKVIRKKLVRKTLD |
| P14625 | T519 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | DHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEKQDKIy |
| P14866 | S544 | Sugiyama | HNRNPL HNRPL P/OKcl.14 | LGVKRPSSVKVFSGKsERsssGLLEWEsKSDALETLGFLNH |
| P15259 | S189 | Sugiyama | PGAM2 PGAMM | EEIVPQIKAGKRVLIAAHGNsLRGIVKHLEGMSDQAIMELN |
| P15259 | T96 | Sugiyama | PGAM2 PGAMM | QMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEEQVKIWR |
| P15311 | T299 | Sugiyama | EZR VIL2 | RILQLCMGNHELYMRRRKPDtIEVQQMKAQAREEKHQKQLE |
| P15531 | S120 | Sugiyama | NME1 NDPKA NM23 | KPGtIRGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELV |
| P15531 | S122 | Sugiyama | NME1 NDPKA NM23 | GtIRGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELVDy |
| P15880 | S206 | Sugiyama | RPS2 RPS4 | GRCGsVLVRLIPAPRGtGIVsAPVPKKLLMMAGIDDCytsA |
| P15880 | T202 | Sugiyama | RPS2 RPS4 | CKVTGRCGsVLVRLIPAPRGtGIVsAPVPKKLLMMAGIDDC |
| P15880 | T230 | Sugiyama | RPS2 RPS4 | PKKLLMMAGIDDCytsARGCtAtLGNFAKATFDAISKTysy |
| P15880 | T232 | Sugiyama | RPS2 RPS4 | KLLMMAGIDDCytsARGCtAtLGNFAKATFDAISKTysyLt |
| P16083 | S80 | Sugiyama | NQO2 NMOR2 | LSNPEVFNyGVEtHEAyKQRsLAsDITDEQKKVREADLVIF |
| P16402 | S37 | Sugiyama | H1-3 H1F3 HIST1H1D | KtPVKKKAKKAGATAGKRKAsGPPVsELItKAVAASKERsG |
| P16402 | S56 | Sugiyama | H1-3 H1F3 HIST1H1D | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P16402 | S59 | Sugiyama | H1-3 H1F3 HIST1H1D | PPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEKNNS |
| P16403 | S36 | Sugiyama | H1-2 H1F2 HIST1H1C | EKAPVKKKAAKKAGGtPRKAsGPPVsELItKAVAASKERsG |
| P16403 | S55 | Sugiyama | H1-2 H1F2 HIST1H1C | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P16403 | S58 | Sugiyama | H1-2 H1F2 HIST1H1C | PPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEKNNS |
| P16949 | S46 | Sugiyama | STMN1 C1orf215 LAP18 OP18 | PRsKEsVPEFPLsPPKKKDLsLEEIQKKLEAAEERRKsHEA |
| P17066 | T228 | Sugiyama | HSPA6 HSP70B' | DVSVLSIDAGVFEVKAtAGDtHLGGEDFDNRLVNHFMEEFR |
| P17987 | S35 | Sugiyama | TCP1 CCT1 CCTA | EtIRsQNVMAAAsIANIVKssLGPVGLDKMLVDDIGDVTIT |
| P18621 | S111 | Sugiyama | RPL17 | LLHMLKNAESNAELKGLDVDsLVIEHIQVNKAPKMRRRTYR |
| P18621 | T29 | Sugiyama | RPL17 | ENPtKsCKSRGSNLRVHFKNtRETAQAIKGMHIRKATKYLK |
| P18669 | S189 | Sugiyama | PGAM1 PGAMA CDABP0006 | EEIVPQIKEGKRVLIAAHGNsLRGIVKHLEGLSEEAIMELN |
| P18669 | T96 | Sugiyama | PGAM1 PGAMA CDABP0006 | QMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEAQVKIWR |
| P19338 | S460 | Sugiyama | NCL | ADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNST |
| P19338 | T301 | Sugiyama | NCL | KKEMAKQKAAPEAKKQKVEGtEPttAFNLFVGNLNFNKSAP |
| P19338 | T304 | Sugiyama | NCL | MAKQKAAPEAKKQKVEGtEPttAFNLFVGNLNFNKSAPELK |
| P19338 | T464 | Sugiyama | NCL | KTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNSTWsGE |
| P20042 | S67 | Sugiyama | EIF2S2 EIF2B | EPtEDKDLEADEEDTRKKDAsDDLDDLNFFNQKKKKKKTKK |
| P20290 | S126 | Sugiyama | BTF3 NACB OK/SW-cl.8 | VNMFTNQGTVIHFNNPKVQAsLAANtFtItGHAEtKQLTEM |
| P20290 | T131 | Sugiyama | BTF3 NACB OK/SW-cl.8 | NQGTVIHFNNPKVQAsLAANtFtItGHAEtKQLTEMLPsIL |
| P20290 | T133 | Sugiyama | BTF3 NACB OK/SW-cl.8 | GTVIHFNNPKVQAsLAANtFtItGHAEtKQLTEMLPsILNQ |
| P20618 | S157 | Sugiyama | PSMB1 PSC5 | IIGGLDEEGKGAVysFDPVGsyQRDsFKAGGSASAMLQPLL |
| P20618 | S162 | Sugiyama | PSMB1 PSC5 | DEEGKGAVysFDPVGsyQRDsFKAGGSASAMLQPLLDNQVG |
| P20618 | Y158 | Sugiyama | PSMB1 PSC5 | IGGLDEEGKGAVysFDPVGsyQRDsFKAGGSASAMLQPLLD |
| P22090 | S204 | Sugiyama | RPS4Y1 RPS4Y PRO2646 | IGGANLGRVGVITNRERHPGsFDVVHVKDANGNSFATRLSN |
| P22314 | T600 | Sugiyama | UBA1 A1S9T UBE1 | ARMYMDRRCVYYRKPLLESGtLGtKGNVQVVIPFLTESySS |
| P22314 | T633 | Sugiyama | UBA1 A1S9T UBE1 | FLTESySSSQDPPEKSIPICtLKNFPNAIEHTLQWARDEFE |
| P22314 | T682 | Sugiyama | UBA1 A1S9T UBE1 | NVNQyLtDPKFVERtLRLAGtQPLEVLEAVQRSLVLQRPQT |
| P22626 | S212 | Sugiyama | HNRNPA2B1 HNRPA2B1 | EMQEVQssRsGRGGNFGFGDsRGGGGNFGPGPGsNFRGGsD |
| P22626 | T140 | Sugiyama | HNRNPA2B1 HNRPA2B1 | KEDTEEHHLRDyFEEYGKIDtIEIItDRQsGKKRGFGFVtF |
| P23246 | S283 | Sugiyama | SFPQ PSF | GPGGRsEEKIsDsEGFKANLsLLRRPGEKTyTQRCRLFVGN |
| P23284 | T108 | Sugiyama | PPIB CYPB | YKNSKFHRVIKDFMIQGGDFtRGDGtGGKsIyGERFPDENF |
| P23381 | S378 | Sugiyama | WARS1 IFI53 WARS WRS | sIFLtDtAKQIKTKVNKHAFsGGRDtIEEHRQFGGNCDVDV |
| P23381 | T383 | Sugiyama | WARS1 IFI53 WARS WRS | DtAKQIKTKVNKHAFsGGRDtIEEHRQFGGNCDVDVSFMYL |
| P23528 | T63 | Sugiyama | CFL1 CFL | DKKNIILEEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyA |
| P23528 | T70 | Sugiyama | CFL1 CFL | EEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyALyDAtyE |
| P23588 | S359 | Sugiyama | EIF4B | RstPKEDDSsASTSQSTRAAsIFGGAKPVDtAAREREVEER |
| P23588 | T369 | Sugiyama | EIF4B | ASTSQSTRAAsIFGGAKPVDtAAREREVEERLQKEQEKLQR |
| P23921 | T751 | Sugiyama | RRM1 RR1 | GLKTGMYyLRTRPAANPIQFtLNKEKLKDKEKVSKEEEEKE |
| P24752 | S69 | Sugiyama | ACAT1 ACAT MAT | RTPIGSFLGSLSLLPATKLGsIAIQGAIEKAGIPKEEVKEA |
| P25705 | S198 | Sugiyama | ATP5F1A ATP5A ATP5A1 ATP5AL2 ATPM | GIIPRIsVREPMQTGIKAVDsLVPIGRGQRELIIGDRQTGK |
| P25786 | T11 | Sugiyama | PSMA1 HC2 NU PROS30 PSC2 | __________MFRNQyDNDVtVWsPQGRIHQIEYAMEAVKQ |
| P25789 | T10 | Sugiyama | PSMA4 HC9 PSC9 | ___________MSRRyDsRttIFsPEGRLYQVEYAMEAIGH |
| P25789 | Y5 | Sugiyama | PSMA4 HC9 PSC9 | ________________MSRRyDsRttIFsPEGRLYQVEYAM |
| P26038 | S576 | Sugiyama | MSN | YKtLRQIRQGNTKQRIDEFEsM___________________ |
| P26038 | T299 | Sugiyama | MSN | RILALCMGNHELYMRRRKPDtIEVQQMKAQAREEKHQKQME |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P26373 | T148 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PRKPSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARV |
| P26373 | T151 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARVItE |
| P26373 | T24 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | SRNGMVLKPHFHKDWQRRVAtWFNQPARKIRRRKARQAKAR |
| P26641 | T150 | Sugiyama | EEF1G EF1G PRO1608 | NAKEEVRRILGLLDAYLKTRtFLVGERVTLADITVVCTLLW |
| P26641 | T287 | Sugiyama | EEF1G EF1G PRO1608 | EQALAAEPKAKDPFAHLPKstFVLDEFKRKysNEDtLsVAL |
| P27144 | S195 | Sugiyama | AK4 AK3 AK3L1 | KDVAKPVIELYKSRGVLHQFsGtEtNKIWPYVYTLFSNKIT |
| P27144 | T199 | Sugiyama | AK4 AK3 AK3L1 | KPVIELYKSRGVLHQFsGtEtNKIWPYVYTLFSNKITPIQS |
| P27348 | S45 | Sugiyama | YWHAQ | CMKAVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSI |
| P28066 | T161 | Sugiyama | PSMA5 | LLFGGVDEKGPQLFHMDPsGtFVQCDARAIGsAsEGAQssL |
| P29401 | S124 | Sugiyama | TKT | ssDLDGHPVPKQAFtDVATGsLGQGLGAACGMAYTGKYFDK |
| P29401 | T346 | Sugiyama | TKT | AKLGHAsDRIIALDGDtKNstFsEIFKKEHPDRFIECYIAE |
| P29692 | S119 | Sugiyama | EEF1D EF1D | QELQQAIsKLEARLNVLEKssPGHRAtAPQtQHVsPMRQVE |
| P29692 | S60 | Sugiyama | EEF1D EF1D | ENGAsVILRDIARARENIQKsLAGssGPGAssGtsGDHGEL |
| P29692 | T125 | Sugiyama | EEF1D EF1D | IsKLEARLNVLEKssPGHRAtAPQtQHVsPMRQVEPPAKKP |
| P29692 | T129 | Sugiyama | EEF1D EF1D | EARLNVLEKssPGHRAtAPQtQHVsPMRQVEPPAKKPAtPA |
| P30040 | S244 | Sugiyama | ERP29 C12orf8 ERP28 | IARLIEKNKMSDGKKEELQKsLNILtAFQKKGAEKEEL___ |
| P30040 | T249 | Sugiyama | ERP29 C12orf8 ERP28 | EKNKMSDGKKEELQKsLNILtAFQKKGAEKEEL________ |
| P30043 | T199 | Sugiyama | BLVRB FLR SCAN | HDLGHFMLRCLttDEyDGHstyPsHQyQ_____________ |
| P30048 | S199 | Sugiyama | PRDX3 AOP1 | SGLALRGLFIIDPNGVIKHLsVNDLPVGRSVEETLRLVKAF |
| P30048 | S86 | Sugiyama | PRDX3 AOP1 | TQHAPYFKGTAVVNGEFKDLsLDDFKGKYLVLFFYPLDFTF |
| P30050 | T128 | Sugiyama | RPL12 | EIVNIARQMRHRSLARELsGtIKEILGtAQsVGCNVDGRHP |
| P30050 | T135 | Sugiyama | RPL12 | QMRHRSLARELsGtIKEILGtAQsVGCNVDGRHPHDIIDDI |
| P30050 | T18 | Sugiyama | RPL12 | ___MPPKFDPNEIKVVYLRCtGGEVGAtsALAPKIGPLGLs |
| P30050 | T25 | Sugiyama | RPL12 | FDPNEIKVVYLRCtGGEVGAtsALAPKIGPLGLsPKKVGDD |
| P30086 | S52 | Sugiyama | PEBP1 PBP PEBP | AAVDELGKVLtPtQVKNRPtsIsWDGLDsGKLytLVLtDPD |
| P30086 | S60 | Sugiyama | PEBP1 PBP PEBP | VLtPtQVKNRPtsIsWDGLDsGKLytLVLtDPDAPsRKDPK |
| P30086 | T101 | Sugiyama | PEBP1 PBP PEBP | YREWHHFLVVNMKGNDIssGtVLsDyVGsGPPKGtGLHRyV |
| P30086 | T115 | Sugiyama | PEBP1 PBP PEBP | NDIssGtVLsDyVGsGPPKGtGLHRyVWLVyEQDRPLKCDE |
| P30086 | T167 | Sugiyama | PEBP1 PBP PEBP | GKFKVAsFRKKyELRAPVAGtCyQAEWDDyVPKLyEQLsGK |
| P30101 | T485 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | KKyEGGRELsDFIsyLQREAtNPPVIQEEKPKKKKKAQEDL |
| P30626 | T130 | Sugiyama | SRI | IsFDTDRSGTVDPQELQKALttMGFRLsPQAVNSIAKRYst |
| P30626 | T131 | Sugiyama | SRI | sFDTDRSGTVDPQELQKALttMGFRLsPQAVNSIAKRYstN |
| P30740 | S72 | Sugiyama | SERPINB1 ELANH2 MNEI PI2 | AQLSKTFHFNTVEEVHSRFQsLNADINKRGASYILKLANRL |
| P31153 | T262 | Sugiyama | MAT2A AMS2 MATA2 | yHLQPsGRFVIGGPQGDAGLtGRKIIVDTYGGWGAHGGGAF |
| P31943 | S269 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | YNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGstFQsttGH |
| P31943 | T282 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | RDLNyCFsGMsDHRyGDGGstFQsttGHCVHMRGLPYRAtE |
| P31943 | T286 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | yCFsGMsDHRyGDGGstFQsttGHCVHMRGLPYRAtENDIy |
| P31946 | S47 | Sugiyama | YWHAB | AMKAVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P31947 | S45 | Sugiyama | SFN HME1 | FMKGAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsI |
| P31948 | T145 | Sugiyama | STIP1 | MNPFNMPNLYQKLESDPRtRtLLSDPTYRELIEQLRNKPSD |
| P32929 | T372 | Sugiyama | CTH | AIMtHASVLKNDRDVLGISDtLIRLsVGLEDEEDLLEDLDQ |
| P32969 | T186 | Sugiyama | RPL9 OK/SW-cl.103; RPL9P7; RPL9P8; RPL9P9 | TVKNKDIRKFLDGIyVsEKGtVQQADE______________ |
| P33992 | S417 | Sugiyama | MCM5 CDC46 | CsPIGVytsGKGSSAAGLtAsVMRDPssRNFIMEGGAMVLA |
| P34931 | T228 | Sugiyama | HSPA1L | DVSILTIDDGIFEVKAtAGDtHLGGEDFDNRLVsHFVEEFK |
| P34931 | T47 | Sugiyama | HSPA1L | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPQN |
| P35241 | T299 | Sugiyama | RDX | RILALCMGNHELYMRRRKPDtIEVQQMKAQAREEKHQKQLE |
| P35579 | S304 | Sugiyama | MYH9 | AGEHLKTDLLLEPyNKyRFLsNGHVtIPGQQDKDMFQETME |
| P35579 | T1208 | Sugiyama | MYH9 | QEMRQKHsQAVEELAEQLEQtKRVKANLEKAKQtLENERGE |
| P35579 | T309 | Sugiyama | MYH9 | KTDLLLEPyNKyRFLsNGHVtIPGQQDKDMFQETMEAMRIM |
| P35637 | S462 | Sugiyama | FUS TLS | NECNQCKAPKPDGPGGGPGGsHMGGNyGDDRRGGRGGYDRG |
| P35908 | S191 | Sugiyama | KRT2 KRT2A KRT2E | IQNVKAQEREQIKTLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| P36578 | S131 | Sugiyama | RPL4 RPL1 | WHRRVNTTQKRyAICSALAAsALPALVMsKGHRIEEVPELP |
| P36578 | S139 | Sugiyama | RPL4 RPL1 | QKRyAICSALAAsALPALVMsKGHRIEEVPELPLVVEDKVE |
| P36578 | S87 | Sugiyama | RPL4 RPL1 | WGtGRAVARIPRVRGGGtHRsGQGAFGNMCRGGRMFAPTKT |
| P36578 | T69 | Sugiyama | RPL4 RPL1 | RQPyAVsELAGHQtsAEsWGtGRAVARIPRVRGGGtHRsGQ |
| P36578 | T84 | Sugiyama | RPL4 RPL1 | AEsWGtGRAVARIPRVRGGGtHRsGQGAFGNMCRGGRMFAP |
| P36578 | Y122 | Sugiyama | RPL4 RPL1 | FAPTKTWRRWHRRVNTTQKRyAICSALAAsALPALVMsKGH |
| P37802 | T180 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | RNFsDNQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL_ |
| P37802 | T190 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | GKNVIGLQMGtNRGAsQAGMtGyGMPRQIL___________ |
| P37802 | T84 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | ELINALYPEGQAPVKKIQAstMAFKQMEQIsQFLQAAERYG |
| P38646 | T116 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | DGERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKD |
| P38646 | T120 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | LVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIKNV |
| P38646 | T86 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | CVAVMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAK |
| P38646 | Y118 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | ERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIK |
| P39019 | T55 | Sugiyama | RPS19 | DtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGsM |
| P39019 | Y54 | Sugiyama | RPS19 | VDtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGs |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P39023 | S265 | Sugiyama | RPL3 OK/SW-cl.32 | HRGLRKVACIGAWHPARVAFsVARAGQKGYHHRTEINKKIY |
| P39023 | T189 | Sugiyama | RPL3 OK/SW-cl.32 | RLLPLRQKKAHLMEIQVNGGtVAEKLDWARERLEQQVPVNQ |
| P39687 | S117 | Sugiyama | ANP32A C15orf1 LANP MAPM PHAP1 | GNKIKDLstIEPLKKLENLKsLDLFNCEVtNLNDyRENVFK |
| P39748 | S255 | Sugiyama | FEN1 RAD2 | CESIRGIGPKRAVDLIQKHKsIEEIVRRLDPNKYPVPENWL |
| P40227 | T147 | Sugiyama | CCT6A CCT6 CCTZ | KEKALQFLEEVKVSREMDREtLIDVARTSLRTKVHAELADV |
| P40227 | T82 | Sugiyama | CCT6A CCT6 CCTZ | VLLHEMQIQHPTASLIAKVAtAQDDITGDGTTsNVLIIGEL |
| P40261 | S213 | Sugiyama | NNMT | LVIMDALKSSYYMIGEQKFSsLPLGREAVEAAVKEAGYTIE |
| P40429 | T155 | Sugiyama | RPL13A | FAYLGRLAHEVGWKyQAVtAtLEEKRKEKAKIHYRKKKQLM |
| P41091 | T41 | Sugiyama | EIF2S3 EIF2G | ttLDVtKLTPLSHEVISRQAtINIGtIGHVAHGKSTVVKAI |
| P41091 | T46 | Sugiyama | EIF2S3 EIF2G | tKLTPLSHEVISRQAtINIGtIGHVAHGKSTVVKAISGVHt |
| P42166 | T137 | Sugiyama | TMPO LAP2 | NEDLLDQLVKyGVNPGPIVGttRKLYEKKLLKLREQGtEsR |
| P42167 | T137 | Sugiyama | TMPO LAP2 | NEDLLDQLVKyGVNPGPIVGtTRKLYEKKLLKLREQGTESR |
| P42677 | S78 | Sugiyama | RPS27 MPS1 | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| P43243 | S188 | Sugiyama | MATR3 KIAA0723 | EPPyRVPRDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRs |
| P46776 | T72 | Sugiyama | RPL27A | yFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRVNAAK |
| P46776 | T95 | Sugiyama | RPL27A | LDKLWtLVsEQtRVNAAKNKtGAAPIIDVVRsGyyKVLGKG |
| P46776 | Y52 | Sugiyama | RPL27A | RGNAGGLHHHRINFDKyHPGyFGKVGMKHYHLKRNQsFCPt |
| P46777 | S172 | Sugiyama | RPL5 MSTP030 | RTTTGNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNA |
| P46777 | T177 | Sugiyama | RPL5 MSTP030 | NKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNAEVHRK |
| P46778 | T124 | Sugiyama | RPL21 | sFLKRVKENDQKKKEAKEKGtWVQLKRQPAPPREAHFVRTN |
| P46782 | S75 | Sugiyama | RPS5 | RYAAKRFRKAQCPIVERLtNsMMMHGRNNGKKLMTVRIVKH |
| P46783 | S146 | Sugiyama | RPS10 | TYRRSAVPPGADKKAEAGAGsAtEFQFRGGFGRGRGQPPQ_ |
| P46783 | T148 | Sugiyama | RPS10 | RRSAVPPGADKKAEAGAGsAtEFQFRGGFGRGRGQPPQ___ |
| P47712 | S729 | Sugiyama | PLA2G4A CPLA2 PLA2G4 | KEAMVESIEyRRQNPsRCsVsLsNVEARRFFNKEFLSKPKA |
| P47756 | S192 | Sugiyama | CAPZB | TVMLWLQTNKSGsGtMNLGGsLtRQMEKDEtVsDCsPHIAN |
| P48643 | S51 | Sugiyama | CCT5 CCTE KIAA0098 | LEALKSHIMAAKAVANtMRtsLGPNGLDKMMVDKDGDVtVT |
| P48643 | T47 | Sugiyama | CCT5 CCTE KIAA0098 | RLMGLEALKSHIMAAKAVANtMRtsLGPNGLDKMMVDKDGD |
| P48643 | T50 | Sugiyama | CCT5 CCTE KIAA0098 | GLEALKSHIMAAKAVANtMRtsLGPNGLDKMMVDKDGDVtV |
| P48668 | S176 | Sugiyama | KRT6C KRT6E | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P48741 | T228 | Sugiyama | HSPA7 HSP70B | DVSVLSIDAGVFEVKAtAGDtHLGGEDFDNRLVNHFMEEFR |
| P49327 | T1999 | Sugiyama | FASN FAS | LLENQTPEFFQDVCKPKYsGtLNLDRVTREACPELDYFVVF |
| P49327 | T715 | Sugiyama | FASN FAS | LQELKKVIREPKPRSARWLstsIPEAQWHssLARTSSAEYN |
| P49368 | T430 | Sugiyama | CCT3 CCTG TRIC5 | GGGASEMAVAHALTEKSKAMtGVEQWPyRAVAQALEVIPRT |
| P49368 | T459 | Sugiyama | CCT3 CCTG TRIC5 | AVAQALEVIPRTLIQNCGAstIRLLtSLRAKHtQENCEtWG |
| P49411 | T433 | Sugiyama | TUFM | LRQPMILEKGQRFTLRDGNRtIGTGLVTNTLAMTEEEKNIK |
| P49589 | S34 | Sugiyama | CARS1 CARS | VQPQWsPPAGtQPCRLHLyNsLtRNKEVFIPQDGKKVTWYC |
| P49841 | S9 | SIGNOR|EPSD|PSP | GSK3B | ____________MSGRPRttsFAEsCKPVQQPsAFGsMKVS |
| P50395 | T425 | Sugiyama | GDI2 RABGDIB | DAttHFEttCDDIKNIYKRMtGsEFDFEEMKRKKNDIYGED |
| P50914 | T43 | Sugiyama | RPL14 | KLVAIVDVIDQNRALVDGPCtQVRRQAMPFKCMQLTDFILK |
| P50990 | S162 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | ILPNLVCCsAKNLRDIDEVssLLRTSIMSKQyGNEVFLAKL |
| P50990 | T374 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | EVGDTQVVVFKHEKEDGAIstIVLRGstDNLMDDIERAVDD |
| P50991 | T69 | Sugiyama | CCT4 CCTD SRB | RtsLGPKGMDKMIQDGKGDVtItNDGAtILKQMQVLHPAAR |
| P50991 | T76 | Sugiyama | CCT4 CCTD SRB | GMDKMIQDGKGDVtItNDGAtILKQMQVLHPAARMLVELSK |
| P51149 | T168 | Sugiyama | RAB7A RAB7 | NIPyFEtSAKEAINVEQAFQtIARNALKQETEVELyNEFPE |
| P51858 | S83 | Sugiyama | HDGF HMG1L2 | LFPyEEsKEKFGKPNKRKGFsEGLWEIENNPtVKASGYQSs |
| P51858 | T184 | Sugiyama | HDGF HMG1L2 | DsPKRPKEAENPEGEEKEAAtLEVERPLPMEVEKNstPsEP |
| P51858 | T94 | Sugiyama | HDGF HMG1L2 | GKPNKRKGFsEGLWEIENNPtVKASGYQSsQKKsCVEEPEP |
| P51858 | Y23 | Sugiyama | HDGF HMG1L2 | RSNRQKEYKCGDLVFAKMKGyPHWPARIDEMPEAAVKstAN |
| P51991 | S370 | Sugiyama | HNRNPA3 HNRPA3 | sFGGRssGsPyGGGyGsGGGsGGyGsRRF____________ |
| P53621 | T821 | Sugiyama | COPA | IMPLDTNWPLLTVSKGFFEGtIAsKGKGGALAADIDIDTVG |
| P54652 | T229 | Sugiyama | HSPA2 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVSHLAEEFK |
| P54652 | T46 | Sugiyama | HSPA2 | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPTN |
| P55036 | S358 | Sugiyama | PSMD4 MCB1 | VLENLPGVDPNNEAIRNAMGsLAsQATKDGKKDKKEEDKK_ |
| P55060 | S931 | Sugiyama | CSE1L CAS XPO2 | KKEHDPVGQMVNNPKIHLAQsLHKLSTACPGRVPSMVSTSL |
| P55209 | S69 | Sugiyama | NAP1L1 NRP | LAALQERLDGLVEtPtGyIEsLPRVVKRRVNALKNLQVKCA |
| P55209 | T64 | Sugiyama | NAP1L1 NRP | QNPQILAALQERLDGLVEtPtGyIEsLPRVVKRRVNALKNL |
| P55209 | Y66 | Sugiyama | NAP1L1 NRP | PQILAALQERLDGLVEtPtGyIEsLPRVVKRRVNALKNLQV |
| P55795 | S269 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | YNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGssFQstTGH |
| P56192 | S127 | Sugiyama | MARS1 MARS | GKKGEDVLGSVRRALTHIDHsLSRQNCPFLAGETESLADIV |
| P56192 | S812 | Sugiyama | MARS1 MARS | GHQIGTVSPLFQKLENDQIEsLRQRFGGGQAKtsPKPAVVE |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60174 | T173 | Sugiyama | TPI1 TPI | DNVKDWSKVVLAyEPVWAIGtGKtATPQQAQEVHEKLRGWL |
| P60174 | T217 | Sugiyama | TPI1 TPI | VsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLVGGAsL |
| P60174 | T76 | Sugiyama | TPI1 TPI | LDPKIAVAAQNCyKVTNGAFtGEIsPGMIKDCGAtWVVLGH |
| P60660 | Y86 | Sugiyama | MYL6 | DFEHFLPMLQTVAKNKDQGtyEDyVEGLRVFDKEGNGtVMG |
| P60709 | S199 | Sugiyama | ACTB | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P60709 | S323 | Sugiyama | ACTB | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P60709 | S60 | Sugiyama | ACTB | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P60709 | T201 | Sugiyama | ACTB | AGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVAL |
| P60709 | T203 | Sugiyama | ACTB | RDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVALDF |
| P60709 | T249 | Sugiyama | ACTB | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P60709 | T324 | Sugiyama | ACTB | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P60709 | T89 | Sugiyama | ACTB | YPIEHGIVTNWDDMEKIWHHtFyNELRVAPEEHPVLLtEAP |
| P60709 | Y188 | Sugiyama | ACTB | GyALPHAILRLDLAGRDLTDyLMKILtERGysFtttAEREI |
| P60709 | Y53 | Sugiyama | ACTB | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P60842 | T80 | Sugiyama | EIF4A1 DDX2A EIF4A | QRAILPCIKGyDVIAQAQsGtGKTATFAISILQQIELDLKA |
| P61221 | S186 | Sugiyama | ABCE1 RLI RNASEL1 RNASELI RNS4I OK/SW-cl.40 | AIIKPQYVDQIPKAAKGtVGsILDRKDETKTQAIVCQQLDL |
| P61221 | T183 | Sugiyama | ABCE1 RLI RNASEL1 RNASELI RNS4I OK/SW-cl.40 | DLKAIIKPQYVDQIPKAAKGtVGsILDRKDETKTQAIVCQQ |
| P61247 | S203 | Sugiyama | RPS3A FTE1 MFTL | EVVNKLIPDsIGKDIEKACQsIyPLHDVFVRKVKMLKKPKF |
| P61247 | S237 | Sugiyama | RPS3A FTE1 MFTL | MLKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGyE |
| P61247 | S238 | Sugiyama | RPS3A FTE1 MFTL | LKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGyEP |
| P61247 | S263 | Sugiyama | RPS3A FTE1 MFTL | GDEtGAKVERADGyEPPVQEsV___________________ |
| P61254 | S23 | Sugiyama | RPL26 | FNPFVtsDRsKNRKRHFNAPsHIRRKIMssPLSKELRQKYN |
| P61254 | T8 | Sugiyama | RPL26 | _____________MKFNPFVtsDRsKNRKRHFNAPsHIRRK |
| P61254 | T93 | Sugiyama | RPL26 | VYRKKyVIyIERVQREKANGttVHVGIHPSKVVITRLKLDK |
| P61313 | T80 | Sugiyama | RPL15 EC45 TCBAP0781 | VIyRIRVRRGGRKRPVPKGAtyGKPVHHGVNQLKFARsLQs |
| P61313 | Y6 | Sugiyama | RPL15 EC45 TCBAP0781 | _______________MGAYKyIQELWRKKQSDVMRFLLRVR |
| P61513 | S21 | Sugiyama | RPL37A | MAKRTKKVGIVGKyGtRYGAsLRKMVKKIEISQHAKYTCSF |
| P61513 | T16 | Sugiyama | RPL37A | _____MAKRTKKVGIVGKyGtRYGAsLRKMVKKIEISQHAK |
| P61513 | Y14 | Sugiyama | RPL37A | _______MAKRTKKVGIVGKyGtRYGAsLRKMVKKIEISQH |
| P61604 | T79 | Sugiyama | HSPE1 | EIQPVsVKVGDKVLLPEyGGtKVVLDDKDyFLFRDGDILGK |
| P61604 | Y76 | Sugiyama | HSPE1 | KGGEIQPVsVKVGDKVLLPEyGGtKVVLDDKDyFLFRDGDI |
| P61758 | S157 | Sugiyama | VBP1 PFDN3 | IDEAQALLEKNLSTATKNLDsLEEDLDFLRDQFTtTEVNMA |
| P61758 | T171 | Sugiyama | VBP1 PFDN3 | ATKNLDsLEEDLDFLRDQFTtTEVNMARVyNWDVKRRNKDD |
| P61916 | T44 | Sugiyama | NPC2 HE1 | FKDCGsVDGVIKEVNVsPCPtQPCQLSKGQSYSVNVTFTSN |
| P61970 | S58 | Sugiyama | NUTF2 NTF2 | CLTWEGQQFQGKAAIVEKLssLPFQKIQHSITAQDHQPTPD |
| P61978 | S401 | Sugiyama | HNRNPK HNRPK | GDLGGPIIttQVtIPKDLAGsIIGKGGQRIKQIRHEsGAsI |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P61981 | S46 | Sugiyama | YWHAG | AMKNVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P62081 | T172 | Sugiyama | RPS7 | RLIKVHLDKAQQNNVEHKVEtFsGVyKKLTGKDVNFEFPEF |
| P62241 | S160 | Sugiyama | RPS8 OK/SW-cl.83 | KRSKKIQKKYDERKKNAKIssLLEEQFQQGKLLACIASRPG |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62258 | S148 | Sugiyama | YWHAE | YHRyLAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHP |
| P62258 | S46 | Sugiyama | YWHAE | SMKKVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssI |
| P62258 | T114 | Sugiyama | YWHAE | KLICCDILDVLDKHLIPAANtGEsKVFyyKMKGDYHRyLAE |
| P62263 | S139 | Sugiyama | RPS14 PRO2640 | LARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL________ |
| P62263 | S69 | Sugiyama | RPS14 PRO2640 | GKETICRVTGGMKVKADRDEssPyAAMLAAQDVAQRCKELG |
| P62263 | T140 | Sugiyama | RPS14 PRO2640 | ARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL_________ |
| P62266 | S45 | Sugiyama | RPS23 | KQYKKAHLGtALKANPFGGAsHAKGIVLEKVGVEAKQPNSA |
| P62266 | T34 | Sugiyama | RPS23 | RSHRRDQKWHDKQYKKAHLGtALKANPFGGAsHAKGIVLEK |
| P62269 | T60 | Sugiyama | RPS18 D6S218E | YAHVVLRKADIDLTKRAGELtEDEVERVItIMQNPRQYKIP |
| P62269 | T69 | Sugiyama | RPS18 D6S218E | DIDLTKRAGELtEDEVERVItIMQNPRQYKIPDWFLNRQKD |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62277 | T24 | Sugiyama | RPS13 | MHAPGKGLsQsALPyRRsVPtWLKLTsDDVKEQIyKLAKKG |
| P62280 | S74 | Sugiyama | RPS11 | tyIDKKCPFTGNVsIRGRILsGVVTKMKMQRTIVIRRDYLH |
| P62280 | T54 | Sugiyama | RPS11 | PRYYKNIGLGFKtPKEAIEGtyIDKKCPFTGNVsIRGRILs |
| P62424 | T142 | Sugiyama | RPL7A SURF-3 SURF3 | AAGKGDVPTKRPPVLRAGVNtVttLVENKKAQLVVIAHDVD |
| P62424 | T145 | Sugiyama | RPL7A SURF-3 SURF3 | KGDVPTKRPPVLRAGVNtVttLVENKKAQLVVIAHDVDPIE |
| P62424 | T84 | Sugiyama | RPL7A SURF-3 SURF3 | QRQRAILyKRLKVPPAINQFtQALDRQTAtQLLKLAHKYRP |
| P62701 | S204 | Sugiyama | RPS4X CCG2 RPS4 SCAR | tGGANLGRIGVITNRERHPGsFDVVHVKDANGNSFATRLsN |
| P62701 | T177 | Sugiyama | RPS4X CCG2 RPS4 SCAR | NDtIQIDLEtGKITDFIKFDtGNLCMVtGGANLGRIGVITN |
| P62701 | T184 | Sugiyama | RPS4X CCG2 RPS4 SCAR | LEtGKITDFIKFDtGNLCMVtGGANLGRIGVITNRERHPGs |
| P62736 | S325 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62736 | S62 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P62736 | T251 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P62736 | T326 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P62736 | Y190 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | GyALPHAIMRLDLAGRDLTDyLMKILTERGysFVttAEREI |
| P62736 | Y55 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P62750 | T126 | Sugiyama | RPL23A | KHQIKQAVKKLyDIDVAKVNtLIRPDGEKKAYVRLAPDyDA |
| P62826 | S135 | Sugiyama | RAN ARA24 OK/SW-cl.81 | IPIVLCGNKVDIKDRKVKAKsIVFHRKKNLQyyDIsAKSNy |
| P62826 | T21 | Sugiyama | RAN ARA24 OK/SW-cl.81 | MAAQGEPQVQFKLVLVGDGGtGKttFVKRHLtGEFEKKyVA |
| P62826 | T32 | Sugiyama | RAN ARA24 OK/SW-cl.81 | KLVLVGDGGtGKttFVKRHLtGEFEKKyVATLGVEVHPLVF |
| P62851 | T110 | Sugiyama | RPS25 | ELLsKGLIKLVSKHRAQVIytRNtKGGDAPAAGEDA_____ |
| P62851 | T113 | Sugiyama | RPS25 | sKGLIKLVSKHRAQVIytRNtKGGDAPAAGEDA________ |
| P62857 | S41 | Sugiyama | RPS28 | tGsQGQCtQVRVEFMDDtsRsIIRNVKGPVREGDVLtLLEs |
| P62857 | T38 | Sugiyama | RPS28 | LGRtGsQGQCtQVRVEFMDDtsRsIIRNVKGPVREGDVLtL |
| P62857 | T57 | Sugiyama | RPS28 | DtsRsIIRNVKGPVREGDVLtLLEsEREARRLR________ |
| P62899 | S15 | Sugiyama | RPL31 | ______MAPAKKGGEKKKGRsAINEVVtREytINIHKRIHG |
| P62899 | T22 | Sugiyama | RPL31 | APAKKGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRA |
| P62899 | T26 | Sugiyama | RPL31 | KGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRAPRAL |
| P62906 | T9 | Sugiyama | RPL10A NEDD6 | ____________MSSKVsRDtLyEAVREVLHGNQRKRRKFL |
| P62917 | S130 | Sugiyama | RPL8 | GTIVCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKL |
| P62917 | S14 | Sugiyama | RPL8 | _______MGRVIRGQRKGAGsVFRAHVKHRKGAARLRAVDF |
| P62917 | T135 | Sugiyama | RPL8 | CLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSK |
| P62917 | T143 | Sugiyama | RPL8 | RGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSKKVISSANR |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P62937 | T157 | Sugiyama | PPIA CYPA | NIVEAMERFGsRNGKTSKKItIADCGQLE____________ |
| P62942 | T22 | Sugiyama | FKBP1A FKBP1 FKBP12 | GVQVEtIsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRD |
| P62942 | T28 | Sugiyama | FKBP1A FKBP1 FKBP12 | IsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRDRNKPFK |
| P63104 | S45 | Sugiyama | YWHAZ | CMKsVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssI |
| P63104 | T205 | Sugiyama | YWHAZ | PEKACSLAKtAFDEAIAELDtLsEEsyKDstLIMQLLRDNL |
| P63220 | S68 | Sugiyama | RPS21 | GQFKtyAICGAIRRMGEsDDsILRLAKADGIVSKNF_____ |
| P63261 | S199 | Sugiyama | ACTG1 ACTG | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P63261 | S323 | Sugiyama | ACTG1 ACTG | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63261 | S60 | Sugiyama | ACTG1 ACTG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P63261 | T201 | Sugiyama | ACTG1 ACTG | AGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVAL |
| P63261 | T203 | Sugiyama | ACTG1 ACTG | RDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVALDF |
| P63261 | T249 | Sugiyama | ACTG1 ACTG | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P63261 | T324 | Sugiyama | ACTG1 ACTG | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P63261 | T89 | Sugiyama | ACTG1 ACTG | YPIEHGIVTNWDDMEKIWHHtFyNELRVAPEEHPVLLtEAP |
| P63261 | Y188 | Sugiyama | ACTG1 ACTG | GyALPHAILRLDLAGRDLTDyLMKILtERGysFtttAEREI |
| P63261 | Y53 | Sugiyama | ACTG1 ACTG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P63267 | S324 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P63267 | S61 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P63267 | T250 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P63267 | T325 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P63267 | Y189 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | GyALPHAIMRLDLAGRDLTDyLMKILTERGysFVttAEREI |
| P63267 | Y54 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P67809 | S102 | Sugiyama | YBX1 NSEP1 YB1 | EDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEA |
| P67809 | S209 | Sugiyama | YBX1 NSEP1 YB1 | RRRRFPPyyMRRPYGRRPQysNPPVQGEVMEGADNQGAGEQ |
| P67809 | T108 | Sugiyama | YBX1 NSEP1 YB1 | QtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEAANVtGP |
| P67936 | T237 | Sugiyama | TPM4 | IDDLEEKLAQAKEENVGLHQtLDQtLNELNCI_________ |
| P68032 | S325 | Sugiyama | ACTC1 ACTC | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68032 | S62 | Sugiyama | ACTC1 ACTC | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68032 | T251 | Sugiyama | ACTC1 ACTC | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68032 | T326 | Sugiyama | ACTC1 ACTC | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68032 | T91 | Sugiyama | ACTC1 ACTC | yPIEHGIItNWDDMEKIWHHtFyNELRVAPEEHPtLLTEAP |
| P68032 | Y190 | Sugiyama | ACTC1 ACTC | GyALPHAIMRLDLAGRDLTDyLMKILTERGysFVttAEREI |
| P68032 | Y55 | Sugiyama | ACTC1 ACTC | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68104 | T23 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | KEKtHINIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKFE |
| P68104 | T261 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | PTDKPLRLPLQDVyKIGGIGtVPVGRVEtGVLKPGMVVtFA |
| P68104 | T269 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | PLQDVyKIGGIGtVPVGRVEtGVLKPGMVVtFAPVNVttEV |
| P68104 | T279 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | IGtVPVGRVEtGVLKPGMVVtFAPVNVttEVKsVEMHHEAL |
| P68104 | T432 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| P68133 | S325 | Sugiyama | ACTA1 ACTA | TTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68133 | S62 | Sugiyama | ACTA1 ACTA | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68133 | T251 | Sugiyama | ACTA1 ACTA | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68133 | T326 | Sugiyama | ACTA1 ACTA | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68133 | T91 | Sugiyama | ACTA1 ACTA | yPIEHGIItNWDDMEKIWHHtFyNELRVAPEEHPtLLTEAP |
| P68133 | Y190 | Sugiyama | ACTA1 ACTA | GyALPHAIMRLDLAGRDLTDyLMKILTERGysFVttAEREI |
| P68133 | Y55 | Sugiyama | ACTA1 ACTA | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68363 | T334 | Sugiyama | TUBA1B | ACCLLyRGDVVPKDVNAAIAtIKtKRsIQFVDWCPTGFKVG |
| P68363 | T41 | Sugiyama | TUBA1B | WELYCLEHGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKH |
| P68431 | T46 | Sugiyama | H3C1 H3FA HIST1H3A; H3C2 H3FL HIST1H3B; H3C3 H3FC HIST1H3C; H3C4 H3FB HIST1H3D; H3C6 H3FD HIST1H3E; H3C7 H3FI HIST1H3F; H3C8 H3FH HIST1H3G; H3C10 H3FK HIST1H3H; H3C11 H3FF HIST1H3I; H3C12 H3FJ HIST1H3J | ARKsAPATGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| P78371 | T474 | Sugiyama | CCT2 99D8.1 CCTB | AGYDSADLVAQLRAAHsEGNttAGLDMREGTIGDMAILGIT |
| P78371 | T69 | Sugiyama | CCT2 99D8.1 CCTB | DKILLsSGRDAsLMVtNDGAtILKNIGVDNPAAKVLVDMSR |
| P83731 | S86 | Sugiyama | RPL24 | EIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKAQRE |
| P83731 | T83 | Sugiyama | RPL24 | QsEEIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKA |
| P84098 | S37 | Sugiyama | RPL19 | CGKKKVWLDPNEtNEIANANsRQQIRKLIKDGLIIRKPVtV |
| P84098 | T187 | Sugiyama | RPL19 | KEARKRREERLQAKKEEIIKtLsKEEETKK___________ |
| P84098 | T29 | Sugiyama | RPL19 | RLAssVLRCGKKKVWLDPNEtNEIANANsRQQIRKLIKDGL |
| P84243 | T46 | Sugiyama | H3-3A H3.3A H3F3 H3F3A PP781; H3-3B H3.3B H3F3B | ARKsAPsTGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| Q00610 | S432 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | sPLLQYFGILLDQGQLNKyEsLELCRPVLQQGRKQLLEKWL |
| Q01105 | S168 | Sugiyama | SET | ENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQTQN |
| Q01518 | T24 | Sugiyama | CAP1 CAP | MQNLVERLERAVGRLEAVSHtsDMHRGyADsPsKAGAAPyV |
| Q01546 | S196 | Sugiyama | KRT76 KRT2B KRT2P | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWE |
| Q01650 | T45 | Sugiyama | SLC7A5 CD98LC LAT1 MPE16 | KMLAAKsADGsAPAGEGEGVtLQRNITLLNGVAIIVGTIIG |
| Q02543 | S123 | Sugiyama | RPL18A | AGAVtQCyRDMGARHRARAHsIQIMKVEEIAASKCRRPAVK |
| Q02543 | T101 | Sugiyama | RPL18A | WLRYDsRSGtHNMYREyRDLttAGAVtQCyRDMGARHRARA |
| Q02543 | T107 | Sugiyama | RPL18A | RSGtHNMYREyRDLttAGAVtQCyRDMGARHRARAHsIQIM |
| Q02543 | T168 | Sugiyama | RPL18A | SKIKFPLPHRVLRRQHKPRFttKRPNtFF____________ |
| Q02543 | T169 | Sugiyama | RPL18A | KIKFPLPHRVLRRQHKPRFttKRPNtFF_____________ |
| Q02878 | S255 | Sugiyama | RPL6 TXREB1 | tEKEKYEITEQRKIDQKAVDsQILPKIKAIPQLQGYLRSVF |
| Q02878 | T118 | Sugiyama | RPL6 TXREB1 | GDKNGGTRVVKLRKMPRyyPtEDVPRKLLSHGKKPFSQHVR |
| Q02878 | T235 | Sugiyama | RPL6 TXREB1 | AyFKKKKLRKPRHQEGEIFDtEKEKYEITEQRKIDQKAVDs |
| Q02878 | T91 | Sugiyama | RPL6 TXREB1 | RKYSAAKSKVEKKKKEKVLAtVtKPVGGDKNGGTRVVKLRK |
| Q04637 | T718 | Sugiyama | EIF4G1 EIF4F EIF4G EIF4GI | GLGPRRsQQGPRKEPRKIIAtVLMtEDIKLNKAEKAWKPSS |
| Q04637 | T722 | Sugiyama | EIF4G1 EIF4F EIF4G EIF4GI | RRsQQGPRKEPRKIIAtVLMtEDIKLNKAEKAWKPSSKRTA |
| Q04917 | S46 | Sugiyama | YWHAH YWHA1 | AMKAVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSI |
| Q05639 | T23 | Sugiyama | EEF1A2 EEF1AL STN | KEKtHINIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKFE |
| Q05639 | T261 | Sugiyama | EEF1A2 EEF1AL STN | PTDKPLRLPLQDVyKIGGIGtVPVGRVETGILRPGMVVTFA |
| Q05639 | T432 | Sugiyama | EEF1A2 EEF1AL STN | VESFSQYPPLGRFAVRDMRQtVAVGVIKNVEKKSGGAGKVT |
| Q06830 | T18 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | ___MSSGNAKIGHPAPNFKAtAVMPDGQFKDIsLsDyKGKY |
| Q07020 | T79 | Sugiyama | RPL18 | PPLsLsRMIRKMKLPGRENKtAVVVGtItDDVRVQEVPKLK |
| Q07020 | T85 | Sugiyama | RPL18 | RMIRKMKLPGRENKtAVVVGtItDDVRVQEVPKLKVCALRV |
| Q07020 | T87 | Sugiyama | RPL18 | IRKMKLPGRENKtAVVVGtItDDVRVQEVPKLKVCALRVTS |
| Q07157 | T1167 | Sugiyama | TJP1 ZO1 | EQAPRAsALRHEEQPAPGyDtHGRLRPEAQPHPsAGPKPAE |
| Q12906 | T300 | Sugiyama | ILF3 DRBF MPHOSPH4 NF90 | ASGIVMPDGSGIYDPCEKEAtDAIGHLDRQQREDItQsAQH |
| Q12931 | T641 | Sugiyama | TRAP1 HSP75 HSPC5 | FLRMQQLAKTQEERAQLLQPtLEINPRHALIKKLNQLRASE |
| Q13247 | T146 | Sugiyama | SRSF6 SFRS6 SRP55 | LKDFMRQAGEVTYADAHKERtNEGVIEFRSYSDMKRALDKL |
| Q13283 | S119 | Sugiyama | G3BP1 G3BP | SNNNQALRRFMQtFVLAPEGsVANKFyVHNDIFRyQDEVFG |
| Q13283 | S250 | Sugiyama | G3BP1 G3BP | sssPAPADIAQtVQEDLRtFsWAsVtsKNLPPSGAVPVTGI |
| Q13283 | S253 | Sugiyama | G3BP1 G3BP | PAPADIAQtVQEDLRtFsWAsVtsKNLPPSGAVPVTGIPPH |
| Q13283 | T111 | Sugiyama | G3BP1 G3BP | VVQVMGLLSNNNQALRRFMQtFVLAPEGsVANKFyVHNDIF |
| Q13283 | T21 | Sugiyama | G3BP1 G3BP | MVMEKPsPLLVGREFVRQyytLLNQAPDMLHRFYGKNssyV |
| Q13310 | T191 | Sugiyama | PABPC4 APP1 PABP4 | GRFKSRKEREAELGAKAKEFtNVyIKNFGEEVDDEsLKELF |
| Q13310 | T71 | Sugiyama | PABPC4 APP1 PABP4 | sLGyAyVNFQQPADAERALDtMNFDVIKGKPIRIMWSQRDP |
| Q13409 | T617 | Sugiyama | DYNC1I2 DNCI2 DNCIC2 | YDVGEQIAVPRNDEWARFGRtLAEINANRADAEEEAATRIP |
| Q13509 | S115 | Sugiyama | TUBB3 TUBB4 | SGAGNNWAKGHytEGAELVDsVLDVVRKECENCDCLQGFQL |
| Q13509 | T107 | Sugiyama | TUBB3 TUBB4 | PDNFIFGQSGAGNNWAKGHytEGAELVDsVLDVVRKECENC |
| Q13509 | T312 | Sugiyama | TUBB3 TUBB4 | QMFDAKNMMAACDPRHGRYLtVAtVFRGRMSMKEVDEQMLA |
| Q13509 | T315 | Sugiyama | TUBB3 TUBB4 | DAKNMMAACDPRHGRYLtVAtVFRGRMSMKEVDEQMLAIQS |
| Q13509 | T72 | Sugiyama | TUBB3 TUBB4 | NEASSHKYVPRAILVDLEPGtMDsVRSGAFGHLFRPDNFIF |
| Q13642 | T138 | Sugiyama | FHL1 SLIM1 | KGtVWHKDCFTCSNCKQVIGtGSFFPKGEDFyCVtCHETKF |
| Q13885 | S115 | Sugiyama | TUBB2A TUBB2 | sGAGNNWAKGHytEGAELVDsVLDVVRKESESCDCLQGFQL |
| Q13885 | T107 | Sugiyama | TUBB2A TUBB2 | PDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKESESC |
| Q13885 | T72 | Sugiyama | TUBB2A TUBB2 | NEAAGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVF |
| Q14152 | S1028 | Sugiyama | EIF3A EIF3S10 KIAA0139 | NWRHADDDRPPRRGLDEDRGsWRtADEDRGPRRGMDDDRGP |
| Q14152 | S1188 | Sugiyama | EIF3A EIF3S10 KIAA0139 | PWRPLVKPGGWREKEKAREEsWGPPRESRPsEEREWDREKE |
| Q14152 | S584 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EHQRILARRQtIEERKERLEsLNIQREKEELEQREAELQKV |
| Q14240 | T81 | Sugiyama | EIF4A2 DDX2B EIF4F | QRAIIPCIKGyDVIAQAQsGtGKTATFAISILQQLEIEFKE |
| Q14247 | T219 | Sugiyama | CTTN EMS1 | yGIDKDKVDKsAVGFEyQGKtEKHESQKDyVKGFGGKFGVQ |
| Q14247 | T68 | Sugiyama | CTTN EMS1 | GHQEHINIHKLRENVFQEHQtLKEKELETGPKASHGyGGKF |
| Q14568 | S165 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | AEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGERMGRGTK |
| Q14568 | S169 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | TVITKHNDDEQyAWEssAGGsFtVRTDTGERMGRGTKVILH |
| Q14568 | S52 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | LIINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDS |
| Q14568 | T171 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | ITKHNDDEQyAWEssAGGsFtVRTDTGERMGRGTKVILHLK |
| Q14914 | T83 | Sugiyama | PTGR1 LTB4DH | MMGQQVAKVVESKNVALPKGtIVLAsPGWttHSISDGKDLE |
| Q14914 | T93 | Sugiyama | PTGR1 LTB4DH | ESKNVALPKGtIVLAsPGWttHSISDGKDLEKLLTEWPDTI |
| Q14974 | S201 | Sugiyama | KPNB1 NTF97 | MRKEEPSNNVKLAAtNALLNsLEFTKANFDKESERHFIMQV |
| Q14974 | T195 | Sugiyama | KPNB1 NTF97 | TAIIQGMRKEEPSNNVKLAAtNALLNsLEFTKANFDKESER |
| Q14980 | S1991 | Sugiyama | NUMA1 NMP22 NUMA | QPIQIAEGTGITTRQQRKRVsLEPHQGPGtPEsKKATSCFP |
| Q14CN4 | S138 | Sugiyama | KRT72 K6IRS2 KB35 KRT6 KRT6IRS2 | IQRVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWN |
| Q15056 | S110 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | DEVDsLKEALtyDGALLGDRsLRVDIAEGRKQDKGGFGFRK |
| Q15084 | S88 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | AATALKDVVKVGAVDADKHHsLGGQyGVQGFPtIKIFGSNK |
| Q15084 | T100 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | AVDADKHHsLGGQyGVQGFPtIKIFGSNKNRPEDYQGGRTG |
| Q15084 | T395 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | sFsEQGINEFLRELsFGRGstAPVGGGAFPtIVEREPWDGR |
| Q15084 | T405 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | LRELsFGRGstAPVGGGAFPtIVEREPWDGRDGELPVEDDI |
| Q15084 | Y93 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | KDVVKVGAVDADKHHsLGGQyGVQGFPtIKIFGSNKNRPED |
| Q15185 | S39 | Sugiyama | PTGES3 P23 TEBP | FCVEDSKDVNVNFEKsKLTFsCLGGsDNFKHLNEIDLFHCI |
| Q15185 | S44 | Sugiyama | PTGES3 P23 TEBP | SKDVNVNFEKsKLTFsCLGGsDNFKHLNEIDLFHCIDPNDs |
| Q15185 | S72 | Sugiyama | PTGES3 P23 TEBP | EIDLFHCIDPNDsKHKRtDRsILCCLRKGEsGQsWPRLTKE |
| Q15293 | S69 | Sugiyama | RCN1 RCN | PPEDNQsFQYDHEAFLGKEDsKtFDQLtPDEsKERLGKIVD |
| Q15293 | T211 | Sugiyama | RCN1 RCN | FTAFLHPEEFEHMKEIVVLEtLEDIDKNGDGFVDQDEyIAD |
| Q15293 | T71 | Sugiyama | RCN1 RCN | EDNQsFQYDHEAFLGKEDsKtFDQLtPDEsKERLGKIVDRI |
| Q15369 | T41 | Sugiyama | ELOC TCEB1 | LISSDGHEFIVKREHALtsGtIKAMLSGPGQFAENETNEVN |
| Q15459 | S508 | Sugiyama | SF3A1 SAP114 | IGEEEIQKPEEKVTWDGHsGsMARTQQAAQANITLQEQIEA |
| Q15785 | S160 | Sugiyama | TOMM34 URCC3 | WRLKLPSIPLVPVsAQKRWNsLPSENHKEMAKSKSKETTAT |
| Q16576 | T373 | Sugiyama | RBBP7 RBAP46 | QsAEDAEDGPPELLFIHGGHtAKISDFSWNPNEPWVICSVS |
| Q16658 | S237 | Sugiyama | FSCN1 FAN1 HSN SNL | RsGKVAFRDCEGRyLAPsGPsGtLKAGKATKVGKDELFALE |
| Q16658 | T213 | Sugiyama | FSCN1 FAN1 HSN SNL | HRFLRHDGRLVARPEPATGytLEFRsGKVAFRDCEGRyLAP |
| Q16658 | T239 | Sugiyama | FSCN1 FAN1 HSN SNL | GKVAFRDCEGRyLAPsGPsGtLKAGKATKVGKDELFALEQs |
| Q16695 | T46 | Sugiyama | H3-4 H3FT HIST3H3 | ARKsAPATGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| Q2VIR3 | T41 | Sugiyama | EIF2S3B | ttLDVtKLTPLSHEVISRQAtINIGtIGHVAHGKSTVVKAI |
| Q2VIR3 | T46 | Sugiyama | EIF2S3B | tKLTPLSHEVISRQAtINIGtIGHVAHGKSTVVKAISGVHT |
| Q32P51 | S95 | Sugiyama | HNRNPA1L2 HNRNPA1L | TPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| Q3SY84 | S143 | Sugiyama | KRT71 K6IRS1 KB34 KRT6IRS1 | IQKVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q3ZCM7 | S75 | Sugiyama | TUBB8 | SGGRYVPRAVLVDLEPGtMDsVRSGPFGQVFRPDNFIFGQC |
| Q4G0X9 | S553 | Sugiyama | CCDC40 KIAA1640 | EIEAYKKSIMKEEEKNEKLAsILNRTETEATLLQKLTTQCL |
| Q52LJ0 | T265 | Sugiyama | FAM98B | KTDDIARIYQPKRYALSPKTtItMAHLLAAREDLSKIIRTs |
| Q52LJ0 | T267 | Sugiyama | FAM98B | DDIARIYQPKRYALSPKTtItMAHLLAAREDLSKIIRTsSG |
| Q562R1 | T250 | Sugiyama | ACTBL2 | RAAAssSPERsyELPDGQVItIGNERFRCPEAIFQPSFLGI |
| Q562R1 | Y189 | Sugiyama | ACTBL2 | GYALPHAILRLDLAGRDLTDyLMKILTERGYNFTTTAEREI |
| Q58FF6 | S34 | Sugiyama | HSP90AB4P | IFLQELISNASDALDKIRyEsLtDPsKLDGGKELKIDIIPN |
| Q58FF6 | T36 | Sugiyama | HSP90AB4P | LQELISNASDALDKIRyEsLtDPsKLDGGKELKIDIIPNPR |
| Q58FF7 | S58 | Sugiyama | HSP90AB3P HSP90BC | IFLQELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| Q58FF7 | T489 | Sugiyama | HSP90AB3P HSP90BC | YGWTANMEQIMKAQALRDNstMGyMMAKKHLEINPDHPIME |
| Q58FF7 | T60 | Sugiyama | HSP90AB3P HSP90BC | LQELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPNPQ |
| Q58FF8 | S58 | Sugiyama | HSP90AB2P HSP90BB | IFLWELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| Q58FF8 | T60 | Sugiyama | HSP90AB2P HSP90BB | LWELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPNTQ |
| Q58FG1 | T28 | Sugiyama | HSP90AA4P HSP90AD HSPCAL2 | SKLDSGKEPHISLIPNKQDRtLtIVDtGIGMTKADLINNLG |
| Q58FG1 | T30 | Sugiyama | HSP90AA4P HSP90AD HSPCAL2 | LDSGKEPHISLIPNKQDRtLtIVDtGIGMTKADLINNLGTI |
| Q58FG1 | T34 | Sugiyama | HSP90AA4P HSP90AD HSPCAL2 | KEPHISLIPNKQDRtLtIVDtGIGMTKADLINNLGTITKSE |
| Q5VTE0 | T23 | Sugiyama | EEF1A1P5 EEF1AL3 | KEKtHINIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKFE |
| Q5VTE0 | T261 | Sugiyama | EEF1A1P5 EEF1AL3 | PTDKPLRLPLQDVyKIGGIGtVPVGRVEtGVLKPGMVVtFA |
| Q5VTE0 | T269 | Sugiyama | EEF1A1P5 EEF1AL3 | PLQDVyKIGGIGtVPVGRVEtGVLKPGMVVtFAPVNVttEV |
| Q5VTE0 | T279 | Sugiyama | EEF1A1P5 EEF1AL3 | IGtVPVGRVEtGVLKPGMVVtFAPVNVttEVKSVEMHHEAL |
| Q5VTE0 | T432 | Sugiyama | EEF1A1P5 EEF1AL3 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| Q5XKE5 | S155 | Sugiyama | KRT79 K6L KB38 KRT6L | IQRVRTQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| Q6NXT2 | T45 | Sugiyama | H3-5 H3F3C | AARKSTPSTCGVKPHRyRPGtVALREIRRYQKstELLIRKL |
| Q6PEY2 | T334 | Sugiyama | TUBA3E | ACCMLYRGDVVPKDVNAAIAtIKtKRTIQFVDWCPTGFKVG |
| Q6PEY2 | T41 | Sugiyama | TUBA3E | WELYCLEHGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKH |
| Q6S8J3 | T789 | Sugiyama | POTEE A26C1A POTE2 | YPMEHGIITNWDDMEKIWHHtFyNELRVAPEEHPILLTEAP |
| Q6S8J3 | T949 | Sugiyama | POTEE A26C1A POTE2 | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q6ZMR3 | S167 | Sugiyama | LDHAL6A LDHL2 | AWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIHSESCHG |
| Q71DI3 | T46 | Sugiyama | H3C15 HIST2H3A; H3C14 H3F2 H3FM HIST2H3C; H3C13 HIST2H3D | ARKsAPATGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| Q71U36 | T334 | Sugiyama | TUBA1A TUBA3 | ACCLLyRGDVVPKDVNAAIAtIKtKRTIQFVDWCPTGFKVG |
| Q71U36 | T41 | Sugiyama | TUBA1A TUBA3 | WELYCLEHGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKH |
| Q71UM5 | S11 | Sugiyama | RPS27L | __________MPLARDLLHPsLEEEKKKHKKKRLVQsPNsy |
| Q71UM5 | S78 | Sugiyama | RPS27L | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| Q7KZF4 | T98 | Sugiyama | SND1 TDRD11 | WAFPAREFLRKKLIGKEVCFtIENKtPQGREyGMIyLGKDT |
| Q7RTS7 | S153 | Sugiyama | KRT74 K6IRS4 KB37 KRT5C KRT6IRS4 | IQKVRAQEREQIKVLNDKFAsFIDKVRFLEQQNQVLETKWE |
| Q7Z4V5 | Y18 | Sugiyama | HDGFL2 HDGF2 HDGFRP2 HRP2 UNQ785/PRO1604 | ___MPHAFKPGDLVFAKMKGyPHWPARIDDIADGAVKPPPN |
| Q7Z794 | S177 | Sugiyama | KRT77 KRT1B | IQRIKTQEREQIMVLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| Q86U42 | S235 | Sugiyama | PABPN1 PAB2 PABP2 | FAyIEFSDKEsVRTSLALDEsLFRGRQIKVIPKRTNRPGIS |
| Q86Y46 | S145 | Sugiyama | KRT73 K6IRS3 KB36 KRT6IRS3 | IQKVRAQEREQIKVLNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q8IYP9 | S200 | Sugiyama | ZDHHC23 | LILLALHRAKKNPGYLSNPAsGDRSLsSSQLECLSRKGQEK |
| Q8N0Y7 | T96 | Sugiyama | PGAM4 PGAM3 | QMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEAQVKIWR |
| Q8NBT2 | S16 | Sugiyama | SPC24 SPBC24 | _____MAAFRDIEEVSQGLLsLLGANRAEAQQRRLLGRHEQ |
| Q8TAM6 | S280 | Sugiyama | ERMN KIAA1189 | TISYRKIRKGNTKQRIDEFEsMMHL________________ |
| Q8WXX5 | S215 | Sugiyama | DNAJC9 | EEAKEAEMSRKELGLDEGVDsLKAAIQSRQKDRQKEMDNFL |
| Q92522 | T55 | Sugiyama | H1-10 H1FX | KRKNSKKKNQPGKySQLVVEtIRRLGERNGSSLAKIYTEAK |
| Q92598 | T63 | Sugiyama | HSPH1 HSP105 HSP110 KIAA0201 | SKNRTIGVAAKNQQITHANNtVsNFKRFHGRAFNDPFIQKE |
| Q92688 | S117 | Sugiyama | ANP32B APRIL PHAPI2 | GNKLKDIstLEPLKKLECLKsLDLFNCEVtNLNDyREsVFK |
| Q92688 | T105 | Sugiyama | ANP32B APRIL PHAPI2 | EKLPNLTHLNLsGNKLKDIstLEPLKKLECLKsLDLFNCEV |
| Q93045 | S80 | Sugiyama | STMN2 SCG10 SCGN10 | PPsPISEAPRTLAsPKKKDLsLEEIQKKLEAAEERRKsQEA |
| Q96AY3 | T441 | Sugiyama | FKBP10 FKBP65 PSEC0056 | DYGAPQEATLGANKVIEGLDtGLQGMCVGERRQLIVPPHLA |
| Q96QK1 | T773 | Sugiyama | VPS35 MEM3 TCCCTA00141 | DLPNLEssEEtEQINKHFHNtLEHLRLRREsPEsEGPIyEG |
| Q99439 | T58 | Sugiyama | CNN2 | IEGLTGLSIGPDFQKGLKDGtILCtLMNKLQPGSVPKINRS |
| Q99439 | T62 | Sugiyama | CNN2 | TGLSIGPDFQKGLKDGtILCtLMNKLQPGSVPKINRSMQNW |
| Q99613 | T880 | Sugiyama | EIF3C EIF3S8 | AEKLGsLVENNERVFDHKQGtyGGyFRDQKDGYRKNEGYMR |
| Q99832 | T458 | Sugiyama | CCT7 CCTH NIP7-1 | yAKALEIIPRQLCDNAGFDAtNILNKLRARHAQGGTWYGVD |
| Q9BQE3 | T334 | Sugiyama | TUBA1C TUBA6 | ACCLLyRGDVVPKDVNAAIAtIKtKRTIQFVDWCPTGFKVG |
| Q9BQE3 | T41 | Sugiyama | TUBA1C TUBA6 | WELYCLEHGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKH |
| Q9BRA2 | T91 | Sugiyama | TXNDC17 TXNL5 | VGEKPYWKDPNNDFRKNLKVtAVPtLLKYGTPQKLVESECL |
| Q9BRA2 | T95 | Sugiyama | TXNDC17 TXNL5 | PYWKDPNNDFRKNLKVtAVPtLLKYGTPQKLVESECLQANL |
| Q9BS26 | T155 | Sugiyama | ERP44 KIAA0573 TXNDC4 UNQ532/PRO1075 | yIRQQKSDPIQEIRDLAEIttLDRSKRNIIGYFEQKDSDNy |
| Q9BUF5 | T312 | Sugiyama | TUBB6 | QMFDARNMMAACDPRHGRYLtVAtVFRGPMSMKEVDEQMLA |
| Q9BUF5 | T315 | Sugiyama | TUBB6 | DARNMMAACDPRHGRYLtVAtVFRGPMSMKEVDEQMLAIQS |
| Q9BVA1 | S115 | Sugiyama | TUBB2B | sGAGNNWAKGHytEGAELVDsVLDVVRKESESCDCLQGFQL |
| Q9BVA1 | T107 | Sugiyama | TUBB2B | PDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKESESC |
| Q9BVA1 | T72 | Sugiyama | TUBB2B | NEAtGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVF |
| Q9BYX7 | T249 | Sugiyama | POTEKP ACTBL3 FKSG30 | MAASSSSVEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q9BYX7 | T89 | Sugiyama | POTEKP ACTBL3 FKSG30 | YPMEHGIITNWDDMEKIWHHtFyNELRVAPEEHPILLTEAP |
| Q9GZT8 | T149 | Sugiyama | NIF3L1 ALS2CR1 MDS015 My018 | AYDAAPQGVNNWLAKGLGACtSRPIHPSKAPNyPTEGNHRV |
| Q9H3G5 | S334 | Sugiyama | CPVL VLP PSEC0124 UNQ197/PRO223 | YYNFLRCTEPEDQLyyVKFLsLPEVRQAIHVGNQTFNDGTI |
| Q9H788 | S124 | Sugiyama | SH2D4A PPP1R38 SH2A | LKAEQEAEEPRKTHsEEFTNsLKTKsQyHDLQAPDNQQtKD |
| Q9HA77 | T546 | Sugiyama | CARS2 OK/SW-cl.10 | CDTLRRGLTAHGINIKDRssttstWELLDQRTKDQKSAG__ |
| Q9HB07 | T49 | Sugiyama | MYG1 C12orf10 | ESVPPPKRSRsKLMAPPRIGtHNGtFHCDEALACALLRLLP |
| Q9HB07 | T53 | Sugiyama | MYG1 C12orf10 | PPKRSRsKLMAPPRIGtHNGtFHCDEALACALLRLLPEYRD |
| Q9HB71 | T209 | Sugiyama | CACYBP S100A6BP SIP PNAS-107 | EGLMNVLKKIyEDGDDDMKRtINKAWVESREKQAKGDTEF_ |
| Q9NQ39 | S157 | Sugiyama | RPS10P5 RPS10L | TYRRCSVPPGADKKAEAGAGsAtEFQFRGRCGRGRGQPPQ_ |
| Q9NQ39 | T159 | Sugiyama | RPS10P5 RPS10L | RRCSVPPGADKKAEAGAGsAtEFQFRGRCGRGRGQPPQ___ |
| Q9NR30 | T371 | Sugiyama | DDX21 | DQVEEILSVAYKKDSEDNPQtLLFSAtCPHWVFNVAKKYMK |
| Q9NR30 | T377 | Sugiyama | DDX21 | LSVAYKKDSEDNPQtLLFSAtCPHWVFNVAKKYMKSTYEQV |
| Q9NR45 | S251 | Sugiyama | NANS SAS | GAKVLERHITLDKTWKGsDHsAsLEPGELAELVRSVRLVER |
| Q9NSB2 | S178 | Sugiyama | KRT84 KRTHB4 | AQRVKKDEKEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWS |
| Q9NTJ3 | T890 | Sugiyama | SMC4 CAPC SMC4L1 | YDAVAEKAGKVEAEVKRLHNtIVEINNHKLKAQQDKLDKIN |
| Q9NZB2 | S847 | Sugiyama | FAM120A C9orf10 KIAA0183 OSSA | GQADQAAKVEKMRQSVLEGLsFsRQSHTLPFPPPPALPFYP |
| Q9P2J5 | S720 | Sugiyama | LARS1 KIAA1352 LARS | WPTAVRANGHLLLNSEKMSKstGNFLtLtQAIDKFSADGMR |
| Q9P2J5 | T726 | Sugiyama | LARS1 KIAA1352 LARS | ANGHLLLNSEKMSKstGNFLtLtQAIDKFSADGMRLALADA |
| Q9P2J5 | T728 | Sugiyama | LARS1 KIAA1352 LARS | GHLLLNSEKMSKstGNFLtLtQAIDKFSADGMRLALADAGD |
| Q9UBQ5 | T28 | Sugiyama | EIF3K EIF3S12 ARG134 HSPC029 MSTP001 PTD001 | RANVGKLLKGIDRyNPENLAtLERYVETQAKENAyDLEANL |
| Q9UI15 | T190 | Sugiyama | TAGLN3 NP25 | GQNVIGLQMGSNKGAsQAGMtGyGMPRQIM___________ |
| Q9UNX3 | T8 | Sugiyama | RPL26L1 RPL26P1 | _____________MKFNPFVtsDRsKNRKRHFNAPSHVRRK |
| Q9UNX3 | T93 | Sugiyama | RPL26L1 RPL26P1 | VYRKKyVIyIERVQREKANGttVHVGIHPSKVVITRLKLDK |
| Q9UNZ2 | S192 | Sugiyama | NSFL1C UBXN2C | KRQHssQDVHVVLKLWKsGFsLDNGELRSyQDPsNAQFLEs |
| Q9Y2B0 | T132 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | NGEssELDLQGIRIDsDISGtLKFACEsIVEEyEDELIEFF |
| Q9Y2T7 | T143 | Sugiyama | YBX2 CSDA3 MSY2 | QtAIKRNNPRKFLRsVGDGEtVEFDVVEGEKGAEATNVTGP |
| Q9Y3E1 | Y22 | Sugiyama | HDGFL3 HDGF2 HDGFRP3 CGI-142 | ARPRPREYKAGDLVFAKMKGyPHWPARIDELPEGAVKPPAN |
| Q9Y3F4 | S230 | Sugiyama | STRAP MAWD UNRIP | SAVSLDPIKsFEAPAtINsAsLHPEKEFLVAGGEDFKLyKy |
| Q9Y3F4 | T225 | Sugiyama | STRAP MAWD UNRIP | SIAFHSAVSLDPIKsFEAPAtINsAsLHPEKEFLVAGGEDF |
| Q9Y3F4 | T54 | Sugiyama | STRAP MAWD UNRIP | SACKDGKPMLRQGDtGDWIGtFLGHKGAVWGAtLNKDATKA |
| Q9Y3U8 | S91 | Sugiyama | RPL36 | KFIKKRVGTHIRAKRKREELsNVLAAMRKAAAKKD______ |
| Q9Y4K4 | S28 | Sugiyama | MAP4K5 | AADILRRNPQQDyELVQRVGsGTYGDVYKARNVHtGELAAV |
| Q9Y4K4 | S413 | Sugiyama | MAP4K5 | PPKPRIssyPEDNFPDEEKAsTIKHCPDsEsRAPQILRRQs |
| Q9Y4K4 | S421 | Sugiyama | MAP4K5 | yPEDNFPDEEKAsTIKHCPDsEsRAPQILRRQssPsCGPVA |
| Q9Y4K4 | S423 | Sugiyama | MAP4K5 | EDNFPDEEKAsTIKHCPDsEsRAPQILRRQssPsCGPVAET |
| Q9Y4K4 | S60 | Sugiyama | MAP4K5 | VHtGELAAVKIIKLEPGDDFsLIQQEIFMVKECKHCNIVAY |
| Q9Y4K4 | S764 | Sugiyama | MAP4K5 | DKFVKIVNLQGKLKSSKKLAsELSFDFRIESVVCLQDSVLA |
| Q9Y4K4 | T304 | Sugiyama | MAP4K5 | RALAVELLDKVNNPDNHAHytEADDDDFEPHAIIRHTIRST |
| Q9Y4K4 | T42 | Sugiyama | MAP4K5 | LVQRVGsGTYGDVYKARNVHtGELAAVKIIKLEPGDDFsLI |
| Q9Y4K4 | T801 | Sugiyama | MAP4K5 | SVLAFWKHGMQGKSFKSDEVtQEISDEtRVFRLLGSDRVVV |
| Q9Y4K4 | T808 | Sugiyama | MAP4K5 | HGMQGKSFKSDEVtQEISDEtRVFRLLGSDRVVVLESRPtE |
| Q9Y4K4 | T827 | Sugiyama | MAP4K5 | EtRVFRLLGSDRVVVLESRPtENPtAHSNLYILAGHENsY_ |
| Q9Y4K4 | T831 | Sugiyama | MAP4K5 | FRLLGSDRVVVLESRPtENPtAHSNLYILAGHENsY_____ |
| Q9Y4K4 | Y20 | Sugiyama | MAP4K5 | _MEAPLRPAADILRRNPQQDyELVQRVGsGTYGDVYKARNV |
| Q9Y4L1 | S742 | Sugiyama | HYOU1 GRP170 HSPH4 ORP150 | KLQDLTLRDLEKQEREKAANsLEAFIFEtQDKLyQPEyQEV |
| Q9Y4L1 | T750 | Sugiyama | HYOU1 GRP170 HSPH4 ORP150 | DLEKQEREKAANsLEAFIFEtQDKLyQPEyQEVsTEEQREE |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Axon guidance | R-HSA-422475 | 7.881964e-07 | 6.103 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.962787e-06 | 5.707 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 3.491593e-06 | 5.457 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 5.488808e-06 | 5.261 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 5.513451e-06 | 5.259 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 1.658735e-05 | 4.780 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.623559e-05 | 4.790 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 2.468825e-05 | 4.608 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 7.046296e-05 | 4.152 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.019105e-04 | 3.992 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.567591e-04 | 3.805 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.692021e-04 | 3.570 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 6.059662e-04 | 3.218 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 6.059662e-04 | 3.218 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 8.030170e-04 | 3.095 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 7.839472e-04 | 3.106 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 1.013798e-03 | 2.994 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 1.019304e-03 | 2.992 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 1.332878e-03 | 2.875 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 1.577688e-03 | 2.802 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.915166e-03 | 2.718 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 1.989953e-03 | 2.701 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 2.141790e-03 | 2.669 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 2.097425e-03 | 2.678 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 2.857017e-03 | 2.544 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 3.275237e-03 | 2.485 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 3.275237e-03 | 2.485 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 3.295373e-03 | 2.482 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 3.275237e-03 | 2.485 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 4.051198e-03 | 2.392 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 3.994115e-03 | 2.399 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 4.065860e-03 | 2.391 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 4.637735e-03 | 2.334 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 4.804590e-03 | 2.318 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 4.921172e-03 | 2.308 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 5.415015e-03 | 2.266 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 5.301616e-03 | 2.276 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 6.173214e-03 | 2.209 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 6.844729e-03 | 2.165 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 7.068190e-03 | 2.151 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 8.063950e-03 | 2.093 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 7.586415e-03 | 2.120 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 7.883248e-03 | 2.103 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 8.297049e-03 | 2.081 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 8.297049e-03 | 2.081 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 8.315232e-03 | 2.080 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 8.994994e-03 | 2.046 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 9.159101e-03 | 2.038 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 9.662601e-03 | 2.015 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 9.927487e-03 | 2.003 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.032453e-02 | 1.986 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.032453e-02 | 1.986 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 9.965503e-03 | 2.002 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 9.927487e-03 | 2.003 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 1.105863e-02 | 1.956 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.137544e-02 | 1.944 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.123908e-02 | 1.949 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 1.160156e-02 | 1.935 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.228692e-02 | 1.911 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.190378e-02 | 1.924 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.309443e-02 | 1.883 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.344683e-02 | 1.871 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.506413e-02 | 1.822 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.456211e-02 | 1.837 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.585960e-02 | 1.800 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.506413e-02 | 1.822 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.488334e-02 | 1.827 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.421207e-02 | 1.847 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 2.363922e-02 | 1.626 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 2.363922e-02 | 1.626 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 2.363922e-02 | 1.626 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 2.363922e-02 | 1.626 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 2.363922e-02 | 1.626 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.618682e-02 | 1.791 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.618682e-02 | 1.791 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 1.978820e-02 | 1.704 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 2.177070e-02 | 1.662 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 2.387796e-02 | 1.622 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 2.091742e-02 | 1.679 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 2.091742e-02 | 1.679 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 2.091742e-02 | 1.679 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 2.340873e-02 | 1.631 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 2.340873e-02 | 1.631 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 2.387796e-02 | 1.622 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 2.091742e-02 | 1.679 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.767234e-02 | 1.753 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 2.313867e-02 | 1.636 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 2.313867e-02 | 1.636 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 2.313867e-02 | 1.636 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 2.387796e-02 | 1.622 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 1.828675e-02 | 1.738 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 2.363922e-02 | 1.626 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.838804e-02 | 1.735 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.907303e-02 | 1.720 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 2.406921e-02 | 1.619 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 1.720481e-02 | 1.764 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 1.720481e-02 | 1.764 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 2.406921e-02 | 1.619 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 1.873521e-02 | 1.727 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 2.177070e-02 | 1.662 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 2.298097e-02 | 1.639 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.689437e-02 | 1.772 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 2.072466e-02 | 1.684 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 2.340873e-02 | 1.631 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 2.387796e-02 | 1.622 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 2.264097e-02 | 1.645 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 2.305192e-02 | 1.637 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 2.377222e-02 | 1.624 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 1.921647e-02 | 1.716 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 2.413502e-02 | 1.617 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 2.499329e-02 | 1.602 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 2.579103e-02 | 1.589 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 2.579103e-02 | 1.589 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 2.611235e-02 | 1.583 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 2.612571e-02 | 1.583 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.664981e-02 | 1.574 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 2.664981e-02 | 1.574 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 2.838043e-02 | 1.547 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 2.837957e-02 | 1.547 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 2.739652e-02 | 1.562 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 3.019403e-02 | 1.520 | 0 | 0 |
| M Phase | R-HSA-68886 | 3.062508e-02 | 1.514 | 0 | 0 |
| Immune System | R-HSA-168256 | 3.067293e-02 | 1.513 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 3.136587e-02 | 1.504 | 0 | 0 |
| IRS activation | R-HSA-74713 | 3.136587e-02 | 1.504 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 3.154542e-02 | 1.501 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 3.097102e-02 | 1.509 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 3.097102e-02 | 1.509 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 3.206365e-02 | 1.494 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 3.097102e-02 | 1.509 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 3.470483e-02 | 1.460 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 3.281624e-02 | 1.484 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 3.136587e-02 | 1.504 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 3.359896e-02 | 1.474 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 3.490945e-02 | 1.457 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 3.842860e-02 | 1.415 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 3.994014e-02 | 1.399 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 4.221398e-02 | 1.375 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 4.221398e-02 | 1.375 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 3.994014e-02 | 1.399 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 4.157693e-02 | 1.381 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 3.847353e-02 | 1.415 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 3.950048e-02 | 1.403 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 3.950048e-02 | 1.403 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 3.925953e-02 | 1.406 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 3.966617e-02 | 1.402 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 3.994014e-02 | 1.399 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 4.221398e-02 | 1.375 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 3.772255e-02 | 1.423 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 3.925953e-02 | 1.406 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 3.925953e-02 | 1.406 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 3.994014e-02 | 1.399 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 3.787133e-02 | 1.422 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 3.772255e-02 | 1.423 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 4.223814e-02 | 1.374 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 4.229447e-02 | 1.374 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 4.229447e-02 | 1.374 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 4.229447e-02 | 1.374 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 4.229447e-02 | 1.374 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 4.500229e-02 | 1.347 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 5.036843e-02 | 1.298 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 4.546701e-02 | 1.342 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 4.498850e-02 | 1.347 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 4.546701e-02 | 1.342 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 4.500229e-02 | 1.347 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 4.500229e-02 | 1.347 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 4.649785e-02 | 1.333 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 5.036843e-02 | 1.298 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 4.467540e-02 | 1.350 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 4.467540e-02 | 1.350 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 5.036843e-02 | 1.298 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 4.928568e-02 | 1.307 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 4.815672e-02 | 1.317 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 4.976776e-02 | 1.303 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 4.649785e-02 | 1.333 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 4.557087e-02 | 1.341 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 4.928568e-02 | 1.307 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 4.971317e-02 | 1.304 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 5.055536e-02 | 1.296 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 5.055536e-02 | 1.296 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 5.062355e-02 | 1.296 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 5.065587e-02 | 1.295 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 5.222708e-02 | 1.282 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 5.222708e-02 | 1.282 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 5.386967e-02 | 1.269 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 5.581513e-02 | 1.253 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 5.933075e-02 | 1.227 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 5.933075e-02 | 1.227 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 6.293511e-02 | 1.201 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 5.929471e-02 | 1.227 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 6.405266e-02 | 1.193 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 5.663629e-02 | 1.247 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 5.663629e-02 | 1.247 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 5.763202e-02 | 1.239 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 5.954186e-02 | 1.225 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 6.741012e-02 | 1.171 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 6.293511e-02 | 1.201 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 6.281360e-02 | 1.202 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 5.929471e-02 | 1.227 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 5.954186e-02 | 1.225 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 6.741012e-02 | 1.171 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 6.293511e-02 | 1.201 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 6.085678e-02 | 1.216 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 5.983822e-02 | 1.223 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 5.933075e-02 | 1.227 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 6.340702e-02 | 1.198 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 6.827690e-02 | 1.166 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 6.827690e-02 | 1.166 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 6.827690e-02 | 1.166 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 6.900441e-02 | 1.161 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 6.900441e-02 | 1.161 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 6.900441e-02 | 1.161 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 6.954308e-02 | 1.158 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 6.989296e-02 | 1.156 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 7.000797e-02 | 1.155 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 7.000797e-02 | 1.155 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 7.000797e-02 | 1.155 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 7.000797e-02 | 1.155 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 7.000797e-02 | 1.155 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 7.155050e-02 | 1.145 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 7.155050e-02 | 1.145 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 7.538270e-02 | 1.123 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 7.538270e-02 | 1.123 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 7.538270e-02 | 1.123 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 7.538270e-02 | 1.123 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 7.538270e-02 | 1.123 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 7.538270e-02 | 1.123 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 7.538270e-02 | 1.123 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 7.538270e-02 | 1.123 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 8.125410e-02 | 1.090 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 8.364619e-02 | 1.078 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 8.364619e-02 | 1.078 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 9.111985e-02 | 1.040 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.111985e-02 | 1.040 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 9.036085e-02 | 1.044 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 8.364619e-02 | 1.078 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 8.364619e-02 | 1.078 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 9.111985e-02 | 1.040 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 7.414739e-02 | 1.130 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 7.538270e-02 | 1.123 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 8.499519e-02 | 1.071 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 7.939516e-02 | 1.100 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 8.499519e-02 | 1.071 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 7.711868e-02 | 1.113 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 7.998398e-02 | 1.097 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 8.125410e-02 | 1.090 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 7.312191e-02 | 1.136 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 8.780293e-02 | 1.056 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 7.700304e-02 | 1.113 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 9.111985e-02 | 1.040 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 7.645027e-02 | 1.117 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 8.005367e-02 | 1.097 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 9.111985e-02 | 1.040 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 9.300980e-02 | 1.031 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 9.300980e-02 | 1.031 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 9.300980e-02 | 1.031 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 9.300980e-02 | 1.031 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 9.300980e-02 | 1.031 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 9.300980e-02 | 1.031 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 9.446648e-02 | 1.025 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 9.655938e-02 | 1.015 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.656918e-02 | 1.015 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 9.760573e-02 | 1.011 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 9.784433e-02 | 1.009 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 9.885987e-02 | 1.005 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 9.885987e-02 | 1.005 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.019494e-01 | 0.992 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 1.026188e-01 | 0.989 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 1.033855e-01 | 0.986 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 1.052194e-01 | 0.978 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 1.052194e-01 | 0.978 | 0 | 0 |
| Abasic sugar-phosphate removal via the single-nucleotide replacement pathway | R-HSA-73930 | 1.109188e-01 | 0.955 | 0 | 0 |
| XAV939 stabilizes AXIN | R-HSA-5545619 | 1.109188e-01 | 0.955 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5660724 | 1.109188e-01 | 0.955 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5619081 | 1.109188e-01 | 0.955 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.450912e-01 | 0.838 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.450912e-01 | 0.838 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.450912e-01 | 0.838 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.450912e-01 | 0.838 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.450912e-01 | 0.838 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.450912e-01 | 0.838 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.450912e-01 | 0.838 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.450912e-01 | 0.838 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.450912e-01 | 0.838 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.450912e-01 | 0.838 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.450912e-01 | 0.838 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 1.779521e-01 | 0.750 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 1.779521e-01 | 0.750 | 0 | 0 |
| Defective GCLC causes HAGGSD | R-HSA-5578999 | 1.779521e-01 | 0.750 | 0 | 0 |
| Nucleotide catabolism defects | R-HSA-9735786 | 2.095519e-01 | 0.679 | 0 | 0 |
| Defective PNP disrupts phosphorolysis of (deoxy)guanosine and (deoxy)inosine | R-HSA-9735763 | 2.095519e-01 | 0.679 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 2.095519e-01 | 0.679 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 2.095519e-01 | 0.679 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 2.095519e-01 | 0.679 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 2.095519e-01 | 0.679 | 0 | 0 |
| Activation of AMPA receptors | R-HSA-399710 | 2.399388e-01 | 0.620 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 2.399388e-01 | 0.620 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.399388e-01 | 0.620 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 2.399388e-01 | 0.620 | 0 | 0 |
| Defective SLC1A3 causes episodic ataxia 6 (EA6) | R-HSA-5619062 | 2.399388e-01 | 0.620 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 1.178309e-01 | 0.929 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 1.178309e-01 | 0.929 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 1.178309e-01 | 0.929 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.307954e-01 | 0.883 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 2.691594e-01 | 0.570 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 2.691594e-01 | 0.570 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 2.691594e-01 | 0.570 | 0 | 0 |
| Phase 1 - inactivation of fast Na+ channels | R-HSA-5576894 | 2.691594e-01 | 0.570 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 1.576039e-01 | 0.802 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 2.972582e-01 | 0.527 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 2.972582e-01 | 0.527 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 2.972582e-01 | 0.527 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 1.713654e-01 | 0.766 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 1.713654e-01 | 0.766 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 1.713654e-01 | 0.766 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 1.713654e-01 | 0.766 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 1.150919e-01 | 0.939 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.853145e-01 | 0.732 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 3.242784e-01 | 0.489 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 3.242784e-01 | 0.489 | 0 | 0 |
| FGFR3b ligand binding and activation | R-HSA-190371 | 3.242784e-01 | 0.489 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 3.242784e-01 | 0.489 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 1.994167e-01 | 0.700 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 1.411379e-01 | 0.850 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.136395e-01 | 0.670 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 3.502613e-01 | 0.456 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 3.502613e-01 | 0.456 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 3.502613e-01 | 0.456 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 3.502613e-01 | 0.456 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 2.279531e-01 | 0.642 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 2.279531e-01 | 0.642 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 2.279531e-01 | 0.642 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 1.152219e-01 | 0.938 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.689261e-01 | 0.772 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 3.752466e-01 | 0.426 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 3.752466e-01 | 0.426 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 3.752466e-01 | 0.426 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 3.752466e-01 | 0.426 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 1.785185e-01 | 0.748 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 1.981256e-01 | 0.703 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 2.711684e-01 | 0.567 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 2.711684e-01 | 0.567 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 3.992725e-01 | 0.399 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 3.992725e-01 | 0.399 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 2.855849e-01 | 0.544 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 2.999714e-01 | 0.523 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 4.223759e-01 | 0.374 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 3.285803e-01 | 0.483 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 3.285803e-01 | 0.483 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 2.190103e-01 | 0.660 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 1.670004e-01 | 0.777 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 1.670004e-01 | 0.777 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 3.708416e-01 | 0.431 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 3.984235e-01 | 0.400 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 3.742357e-01 | 0.427 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 3.114015e-01 | 0.507 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 3.114015e-01 | 0.507 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 4.176412e-01 | 0.379 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 1.322459e-01 | 0.879 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 2.284161e-01 | 0.641 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 1.594903e-01 | 0.797 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 1.689261e-01 | 0.772 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 2.284161e-01 | 0.641 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 4.120030e-01 | 0.385 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 3.830950e-01 | 0.417 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 3.114015e-01 | 0.507 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 2.711684e-01 | 0.567 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.337214e-01 | 0.874 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 3.266225e-01 | 0.486 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 1.858265e-01 | 0.731 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.257834e-01 | 0.900 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 1.178309e-01 | 0.929 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 1.994167e-01 | 0.700 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 1.401053e-01 | 0.854 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.279531e-01 | 0.642 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.494772e-01 | 0.825 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 3.742357e-01 | 0.427 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 1.785185e-01 | 0.748 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 1.782918e-01 | 0.749 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 4.089015e-01 | 0.388 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 2.182172e-01 | 0.661 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 1.350798e-01 | 0.869 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 2.136395e-01 | 0.670 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 3.992725e-01 | 0.399 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 4.223759e-01 | 0.374 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 4.120030e-01 | 0.385 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 1.552464e-01 | 0.809 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 1.502235e-01 | 0.823 | 0 | 0 |
| PKA activation | R-HSA-163615 | 2.279531e-01 | 0.642 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 2.006684e-01 | 0.698 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 2.006684e-01 | 0.698 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 3.937088e-01 | 0.405 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.567123e-01 | 0.805 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 3.705539e-01 | 0.431 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.741674e-01 | 0.759 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 3.863810e-01 | 0.413 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 2.711684e-01 | 0.567 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 2.711684e-01 | 0.567 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 2.910755e-01 | 0.536 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 3.016694e-01 | 0.520 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 1.094748e-01 | 0.961 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 3.565446e-01 | 0.448 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 2.399388e-01 | 0.620 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 1.440673e-01 | 0.841 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 1.994167e-01 | 0.700 | 0 | 0 |
| FGFR2b ligand binding and activation | R-HSA-190377 | 4.223759e-01 | 0.374 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 3.229025e-01 | 0.491 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 3.478449e-01 | 0.459 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 3.550701e-01 | 0.450 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 2.200449e-01 | 0.657 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 3.623793e-01 | 0.441 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 3.730020e-01 | 0.428 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 1.713654e-01 | 0.766 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 2.028245e-01 | 0.693 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 3.830182e-01 | 0.417 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 2.779622e-01 | 0.556 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 2.779622e-01 | 0.556 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 2.779622e-01 | 0.556 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 2.779622e-01 | 0.556 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 3.568607e-01 | 0.448 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 1.641093e-01 | 0.785 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 2.095519e-01 | 0.679 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 2.691594e-01 | 0.570 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 2.691594e-01 | 0.570 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 1.713654e-01 | 0.766 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 2.136395e-01 | 0.670 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 3.752466e-01 | 0.426 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 1.057454e-01 | 0.976 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 1.235597e-01 | 0.908 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 2.866010e-01 | 0.543 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 2.629270e-01 | 0.580 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 1.310290e-01 | 0.883 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 1.502235e-01 | 0.823 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 2.279531e-01 | 0.642 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 1.594903e-01 | 0.797 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 2.182172e-01 | 0.661 | 0 | 0 |
| Protein folding | R-HSA-391251 | 2.138855e-01 | 0.670 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 1.981256e-01 | 0.703 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 3.752466e-01 | 0.426 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 2.855849e-01 | 0.544 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 3.708416e-01 | 0.431 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 3.302592e-01 | 0.481 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 1.981256e-01 | 0.703 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 3.568607e-01 | 0.448 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 3.300676e-01 | 0.481 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 1.322279e-01 | 0.879 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 1.741674e-01 | 0.759 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 1.109188e-01 | 0.955 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 1.109188e-01 | 0.955 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 2.399388e-01 | 0.620 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 1.440673e-01 | 0.841 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 2.972582e-01 | 0.527 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 1.853145e-01 | 0.732 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 3.242784e-01 | 0.489 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 1.322459e-01 | 0.879 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 3.502613e-01 | 0.456 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 1.502235e-01 | 0.823 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 3.752466e-01 | 0.426 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 3.992725e-01 | 0.399 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 3.992725e-01 | 0.399 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 3.992725e-01 | 0.399 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 2.999714e-01 | 0.523 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 2.387023e-01 | 0.622 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 3.143091e-01 | 0.503 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 1.179882e-01 | 0.928 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 3.122812e-01 | 0.505 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 4.176412e-01 | 0.379 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 2.279531e-01 | 0.642 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.494439e-01 | 0.826 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 1.494439e-01 | 0.826 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.440673e-01 | 0.841 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 2.355350e-01 | 0.628 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 1.713654e-01 | 0.766 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 3.661046e-01 | 0.436 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 3.242784e-01 | 0.489 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 2.081166e-01 | 0.682 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 3.984235e-01 | 0.400 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 4.048667e-01 | 0.393 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 2.779622e-01 | 0.556 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 3.240435e-01 | 0.489 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 2.399388e-01 | 0.620 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 3.502613e-01 | 0.456 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 2.805087e-01 | 0.552 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 2.805087e-01 | 0.552 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.853145e-01 | 0.732 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 3.830182e-01 | 0.417 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 2.567425e-01 | 0.591 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 1.094748e-01 | 0.961 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 3.016694e-01 | 0.520 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.413863e-01 | 0.850 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 2.387023e-01 | 0.622 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 3.242784e-01 | 0.489 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 3.752466e-01 | 0.426 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 3.992725e-01 | 0.399 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.444846e-01 | 0.840 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 3.929443e-01 | 0.406 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 2.182172e-01 | 0.661 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 1.853145e-01 | 0.732 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 1.502235e-01 | 0.823 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 1.372400e-01 | 0.863 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 2.190103e-01 | 0.660 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 3.984235e-01 | 0.400 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 2.423293e-01 | 0.616 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.150919e-01 | 0.939 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.339338e-01 | 0.873 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 1.152219e-01 | 0.938 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 1.152219e-01 | 0.938 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 1.567123e-01 | 0.805 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.840505e-01 | 0.735 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 1.307954e-01 | 0.883 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.251407e-01 | 0.903 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 1.709262e-01 | 0.767 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.353151e-01 | 0.869 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 1.109188e-01 | 0.955 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 1.779521e-01 | 0.750 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 2.095519e-01 | 0.679 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 2.691594e-01 | 0.570 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 1.853145e-01 | 0.732 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 3.242784e-01 | 0.489 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 3.242784e-01 | 0.489 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 1.235597e-01 | 0.908 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 3.502613e-01 | 0.456 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 3.502613e-01 | 0.456 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 3.502613e-01 | 0.456 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 3.502613e-01 | 0.456 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.279531e-01 | 0.642 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 3.752466e-01 | 0.426 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 2.182172e-01 | 0.661 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 1.372400e-01 | 0.863 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 2.699782e-01 | 0.569 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 1.614719e-01 | 0.792 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 2.805087e-01 | 0.552 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 3.863810e-01 | 0.413 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 1.939167e-01 | 0.712 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 4.172556e-01 | 0.380 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 2.387023e-01 | 0.622 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 3.863810e-01 | 0.413 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 2.017521e-01 | 0.695 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 3.568607e-01 | 0.448 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 2.387023e-01 | 0.622 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 2.972582e-01 | 0.527 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.423293e-01 | 0.616 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 3.752466e-01 | 0.426 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 3.708416e-01 | 0.431 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 3.682233e-01 | 0.434 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 2.579546e-01 | 0.588 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 2.619097e-01 | 0.582 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 2.844678e-01 | 0.546 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 2.692075e-01 | 0.570 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 1.853145e-01 | 0.732 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 3.335247e-01 | 0.477 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 3.863810e-01 | 0.413 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 1.293616e-01 | 0.888 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 3.547404e-01 | 0.450 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 3.122812e-01 | 0.505 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 1.350798e-01 | 0.869 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.809070e-01 | 0.743 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 1.069982e-01 | 0.971 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.733301e-01 | 0.761 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 2.399388e-01 | 0.620 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 2.399388e-01 | 0.620 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.178309e-01 | 0.929 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 2.691594e-01 | 0.570 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 3.242784e-01 | 0.489 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 3.242784e-01 | 0.489 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 3.242784e-01 | 0.489 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 3.502613e-01 | 0.456 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 3.752466e-01 | 0.426 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 3.752466e-01 | 0.426 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 3.122812e-01 | 0.505 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 3.846996e-01 | 0.415 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 4.005361e-01 | 0.397 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.282604e-01 | 0.892 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 3.708416e-01 | 0.431 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 3.568607e-01 | 0.448 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.480446e-01 | 0.830 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.150919e-01 | 0.939 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.150919e-01 | 0.939 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 3.300131e-01 | 0.481 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 1.221322e-01 | 0.913 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 1.576039e-01 | 0.802 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 1.341843e-01 | 0.872 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 2.910755e-01 | 0.536 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 2.844678e-01 | 0.546 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 2.855849e-01 | 0.544 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.411379e-01 | 0.850 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 1.567327e-01 | 0.805 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 2.399388e-01 | 0.620 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 2.691594e-01 | 0.570 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 2.691594e-01 | 0.570 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 1.440673e-01 | 0.841 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 1.994167e-01 | 0.700 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 3.752466e-01 | 0.426 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 3.752466e-01 | 0.426 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 1.063928e-01 | 0.973 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 4.223759e-01 | 0.374 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 4.223759e-01 | 0.374 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 3.018400e-01 | 0.520 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 3.385985e-01 | 0.470 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 4.089015e-01 | 0.388 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 3.698525e-01 | 0.432 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.690691e-01 | 0.772 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 2.986565e-01 | 0.525 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 2.355265e-01 | 0.628 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 2.080672e-01 | 0.682 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.861356e-01 | 0.730 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.940681e-01 | 0.712 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 2.233937e-01 | 0.651 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.494772e-01 | 0.825 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 2.168719e-01 | 0.664 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 1.853145e-01 | 0.732 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 2.108732e-01 | 0.676 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 3.968516e-01 | 0.401 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.658394e-01 | 0.780 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 2.281086e-01 | 0.642 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 3.742357e-01 | 0.427 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 1.447549e-01 | 0.839 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 2.529961e-01 | 0.597 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 3.127236e-01 | 0.505 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 1.440673e-01 | 0.841 | 0 | 0 |
| Zinc efflux and compartmentalization by the SLC30 family | R-HSA-435368 | 2.399388e-01 | 0.620 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 2.279531e-01 | 0.642 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 3.752466e-01 | 0.426 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 4.223759e-01 | 0.374 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 2.711684e-01 | 0.567 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 1.251407e-01 | 0.903 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 2.991069e-01 | 0.524 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 3.752466e-01 | 0.426 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 3.235635e-01 | 0.490 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.068545e-01 | 0.971 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 2.711684e-01 | 0.567 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 3.708416e-01 | 0.431 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 3.992685e-01 | 0.399 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 3.143091e-01 | 0.503 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 3.992725e-01 | 0.399 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 3.285803e-01 | 0.483 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 3.708416e-01 | 0.431 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 2.047960e-01 | 0.689 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 3.752466e-01 | 0.426 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 2.387023e-01 | 0.622 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 3.143091e-01 | 0.503 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 2.570189e-01 | 0.590 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 1.440673e-01 | 0.841 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 3.758679e-01 | 0.425 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 4.086552e-01 | 0.389 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 2.136395e-01 | 0.670 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 2.699782e-01 | 0.569 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 1.576039e-01 | 0.802 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 2.423293e-01 | 0.616 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 2.699782e-01 | 0.569 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 1.726078e-01 | 0.763 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 2.077871e-01 | 0.682 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 3.249275e-01 | 0.488 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 2.646689e-01 | 0.577 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 4.241662e-01 | 0.372 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 4.254291e-01 | 0.371 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 4.254291e-01 | 0.371 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 4.254291e-01 | 0.371 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 4.279486e-01 | 0.369 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 4.279486e-01 | 0.369 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 4.279486e-01 | 0.369 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 4.279486e-01 | 0.369 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 4.285898e-01 | 0.368 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 4.349999e-01 | 0.362 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 4.352751e-01 | 0.361 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 4.445922e-01 | 0.352 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 4.445922e-01 | 0.352 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 4.445922e-01 | 0.352 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 4.445922e-01 | 0.352 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 4.445922e-01 | 0.352 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 4.445922e-01 | 0.352 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 4.445922e-01 | 0.352 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 4.445922e-01 | 0.352 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 4.445922e-01 | 0.352 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 4.445922e-01 | 0.352 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 4.469177e-01 | 0.350 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 4.517887e-01 | 0.345 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 4.517887e-01 | 0.345 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 4.524383e-01 | 0.344 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 4.524383e-01 | 0.344 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 4.550609e-01 | 0.342 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 4.554773e-01 | 0.342 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 4.557896e-01 | 0.341 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 4.609567e-01 | 0.336 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 4.619055e-01 | 0.335 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 4.647081e-01 | 0.333 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 4.647081e-01 | 0.333 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 4.647081e-01 | 0.333 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 4.659552e-01 | 0.332 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 4.659552e-01 | 0.332 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 4.659552e-01 | 0.332 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 4.659552e-01 | 0.332 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 4.659552e-01 | 0.332 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 4.659552e-01 | 0.332 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 4.659552e-01 | 0.332 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 4.659552e-01 | 0.332 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 4.659552e-01 | 0.332 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 4.659552e-01 | 0.332 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 4.659552e-01 | 0.332 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 4.659552e-01 | 0.332 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 4.659552e-01 | 0.332 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 4.659552e-01 | 0.332 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 4.659552e-01 | 0.332 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 4.659552e-01 | 0.332 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 4.659552e-01 | 0.332 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 4.659552e-01 | 0.332 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 4.659552e-01 | 0.332 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 4.659552e-01 | 0.332 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 4.659552e-01 | 0.332 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 4.669299e-01 | 0.331 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 4.669299e-01 | 0.331 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 4.684766e-01 | 0.329 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 4.684766e-01 | 0.329 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 4.694364e-01 | 0.328 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 4.694364e-01 | 0.328 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 4.757765e-01 | 0.323 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 4.768803e-01 | 0.322 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 4.774460e-01 | 0.321 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 4.774460e-01 | 0.321 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 4.778518e-01 | 0.321 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 4.824954e-01 | 0.317 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 4.862228e-01 | 0.313 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 4.864978e-01 | 0.313 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 4.864978e-01 | 0.313 | 0 | 0 |
| FGFR2c ligand binding and activation | R-HSA-190375 | 4.864978e-01 | 0.313 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 4.864978e-01 | 0.313 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 4.864978e-01 | 0.313 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 4.864978e-01 | 0.313 | 0 | 0 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 4.864978e-01 | 0.313 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 4.864978e-01 | 0.313 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 4.864978e-01 | 0.313 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 4.864978e-01 | 0.313 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 4.864978e-01 | 0.313 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 4.864978e-01 | 0.313 | 0 | 0 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 4.864978e-01 | 0.313 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 4.864978e-01 | 0.313 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 4.864978e-01 | 0.313 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 4.864978e-01 | 0.313 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 4.882563e-01 | 0.311 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 4.907701e-01 | 0.309 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 4.916620e-01 | 0.308 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 4.922395e-01 | 0.308 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 4.980111e-01 | 0.303 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 4.980111e-01 | 0.303 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 4.980111e-01 | 0.303 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 4.980111e-01 | 0.303 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 5.023571e-01 | 0.299 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 5.023571e-01 | 0.299 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 5.023571e-01 | 0.299 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 5.023571e-01 | 0.299 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 5.053860e-01 | 0.296 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 5.062515e-01 | 0.296 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 5.062515e-01 | 0.296 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 5.062515e-01 | 0.296 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 5.062515e-01 | 0.296 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 5.062515e-01 | 0.296 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 5.062515e-01 | 0.296 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 5.062515e-01 | 0.296 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 5.062515e-01 | 0.296 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 5.062515e-01 | 0.296 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 5.062890e-01 | 0.296 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 5.062890e-01 | 0.296 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 5.076713e-01 | 0.294 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 5.076713e-01 | 0.294 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 5.109976e-01 | 0.292 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 5.145220e-01 | 0.289 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 5.172336e-01 | 0.286 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 5.172336e-01 | 0.286 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 5.174458e-01 | 0.286 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 5.175206e-01 | 0.286 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 5.252463e-01 | 0.280 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 5.252463e-01 | 0.280 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 5.252463e-01 | 0.280 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 5.252463e-01 | 0.280 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 5.252463e-01 | 0.280 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 5.252463e-01 | 0.280 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 5.252463e-01 | 0.280 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 5.252463e-01 | 0.280 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 5.252463e-01 | 0.280 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 5.252463e-01 | 0.280 | 0 | 0 |
| Dopamine clearance from the synaptic cleft | R-HSA-379401 | 5.252463e-01 | 0.280 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 5.264885e-01 | 0.279 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 5.295468e-01 | 0.276 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 5.350203e-01 | 0.272 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 5.350203e-01 | 0.272 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 5.355165e-01 | 0.271 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 5.382540e-01 | 0.269 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 5.431541e-01 | 0.265 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 5.435116e-01 | 0.265 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 5.435116e-01 | 0.265 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 5.435116e-01 | 0.265 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 5.435116e-01 | 0.265 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 5.435116e-01 | 0.265 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 5.435116e-01 | 0.265 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 5.435116e-01 | 0.265 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 5.435116e-01 | 0.265 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 5.435116e-01 | 0.265 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 5.473641e-01 | 0.262 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 5.498162e-01 | 0.260 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 5.498162e-01 | 0.260 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 5.498162e-01 | 0.260 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 5.519432e-01 | 0.258 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 5.543361e-01 | 0.256 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 5.560600e-01 | 0.255 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 5.588193e-01 | 0.253 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 5.610752e-01 | 0.251 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 5.610752e-01 | 0.251 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 5.610752e-01 | 0.251 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 5.610752e-01 | 0.251 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 5.610752e-01 | 0.251 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 5.610752e-01 | 0.251 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 5.611733e-01 | 0.251 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 5.611733e-01 | 0.251 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 5.611733e-01 | 0.251 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 5.698222e-01 | 0.244 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 5.706648e-01 | 0.244 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 5.723240e-01 | 0.242 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 5.723240e-01 | 0.242 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 5.731333e-01 | 0.242 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 5.731333e-01 | 0.242 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 5.742509e-01 | 0.241 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 5.779641e-01 | 0.238 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 5.779641e-01 | 0.238 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 5.779641e-01 | 0.238 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 5.779641e-01 | 0.238 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 5.779641e-01 | 0.238 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 5.779641e-01 | 0.238 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 5.832673e-01 | 0.234 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 5.832673e-01 | 0.234 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 5.832673e-01 | 0.234 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 5.832673e-01 | 0.234 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 5.854451e-01 | 0.233 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 5.860507e-01 | 0.232 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 5.877672e-01 | 0.231 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 5.899010e-01 | 0.229 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 5.899010e-01 | 0.229 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 5.899010e-01 | 0.229 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 5.942041e-01 | 0.226 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 5.942041e-01 | 0.226 | 0 | 0 |
| Activated point mutants of FGFR2 | R-HSA-2033519 | 5.942041e-01 | 0.226 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 5.942041e-01 | 0.226 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 5.942041e-01 | 0.226 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 5.942041e-01 | 0.226 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 5.942041e-01 | 0.226 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 5.942041e-01 | 0.226 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 5.942041e-01 | 0.226 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 5.975724e-01 | 0.224 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 6.021587e-01 | 0.220 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 6.040040e-01 | 0.219 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 6.045301e-01 | 0.219 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 6.069315e-01 | 0.217 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 6.069315e-01 | 0.217 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 6.098201e-01 | 0.215 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 6.098201e-01 | 0.215 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 6.098201e-01 | 0.215 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 6.098201e-01 | 0.215 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 6.098201e-01 | 0.215 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 6.098201e-01 | 0.215 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 6.098201e-01 | 0.215 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 6.098201e-01 | 0.215 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 6.098201e-01 | 0.215 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 6.098201e-01 | 0.215 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 6.098201e-01 | 0.215 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 6.098201e-01 | 0.215 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 6.098201e-01 | 0.215 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 6.112567e-01 | 0.214 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 6.148494e-01 | 0.211 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 6.148494e-01 | 0.211 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 6.148494e-01 | 0.211 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 6.148494e-01 | 0.211 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 6.148494e-01 | 0.211 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 6.152685e-01 | 0.211 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 6.152685e-01 | 0.211 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 6.152685e-01 | 0.211 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 6.184270e-01 | 0.209 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 6.209222e-01 | 0.207 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 6.212468e-01 | 0.207 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 6.234854e-01 | 0.205 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 6.248361e-01 | 0.204 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 6.248361e-01 | 0.204 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 6.248361e-01 | 0.204 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 6.248361e-01 | 0.204 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 6.248361e-01 | 0.204 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 6.248361e-01 | 0.204 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 6.248361e-01 | 0.204 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 6.248361e-01 | 0.204 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 6.248361e-01 | 0.204 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 6.248361e-01 | 0.204 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 6.248361e-01 | 0.204 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 6.248361e-01 | 0.204 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 6.248361e-01 | 0.204 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 6.249611e-01 | 0.204 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 6.249611e-01 | 0.204 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 6.262651e-01 | 0.203 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 6.263041e-01 | 0.203 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 6.263041e-01 | 0.203 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 6.270403e-01 | 0.203 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 6.281315e-01 | 0.202 | 0 | 0 |
| Disease | R-HSA-1643685 | 6.322026e-01 | 0.199 | 0 | 0 |
| S Phase | R-HSA-69242 | 6.327823e-01 | 0.199 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 6.348660e-01 | 0.197 | 0 | 0 |
| FGFR2 ligand binding and activation | R-HSA-190241 | 6.392751e-01 | 0.194 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 6.392751e-01 | 0.194 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 6.392751e-01 | 0.194 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 6.392751e-01 | 0.194 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 6.392751e-01 | 0.194 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 6.395564e-01 | 0.194 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 6.408550e-01 | 0.193 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 6.413013e-01 | 0.193 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 6.445649e-01 | 0.191 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 6.462681e-01 | 0.190 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 6.474094e-01 | 0.189 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 6.531593e-01 | 0.185 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 6.531593e-01 | 0.185 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 6.531593e-01 | 0.185 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 6.531593e-01 | 0.185 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 6.531593e-01 | 0.185 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 6.531593e-01 | 0.185 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 6.534744e-01 | 0.185 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 6.551403e-01 | 0.184 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 6.596753e-01 | 0.181 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 6.633499e-01 | 0.178 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 6.633499e-01 | 0.178 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 6.636358e-01 | 0.178 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 6.653437e-01 | 0.177 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 6.665098e-01 | 0.176 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 6.665098e-01 | 0.176 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 6.665098e-01 | 0.176 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 6.665098e-01 | 0.176 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 6.665098e-01 | 0.176 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 6.665098e-01 | 0.176 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 6.665098e-01 | 0.176 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 6.665098e-01 | 0.176 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 6.702349e-01 | 0.174 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 6.724388e-01 | 0.172 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 6.768043e-01 | 0.170 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 6.793473e-01 | 0.168 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 6.793473e-01 | 0.168 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 6.793473e-01 | 0.168 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 6.793473e-01 | 0.168 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 6.813278e-01 | 0.167 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 6.813278e-01 | 0.167 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 6.813278e-01 | 0.167 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 6.813278e-01 | 0.167 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 6.820612e-01 | 0.166 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 6.848401e-01 | 0.164 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 6.854451e-01 | 0.164 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 6.900186e-01 | 0.161 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 6.916683e-01 | 0.160 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 6.916683e-01 | 0.160 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 6.916913e-01 | 0.160 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 6.916913e-01 | 0.160 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 6.916913e-01 | 0.160 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 6.916913e-01 | 0.160 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 6.916913e-01 | 0.160 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 6.916913e-01 | 0.160 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 6.939647e-01 | 0.159 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 6.978037e-01 | 0.156 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 6.985134e-01 | 0.156 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 6.985134e-01 | 0.156 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 6.989572e-01 | 0.156 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 7.015401e-01 | 0.154 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 7.035609e-01 | 0.153 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 7.035609e-01 | 0.153 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 7.035609e-01 | 0.153 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 7.035609e-01 | 0.153 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 7.035609e-01 | 0.153 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 7.035609e-01 | 0.153 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 7.035609e-01 | 0.153 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 7.035609e-01 | 0.153 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 7.035609e-01 | 0.153 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 7.035609e-01 | 0.153 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 7.035609e-01 | 0.153 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 7.035609e-01 | 0.153 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 7.035609e-01 | 0.153 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 7.058336e-01 | 0.151 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 7.068144e-01 | 0.151 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 7.068144e-01 | 0.151 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 7.068144e-01 | 0.151 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 7.068144e-01 | 0.151 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 7.125893e-01 | 0.147 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 7.125893e-01 | 0.147 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 7.149238e-01 | 0.146 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 7.149238e-01 | 0.146 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 7.149238e-01 | 0.146 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 7.149238e-01 | 0.146 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 7.149238e-01 | 0.146 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 7.149741e-01 | 0.146 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 7.149741e-01 | 0.146 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 7.149741e-01 | 0.146 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 7.149741e-01 | 0.146 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 7.155965e-01 | 0.145 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 7.188791e-01 | 0.143 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 7.228442e-01 | 0.141 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 7.228442e-01 | 0.141 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 7.259487e-01 | 0.139 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 7.259487e-01 | 0.139 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 7.259487e-01 | 0.139 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 7.259487e-01 | 0.139 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 7.259487e-01 | 0.139 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 7.259487e-01 | 0.139 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 7.259487e-01 | 0.139 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 7.259487e-01 | 0.139 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 7.259487e-01 | 0.139 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 7.259487e-01 | 0.139 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 7.261331e-01 | 0.139 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 7.268262e-01 | 0.139 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 7.305781e-01 | 0.136 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 7.305781e-01 | 0.136 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 7.305781e-01 | 0.136 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 7.307435e-01 | 0.136 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 7.321378e-01 | 0.135 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 7.365013e-01 | 0.133 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 7.365013e-01 | 0.133 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 7.365013e-01 | 0.133 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 7.365013e-01 | 0.133 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 7.365013e-01 | 0.133 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 7.365013e-01 | 0.133 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 7.365013e-01 | 0.133 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 7.365013e-01 | 0.133 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 7.365013e-01 | 0.133 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 7.381280e-01 | 0.132 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 7.381280e-01 | 0.132 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 7.384170e-01 | 0.132 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 7.454967e-01 | 0.128 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 7.466482e-01 | 0.127 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 7.466482e-01 | 0.127 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 7.466482e-01 | 0.127 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 7.466482e-01 | 0.127 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 7.466482e-01 | 0.127 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 7.490794e-01 | 0.125 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 7.490794e-01 | 0.125 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 7.506249e-01 | 0.125 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 7.506249e-01 | 0.125 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 7.514856e-01 | 0.124 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 7.526869e-01 | 0.123 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 7.526869e-01 | 0.123 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 7.526869e-01 | 0.123 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 7.526869e-01 | 0.123 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 7.564049e-01 | 0.121 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 7.564049e-01 | 0.121 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 7.564049e-01 | 0.121 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 7.564049e-01 | 0.121 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 7.564049e-01 | 0.121 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 7.594401e-01 | 0.120 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 7.597015e-01 | 0.119 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 7.597015e-01 | 0.119 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 7.597015e-01 | 0.119 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 7.597015e-01 | 0.119 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 7.623720e-01 | 0.118 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 7.623720e-01 | 0.118 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 7.623720e-01 | 0.118 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 7.627728e-01 | 0.118 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 7.627728e-01 | 0.118 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 7.646145e-01 | 0.117 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 7.657865e-01 | 0.116 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 7.665432e-01 | 0.115 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 7.680753e-01 | 0.115 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 7.680753e-01 | 0.115 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 7.745485e-01 | 0.111 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 7.748073e-01 | 0.111 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 7.748073e-01 | 0.111 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 7.748073e-01 | 0.111 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 7.748073e-01 | 0.111 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 7.748073e-01 | 0.111 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 7.748073e-01 | 0.111 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 7.791471e-01 | 0.108 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 7.797198e-01 | 0.108 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 7.816183e-01 | 0.107 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 7.834813e-01 | 0.106 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 7.834813e-01 | 0.106 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 7.834813e-01 | 0.106 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 7.834813e-01 | 0.106 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 7.834813e-01 | 0.106 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 7.834813e-01 | 0.106 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 7.834813e-01 | 0.106 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 7.834813e-01 | 0.106 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 7.841497e-01 | 0.106 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 7.845180e-01 | 0.105 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 7.845180e-01 | 0.105 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 7.845180e-01 | 0.105 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 7.860606e-01 | 0.105 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 7.897804e-01 | 0.102 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 7.918216e-01 | 0.101 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 7.918216e-01 | 0.101 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 7.918216e-01 | 0.101 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 7.918216e-01 | 0.101 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 7.918216e-01 | 0.101 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 7.922404e-01 | 0.101 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 7.922404e-01 | 0.101 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 7.949358e-01 | 0.100 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 7.953112e-01 | 0.099 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 7.982621e-01 | 0.098 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 7.993990e-01 | 0.097 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 7.998411e-01 | 0.097 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 7.998411e-01 | 0.097 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 7.998411e-01 | 0.097 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 7.998411e-01 | 0.097 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 7.998411e-01 | 0.097 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 7.998411e-01 | 0.097 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 7.998411e-01 | 0.097 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 7.998411e-01 | 0.097 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 7.998411e-01 | 0.097 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 8.068058e-01 | 0.093 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 8.075522e-01 | 0.093 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 8.075522e-01 | 0.093 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 8.075522e-01 | 0.093 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 8.097720e-01 | 0.092 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 8.097720e-01 | 0.092 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 8.145120e-01 | 0.089 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 8.149667e-01 | 0.089 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 8.149667e-01 | 0.089 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 8.149667e-01 | 0.089 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 8.149667e-01 | 0.089 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 8.149667e-01 | 0.089 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 8.151101e-01 | 0.089 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 8.188803e-01 | 0.087 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 8.205169e-01 | 0.086 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 8.208283e-01 | 0.086 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 8.220959e-01 | 0.085 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 8.220959e-01 | 0.085 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 8.220959e-01 | 0.085 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 8.220959e-01 | 0.085 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 8.220959e-01 | 0.085 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 8.220959e-01 | 0.085 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 8.236922e-01 | 0.084 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 8.289509e-01 | 0.081 | 0 | 0 |
| Depurination | R-HSA-73927 | 8.289509e-01 | 0.081 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 8.289509e-01 | 0.081 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 8.289509e-01 | 0.081 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 8.289509e-01 | 0.081 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 8.289509e-01 | 0.081 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 8.312409e-01 | 0.080 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 8.324818e-01 | 0.080 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 8.324818e-01 | 0.080 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 8.327209e-01 | 0.080 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 8.355421e-01 | 0.078 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 8.355421e-01 | 0.078 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 8.355421e-01 | 0.078 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 8.355421e-01 | 0.078 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 8.362400e-01 | 0.078 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 8.362400e-01 | 0.078 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 8.362400e-01 | 0.078 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 8.367338e-01 | 0.077 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 8.402194e-01 | 0.076 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 8.408925e-01 | 0.075 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 8.418798e-01 | 0.075 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 8.418798e-01 | 0.075 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 8.418798e-01 | 0.075 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 8.418798e-01 | 0.075 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 8.418798e-01 | 0.075 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 8.449593e-01 | 0.073 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 8.479735e-01 | 0.072 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 8.479735e-01 | 0.072 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 8.479735e-01 | 0.072 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 8.479735e-01 | 0.072 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 8.479735e-01 | 0.072 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 8.504438e-01 | 0.070 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 8.504438e-01 | 0.070 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 8.504438e-01 | 0.070 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 8.504438e-01 | 0.070 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 8.538328e-01 | 0.069 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 8.538328e-01 | 0.069 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 8.538328e-01 | 0.069 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 8.538328e-01 | 0.069 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 8.538328e-01 | 0.069 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 8.565293e-01 | 0.067 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 8.565293e-01 | 0.067 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 8.594666e-01 | 0.066 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 8.594666e-01 | 0.066 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 8.624606e-01 | 0.064 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 8.635173e-01 | 0.064 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 8.638193e-01 | 0.064 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 8.639664e-01 | 0.064 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 8.648836e-01 | 0.063 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 8.648836e-01 | 0.063 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 8.648836e-01 | 0.063 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 8.654161e-01 | 0.063 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 8.665516e-01 | 0.062 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 8.686977e-01 | 0.061 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 8.700921e-01 | 0.060 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 8.700921e-01 | 0.060 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 8.700921e-01 | 0.060 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 8.751002e-01 | 0.058 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 8.751002e-01 | 0.058 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 8.770295e-01 | 0.057 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 8.799154e-01 | 0.056 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 8.799154e-01 | 0.056 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 8.799154e-01 | 0.056 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 8.799154e-01 | 0.056 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 8.799154e-01 | 0.056 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 8.808949e-01 | 0.055 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 8.845453e-01 | 0.053 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 8.845453e-01 | 0.053 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 8.845453e-01 | 0.053 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 8.845453e-01 | 0.053 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 8.871247e-01 | 0.052 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 8.889970e-01 | 0.051 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 8.932773e-01 | 0.049 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 8.940039e-01 | 0.049 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 8.949758e-01 | 0.048 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 8.949758e-01 | 0.048 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 8.968918e-01 | 0.047 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 8.973928e-01 | 0.047 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 8.987176e-01 | 0.046 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.013498e-01 | 0.045 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.013498e-01 | 0.045 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 9.013498e-01 | 0.045 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.041027e-01 | 0.044 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 9.051545e-01 | 0.043 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 9.051545e-01 | 0.043 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 9.051545e-01 | 0.043 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 9.051545e-01 | 0.043 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.084281e-01 | 0.042 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 9.088126e-01 | 0.042 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.088126e-01 | 0.042 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.123299e-01 | 0.040 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.123299e-01 | 0.040 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.157117e-01 | 0.038 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.159964e-01 | 0.038 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 9.163925e-01 | 0.038 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 9.189633e-01 | 0.037 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.220896e-01 | 0.035 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 9.250955e-01 | 0.034 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 9.252680e-01 | 0.034 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.273350e-01 | 0.033 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 9.279855e-01 | 0.032 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.279855e-01 | 0.032 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.279855e-01 | 0.032 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 9.293443e-01 | 0.032 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 9.293494e-01 | 0.032 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.293494e-01 | 0.032 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.295597e-01 | 0.032 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 9.307643e-01 | 0.031 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 9.307643e-01 | 0.031 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 9.327169e-01 | 0.030 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.334360e-01 | 0.030 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.352863e-01 | 0.029 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.360047e-01 | 0.029 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 9.360047e-01 | 0.029 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 9.360047e-01 | 0.029 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 9.384745e-01 | 0.028 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.408491e-01 | 0.026 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.474378e-01 | 0.023 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.491057e-01 | 0.023 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 9.494670e-01 | 0.023 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 9.532937e-01 | 0.021 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.532937e-01 | 0.021 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 9.532937e-01 | 0.021 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.550971e-01 | 0.020 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 9.550971e-01 | 0.020 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 9.550971e-01 | 0.020 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.550971e-01 | 0.020 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.568310e-01 | 0.019 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 9.601008e-01 | 0.018 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.616418e-01 | 0.017 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 9.616418e-01 | 0.017 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 9.629743e-01 | 0.016 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 9.631233e-01 | 0.016 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.643388e-01 | 0.016 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 9.644204e-01 | 0.016 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 9.655145e-01 | 0.015 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.672338e-01 | 0.014 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.672338e-01 | 0.014 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 9.697167e-01 | 0.013 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.720118e-01 | 0.012 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.729301e-01 | 0.012 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.730933e-01 | 0.012 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.770179e-01 | 0.010 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.779063e-01 | 0.010 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.795815e-01 | 0.009 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.795815e-01 | 0.009 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 9.815184e-01 | 0.008 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.832353e-01 | 0.007 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.851062e-01 | 0.007 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 9.856823e-01 | 0.006 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.862362e-01 | 0.006 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.863758e-01 | 0.006 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.867687e-01 | 0.006 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 9.882458e-01 | 0.005 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.887006e-01 | 0.005 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.903092e-01 | 0.004 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.904944e-01 | 0.004 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.914285e-01 | 0.004 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.917604e-01 | 0.004 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.917604e-01 | 0.004 | 0 | 0 |
| Translation | R-HSA-72766 | 9.919260e-01 | 0.004 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.933804e-01 | 0.003 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.938848e-01 | 0.003 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 9.942253e-01 | 0.003 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.942326e-01 | 0.003 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.954141e-01 | 0.002 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.965454e-01 | 0.002 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.971946e-01 | 0.001 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.974903e-01 | 0.001 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.976794e-01 | 0.001 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.977641e-01 | 0.001 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.983051e-01 | 0.001 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.983061e-01 | 0.001 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.984993e-01 | 0.001 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.986095e-01 | 0.001 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.994356e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.995766e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.996663e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.996917e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.997665e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.998676e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999258e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999412e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999464e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.999890e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999905e-01 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.999924e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999960e-01 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.999966e-01 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 9.999992e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.999998e-01 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.999999e-01 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 1.110223e-16 | 15.955 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 1.110223e-16 | 15.955 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 1.110223e-16 | 15.955 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 1.110223e-16 | 15.955 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.110223e-16 | 15.955 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.110223e-16 | 15.955 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.110223e-16 | 15.955 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 2.220446e-16 | 15.654 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 5.551115e-16 | 15.256 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 5.551115e-16 | 15.256 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 9.992007e-16 | 15.000 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.110223e-15 | 14.955 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.443290e-15 | 14.841 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 1.665335e-15 | 14.778 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 2.109424e-15 | 14.676 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 2.331468e-15 | 14.632 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 2.442491e-15 | 14.612 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 8.659740e-15 | 14.062 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 1.865175e-14 | 13.729 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 1.865175e-14 | 13.729 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 2.331468e-14 | 13.632 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 2.609024e-14 | 13.584 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 2.919887e-14 | 13.535 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 3.996803e-14 | 13.398 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.348078e-14 | 13.029 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 1.014744e-13 | 12.994 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 1.052491e-13 | 12.978 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 1.362244e-13 | 12.866 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 2.414735e-13 | 12.617 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 2.730038e-13 | 12.564 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 3.430589e-13 | 12.465 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 3.596012e-13 | 12.444 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 5.196954e-13 | 12.284 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 8.116841e-13 | 12.091 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.162181e-12 | 11.935 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.546319e-12 | 11.811 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.485478e-12 | 11.828 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 1.556755e-12 | 11.808 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 2.051581e-12 | 11.688 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 2.165379e-12 | 11.664 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 3.952838e-12 | 11.403 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 3.878342e-12 | 11.411 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 4.484857e-12 | 11.348 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 8.583023e-12 | 11.066 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 8.634427e-12 | 11.064 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.006795e-11 | 10.997 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.440348e-11 | 10.842 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 1.537825e-11 | 10.813 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 1.661804e-11 | 10.779 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 1.850187e-11 | 10.733 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 2.259504e-11 | 10.646 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 3.333844e-11 | 10.477 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 3.395029e-11 | 10.469 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 3.537892e-11 | 10.451 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 4.759237e-11 | 10.322 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 5.589118e-11 | 10.253 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 5.589118e-11 | 10.253 | 0 | 0 |
| Protein folding | R-HSA-391251 | 5.596767e-11 | 10.252 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 6.176282e-11 | 10.209 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 7.787393e-11 | 10.109 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 1.024860e-10 | 9.989 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 9.932732e-11 | 10.003 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.154896e-10 | 9.937 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.211079e-10 | 9.917 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.304304e-10 | 9.885 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.406714e-10 | 9.852 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 1.513105e-10 | 9.820 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 1.521953e-10 | 9.818 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.878340e-10 | 9.726 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 2.100984e-10 | 9.678 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 2.650110e-10 | 9.577 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 3.679772e-10 | 9.434 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 5.060266e-10 | 9.296 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 5.953317e-10 | 9.225 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 5.976848e-10 | 9.224 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 6.696624e-10 | 9.174 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 6.861022e-10 | 9.164 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 7.198246e-10 | 9.143 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 7.623704e-10 | 9.118 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 8.589697e-10 | 9.066 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 9.274217e-10 | 9.033 | 0 | 0 |
| Translation | R-HSA-72766 | 1.047173e-09 | 8.980 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.118021e-09 | 8.952 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.407535e-09 | 8.852 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 2.136957e-09 | 8.670 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 2.426450e-09 | 8.615 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 2.470936e-09 | 8.607 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 2.804590e-09 | 8.552 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 2.921165e-09 | 8.534 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 3.370490e-09 | 8.472 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 3.616856e-09 | 8.442 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 3.811692e-09 | 8.419 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 4.311236e-09 | 8.365 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 4.557095e-09 | 8.341 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 6.873423e-09 | 8.163 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 7.480149e-09 | 8.126 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 7.702039e-09 | 8.113 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 1.029907e-08 | 7.987 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 1.962065e-08 | 7.707 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 2.329591e-08 | 7.633 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 2.679841e-08 | 7.572 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 2.679841e-08 | 7.572 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 2.679841e-08 | 7.572 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 2.679841e-08 | 7.572 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 2.501721e-08 | 7.602 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 2.679841e-08 | 7.572 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 2.716864e-08 | 7.566 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 3.330817e-08 | 7.477 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 4.032802e-08 | 7.394 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 4.839993e-08 | 7.315 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 5.517253e-08 | 7.258 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 5.694878e-08 | 7.245 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 6.583378e-08 | 7.182 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 8.072862e-08 | 7.093 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 8.653614e-08 | 7.063 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 8.726767e-08 | 7.059 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 9.445942e-08 | 7.025 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.028389e-07 | 6.988 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.124654e-07 | 6.949 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.202380e-07 | 6.920 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.478080e-07 | 6.830 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.550616e-07 | 6.809 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.550616e-07 | 6.809 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 1.896623e-07 | 6.722 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.909997e-07 | 6.719 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 2.119894e-07 | 6.674 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 2.195409e-07 | 6.658 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 2.199687e-07 | 6.658 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 4.896179e-07 | 6.310 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 4.896179e-07 | 6.310 | 0 | 0 |
| Kinesins | R-HSA-983189 | 4.896179e-07 | 6.310 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 4.969328e-07 | 6.304 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 7.145414e-07 | 6.146 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 7.332392e-07 | 6.135 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 7.609671e-07 | 6.119 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 8.921262e-07 | 6.050 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 9.690694e-07 | 6.014 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.005786e-06 | 5.997 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.119371e-06 | 5.951 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 1.436989e-06 | 5.843 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.465829e-06 | 5.834 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 2.585514e-06 | 5.587 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 2.867926e-06 | 5.542 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 3.176508e-06 | 5.498 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 3.252188e-06 | 5.488 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 3.287447e-06 | 5.483 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 3.456221e-06 | 5.461 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 3.493752e-06 | 5.457 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 4.030838e-06 | 5.395 | 0 | 0 |
| Disease | R-HSA-1643685 | 4.258097e-06 | 5.371 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 4.268997e-06 | 5.370 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 4.313946e-06 | 5.365 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 5.075678e-06 | 5.295 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 5.291653e-06 | 5.276 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 5.502142e-06 | 5.259 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 5.960984e-06 | 5.225 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 5.393332e-06 | 5.268 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 7.310169e-06 | 5.136 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 8.431220e-06 | 5.074 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 8.635426e-06 | 5.064 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 8.749538e-06 | 5.058 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 8.892299e-06 | 5.051 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.874078e-06 | 5.006 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 1.244255e-05 | 4.905 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.274147e-05 | 4.895 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 1.295360e-05 | 4.888 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.353146e-05 | 4.869 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.353365e-05 | 4.869 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.366953e-05 | 4.864 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 1.460628e-05 | 4.835 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 1.645011e-05 | 4.784 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 1.667229e-05 | 4.778 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.824169e-05 | 4.739 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 1.854788e-05 | 4.732 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.854788e-05 | 4.732 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 1.697564e-05 | 4.770 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 1.842702e-05 | 4.735 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 2.101131e-05 | 4.678 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 2.316305e-05 | 4.635 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 2.316305e-05 | 4.635 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 2.365163e-05 | 4.626 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 2.433445e-05 | 4.614 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 2.433445e-05 | 4.614 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 2.433445e-05 | 4.614 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 2.486237e-05 | 4.604 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 2.486237e-05 | 4.604 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 2.562810e-05 | 4.591 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 2.651338e-05 | 4.577 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 2.678361e-05 | 4.572 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 2.919176e-05 | 4.535 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 2.991321e-05 | 4.524 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 3.017035e-05 | 4.520 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 3.281998e-05 | 4.484 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 3.750070e-05 | 4.426 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 4.075168e-05 | 4.390 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 4.332873e-05 | 4.363 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 4.792050e-05 | 4.319 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 4.350446e-05 | 4.361 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 4.533107e-05 | 4.344 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 4.886307e-05 | 4.311 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 5.760606e-05 | 4.240 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 5.890583e-05 | 4.230 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 6.269559e-05 | 4.203 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 6.525163e-05 | 4.185 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 6.641606e-05 | 4.178 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 6.912917e-05 | 4.160 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 6.965531e-05 | 4.157 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 7.083598e-05 | 4.150 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 7.170034e-05 | 4.144 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 7.295738e-05 | 4.137 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 7.734595e-05 | 4.112 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 7.839612e-05 | 4.106 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 7.991280e-05 | 4.097 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 8.030834e-05 | 4.095 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 8.300371e-05 | 4.081 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 8.575669e-05 | 4.067 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 8.575669e-05 | 4.067 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 8.797365e-05 | 4.056 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 9.370845e-05 | 4.028 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 9.492692e-05 | 4.023 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 9.656325e-05 | 4.015 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 9.734307e-05 | 4.012 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 1.008348e-04 | 3.996 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 1.053214e-04 | 3.977 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.254752e-04 | 3.901 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 1.261617e-04 | 3.899 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 1.093666e-04 | 3.961 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 1.330306e-04 | 3.876 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 1.367435e-04 | 3.864 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 1.427791e-04 | 3.845 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.599451e-04 | 3.796 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 1.627366e-04 | 3.789 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.651914e-04 | 3.782 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 1.781619e-04 | 3.749 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.839224e-04 | 3.735 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 1.971313e-04 | 3.705 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 2.039184e-04 | 3.691 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 2.043627e-04 | 3.690 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 2.117110e-04 | 3.674 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 2.117435e-04 | 3.674 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 2.135038e-04 | 3.671 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 2.149959e-04 | 3.668 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 2.630352e-04 | 3.580 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 2.439000e-04 | 3.613 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 2.418302e-04 | 3.616 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 2.578532e-04 | 3.589 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 2.578532e-04 | 3.589 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 2.266819e-04 | 3.645 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 2.630352e-04 | 3.580 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 2.671912e-04 | 3.573 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 2.832652e-04 | 3.548 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 2.936909e-04 | 3.532 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 2.936909e-04 | 3.532 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 2.936909e-04 | 3.532 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 3.061214e-04 | 3.514 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 3.061214e-04 | 3.514 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 3.465601e-04 | 3.460 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 3.514084e-04 | 3.454 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 3.589521e-04 | 3.445 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 3.589521e-04 | 3.445 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 3.645860e-04 | 3.438 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 3.747969e-04 | 3.426 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 3.963072e-04 | 3.402 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 3.963072e-04 | 3.402 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 3.963072e-04 | 3.402 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 4.098781e-04 | 3.387 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 4.106334e-04 | 3.387 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 4.106334e-04 | 3.387 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 4.126644e-04 | 3.384 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 4.126644e-04 | 3.384 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 4.266515e-04 | 3.370 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 4.540383e-04 | 3.343 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 4.540383e-04 | 3.343 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 4.540383e-04 | 3.343 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 4.576424e-04 | 3.339 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 4.602484e-04 | 3.337 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 4.717036e-04 | 3.326 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 4.898903e-04 | 3.310 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 4.903333e-04 | 3.310 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 4.983312e-04 | 3.302 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 5.047951e-04 | 3.297 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 5.280350e-04 | 3.277 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 5.426193e-04 | 3.266 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 5.433246e-04 | 3.265 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 5.761312e-04 | 3.239 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 5.820098e-04 | 3.235 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 5.848092e-04 | 3.233 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 5.950406e-04 | 3.225 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 6.541288e-04 | 3.184 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 6.857887e-04 | 3.164 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 6.915111e-04 | 3.160 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 7.175251e-04 | 3.144 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 7.457210e-04 | 3.127 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 7.460113e-04 | 3.127 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 7.460113e-04 | 3.127 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 7.941041e-04 | 3.100 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 9.065973e-04 | 3.043 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 9.699430e-04 | 3.013 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 9.447180e-04 | 3.025 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 9.751725e-04 | 3.011 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.049010e-03 | 2.979 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 9.535590e-04 | 3.021 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.138777e-03 | 2.944 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 1.160949e-03 | 2.935 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 1.199370e-03 | 2.921 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 1.252876e-03 | 2.902 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 1.252876e-03 | 2.902 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.256403e-03 | 2.901 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 1.305342e-03 | 2.884 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.307696e-03 | 2.883 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 1.329829e-03 | 2.876 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 1.334988e-03 | 2.875 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 1.339914e-03 | 2.873 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 1.372572e-03 | 2.862 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.416349e-03 | 2.849 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 1.465535e-03 | 2.834 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 1.465535e-03 | 2.834 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.465535e-03 | 2.834 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 1.465535e-03 | 2.834 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.473984e-03 | 2.832 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 1.545053e-03 | 2.811 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 1.566180e-03 | 2.805 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 1.566180e-03 | 2.805 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.566180e-03 | 2.805 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 1.566180e-03 | 2.805 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.585037e-03 | 2.800 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 1.585037e-03 | 2.800 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 1.585037e-03 | 2.800 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 1.585037e-03 | 2.800 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 1.585037e-03 | 2.800 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 1.585037e-03 | 2.800 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 1.608281e-03 | 2.794 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 1.608281e-03 | 2.794 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.673085e-03 | 2.776 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 1.977720e-03 | 2.704 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 2.056182e-03 | 2.687 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 2.204789e-03 | 2.657 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 2.232892e-03 | 2.651 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 2.232892e-03 | 2.651 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 2.244595e-03 | 2.649 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 2.277057e-03 | 2.643 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 2.289088e-03 | 2.640 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 2.322019e-03 | 2.634 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 2.356341e-03 | 2.628 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 2.356341e-03 | 2.628 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 2.518951e-03 | 2.599 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 2.518951e-03 | 2.599 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 2.518951e-03 | 2.599 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 2.589430e-03 | 2.587 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 2.671613e-03 | 2.573 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 2.671613e-03 | 2.573 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 2.671613e-03 | 2.573 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 2.702530e-03 | 2.568 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 2.768379e-03 | 2.558 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 2.792323e-03 | 2.554 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 3.051568e-03 | 2.515 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 3.056928e-03 | 2.515 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 3.102441e-03 | 2.508 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 3.170252e-03 | 2.499 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 3.190684e-03 | 2.496 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 3.296299e-03 | 2.482 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function | R-HSA-9645722 | 3.542958e-03 | 2.451 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 4.277825e-03 | 2.369 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 3.588703e-03 | 2.445 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 4.277825e-03 | 2.369 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 3.461945e-03 | 2.461 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 3.660412e-03 | 2.436 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 3.461945e-03 | 2.461 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 3.996112e-03 | 2.398 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 4.426205e-03 | 2.354 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 4.393229e-03 | 2.357 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 4.426205e-03 | 2.354 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 4.047414e-03 | 2.393 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 3.887943e-03 | 2.410 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 3.887943e-03 | 2.410 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 4.393229e-03 | 2.357 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 4.373841e-03 | 2.359 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 3.927189e-03 | 2.406 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 4.426205e-03 | 2.354 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 4.426205e-03 | 2.354 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 3.461945e-03 | 2.461 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 3.516199e-03 | 2.454 | 0 | 0 |
| Depurination | R-HSA-73927 | 3.906580e-03 | 2.408 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 3.927189e-03 | 2.406 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 4.046994e-03 | 2.393 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 3.580891e-03 | 2.446 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 4.646919e-03 | 2.333 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 4.646919e-03 | 2.333 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 4.867660e-03 | 2.313 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 4.924320e-03 | 2.308 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 4.924320e-03 | 2.308 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 5.066406e-03 | 2.295 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 5.066406e-03 | 2.295 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 5.238691e-03 | 2.281 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 5.245917e-03 | 2.280 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 5.344693e-03 | 2.272 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 5.353028e-03 | 2.271 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 5.353028e-03 | 2.271 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 5.470925e-03 | 2.262 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 5.502304e-03 | 2.259 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 5.502304e-03 | 2.259 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 5.502304e-03 | 2.259 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 5.502304e-03 | 2.259 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 5.540059e-03 | 2.256 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 5.540059e-03 | 2.256 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 5.540059e-03 | 2.256 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 5.540059e-03 | 2.256 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 5.540059e-03 | 2.256 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 5.540059e-03 | 2.256 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 5.540059e-03 | 2.256 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 5.665306e-03 | 2.247 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 5.952757e-03 | 2.225 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 5.952757e-03 | 2.225 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 5.952757e-03 | 2.225 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 6.038335e-03 | 2.219 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 6.038335e-03 | 2.219 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 6.038335e-03 | 2.219 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 6.170369e-03 | 2.210 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 6.697471e-03 | 2.174 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 6.808837e-03 | 2.167 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 6.808837e-03 | 2.167 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 6.808837e-03 | 2.167 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 6.826870e-03 | 2.166 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 6.899909e-03 | 2.161 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 6.942888e-03 | 2.158 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 6.942888e-03 | 2.158 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 6.942888e-03 | 2.158 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 6.942888e-03 | 2.158 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 6.942888e-03 | 2.158 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 6.942888e-03 | 2.158 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 6.942888e-03 | 2.158 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 7.028975e-03 | 2.153 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 7.383447e-03 | 2.132 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 7.542350e-03 | 2.122 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 7.586729e-03 | 2.120 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 7.586729e-03 | 2.120 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 7.747233e-03 | 2.111 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 9.812178e-03 | 2.008 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 7.710893e-03 | 2.113 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 8.661736e-03 | 2.062 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 1.081043e-02 | 1.966 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.081043e-02 | 1.966 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 1.141195e-02 | 1.943 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 8.487412e-03 | 2.071 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 8.487412e-03 | 2.071 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 9.960805e-03 | 2.002 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 1.081043e-02 | 1.966 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 8.549925e-03 | 2.068 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 9.868245e-03 | 2.006 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 7.747233e-03 | 2.111 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 1.059375e-02 | 1.975 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 8.297192e-03 | 2.081 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 9.802357e-03 | 2.009 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.084220e-02 | 1.965 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 7.854629e-03 | 2.105 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 7.710893e-03 | 2.113 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 7.710893e-03 | 2.113 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 9.693742e-03 | 2.014 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 9.693742e-03 | 2.014 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 7.710893e-03 | 2.113 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 1.009361e-02 | 1.996 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.151690e-02 | 1.939 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 8.297192e-03 | 2.081 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 9.812178e-03 | 2.008 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 8.042666e-03 | 2.095 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 7.710893e-03 | 2.113 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 1.067070e-02 | 1.972 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 1.152547e-02 | 1.938 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 1.152547e-02 | 1.938 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 9.960805e-03 | 2.002 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 1.106912e-02 | 1.956 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 7.710893e-03 | 2.113 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 8.297192e-03 | 2.081 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 8.332669e-03 | 2.079 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 8.356178e-03 | 2.078 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 1.151690e-02 | 1.939 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 9.182269e-03 | 2.037 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.176815e-03 | 2.037 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 9.960805e-03 | 2.002 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 1.182668e-02 | 1.927 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 1.182668e-02 | 1.927 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 1.182668e-02 | 1.927 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 1.182668e-02 | 1.927 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 1.201524e-02 | 1.920 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 1.201524e-02 | 1.920 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.265346e-02 | 1.898 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.265346e-02 | 1.898 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 1.314640e-02 | 1.881 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 1.328626e-02 | 1.877 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.338651e-02 | 1.873 | 0 | 0 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 1.338651e-02 | 1.873 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.338651e-02 | 1.873 | 0 | 0 |
| Diseases of cellular response to stress | R-HSA-9675132 | 1.338651e-02 | 1.873 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 1.338651e-02 | 1.873 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.338651e-02 | 1.873 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.338651e-02 | 1.873 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.338651e-02 | 1.873 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.338651e-02 | 1.873 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.338651e-02 | 1.873 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.338651e-02 | 1.873 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.338651e-02 | 1.873 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.338651e-02 | 1.873 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.338651e-02 | 1.873 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 1.364447e-02 | 1.865 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 1.390296e-02 | 1.857 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 1.390296e-02 | 1.857 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 1.390296e-02 | 1.857 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 1.390296e-02 | 1.857 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.390296e-02 | 1.857 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 1.390296e-02 | 1.857 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 1.451484e-02 | 1.838 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 1.451484e-02 | 1.838 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 1.470256e-02 | 1.833 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 1.470256e-02 | 1.833 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.491472e-02 | 1.826 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 1.503191e-02 | 1.823 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 1.537822e-02 | 1.813 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.537822e-02 | 1.813 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 1.537822e-02 | 1.813 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 1.566058e-02 | 1.805 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 1.566058e-02 | 1.805 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.591742e-02 | 1.798 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 1.605577e-02 | 1.794 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 1.605577e-02 | 1.794 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 1.619149e-02 | 1.791 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.619149e-02 | 1.791 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.619149e-02 | 1.791 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 1.619691e-02 | 1.791 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 1.619691e-02 | 1.791 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 1.619691e-02 | 1.791 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 1.619691e-02 | 1.791 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 1.619691e-02 | 1.791 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 1.621234e-02 | 1.790 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.641984e-02 | 1.785 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.641984e-02 | 1.785 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.692301e-02 | 1.772 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 1.699235e-02 | 1.770 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 1.699235e-02 | 1.770 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.702906e-02 | 1.769 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 1.724782e-02 | 1.763 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.778136e-02 | 1.750 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 1.778136e-02 | 1.750 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 1.778136e-02 | 1.750 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 1.810136e-02 | 1.742 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 1.840213e-02 | 1.735 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.871496e-02 | 1.728 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.871496e-02 | 1.728 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 1.909781e-02 | 1.719 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 1.926205e-02 | 1.715 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 1.926205e-02 | 1.715 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.932881e-02 | 1.714 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 1.947509e-02 | 1.711 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 1.961052e-02 | 1.708 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 1.989204e-02 | 1.701 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 1.989204e-02 | 1.701 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 2.066640e-02 | 1.685 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 2.128849e-02 | 1.672 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 2.142482e-02 | 1.669 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 2.146264e-02 | 1.668 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 2.146414e-02 | 1.668 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 2.146414e-02 | 1.668 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 2.212057e-02 | 1.655 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 2.249194e-02 | 1.648 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 2.249194e-02 | 1.648 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 2.249194e-02 | 1.648 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 2.249194e-02 | 1.648 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 2.252258e-02 | 1.647 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 2.312041e-02 | 1.636 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 2.312041e-02 | 1.636 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 2.318512e-02 | 1.635 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 2.318512e-02 | 1.635 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.329870e-02 | 1.633 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.329870e-02 | 1.633 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 2.360308e-02 | 1.627 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 2.373971e-02 | 1.625 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 2.373971e-02 | 1.625 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 2.373971e-02 | 1.625 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 2.444465e-02 | 1.612 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 2.444465e-02 | 1.612 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 2.444465e-02 | 1.612 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 2.520657e-02 | 1.598 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 2.520657e-02 | 1.598 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 2.616201e-02 | 1.582 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 2.621001e-02 | 1.582 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 2.734217e-02 | 1.563 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 2.734217e-02 | 1.563 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 2.734217e-02 | 1.563 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 2.742206e-02 | 1.562 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 2.766482e-02 | 1.558 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 2.766482e-02 | 1.558 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 2.766482e-02 | 1.558 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 2.829379e-02 | 1.548 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 2.831533e-02 | 1.548 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 2.846254e-02 | 1.546 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 2.846254e-02 | 1.546 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 2.846254e-02 | 1.546 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 2.853526e-02 | 1.545 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 2.883863e-02 | 1.540 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 2.959408e-02 | 1.529 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 2.959408e-02 | 1.529 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 2.959408e-02 | 1.529 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 2.959408e-02 | 1.529 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 3.076571e-02 | 1.512 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 3.076571e-02 | 1.512 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 3.091016e-02 | 1.510 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 3.162819e-02 | 1.500 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 3.162819e-02 | 1.500 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 3.196436e-02 | 1.495 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 3.196436e-02 | 1.495 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 3.232883e-02 | 1.490 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 3.232883e-02 | 1.490 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 3.394691e-02 | 1.469 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 3.445484e-02 | 1.463 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 3.458094e-02 | 1.461 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 3.458094e-02 | 1.461 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 3.458094e-02 | 1.461 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 3.458094e-02 | 1.461 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 3.613170e-02 | 1.442 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 3.766587e-02 | 1.424 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 3.766587e-02 | 1.424 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 3.766587e-02 | 1.424 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 3.769882e-02 | 1.424 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 3.769882e-02 | 1.424 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 3.769882e-02 | 1.424 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 3.869497e-02 | 1.412 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 3.878025e-02 | 1.411 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 3.913887e-02 | 1.407 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 3.924569e-02 | 1.406 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 3.980303e-02 | 1.400 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 4.098341e-02 | 1.387 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 4.098463e-02 | 1.387 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p14ARF Defects | R-HSA-9646304 | 4.242124e-02 | 1.372 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p14ARF Defects | R-HSA-9646303 | 4.242124e-02 | 1.372 | 0 | 0 |
| Activation, translocation and oligomerization of BAX | R-HSA-114294 | 8.304539e-02 | 1.081 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 8.304539e-02 | 1.081 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 8.304539e-02 | 1.081 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 8.304539e-02 | 1.081 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 8.304539e-02 | 1.081 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9630791 | 8.304539e-02 | 1.081 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 8.304539e-02 | 1.081 | 0 | 0 |
| RPIA deficiency: failed conversion of RU5P to R5P | R-HSA-6791461 | 8.304539e-02 | 1.081 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9632697 | 8.304539e-02 | 1.081 | 0 | 0 |
| RPIA deficiency: failed conversion of R5P to RU5P | R-HSA-5659996 | 8.304539e-02 | 1.081 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 8.304539e-02 | 1.081 | 0 | 0 |
| Hereditary fructose intolerance | R-HSA-5657560 | 8.304539e-02 | 1.081 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 4.783645e-02 | 1.320 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 4.783645e-02 | 1.320 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 5.887591e-02 | 1.230 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 7.069245e-02 | 1.151 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 7.069245e-02 | 1.151 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 5.740967e-02 | 1.241 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 7.184418e-02 | 1.144 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 5.200453e-02 | 1.284 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 6.249932e-02 | 1.204 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 7.415518e-02 | 1.130 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 7.415518e-02 | 1.130 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 4.251194e-02 | 1.371 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 5.515689e-02 | 1.258 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 5.200453e-02 | 1.284 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 5.993919e-02 | 1.222 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 7.213295e-02 | 1.142 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 5.887591e-02 | 1.230 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 5.583666e-02 | 1.253 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 5.076834e-02 | 1.294 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 5.993919e-02 | 1.222 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 5.076834e-02 | 1.294 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 4.266360e-02 | 1.370 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 5.209963e-02 | 1.283 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 5.076834e-02 | 1.294 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 4.876345e-02 | 1.312 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 6.234992e-02 | 1.205 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 7.415518e-02 | 1.130 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 4.596281e-02 | 1.338 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 4.783645e-02 | 1.320 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 4.452671e-02 | 1.351 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 5.076834e-02 | 1.294 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 6.760208e-02 | 1.170 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 6.423876e-02 | 1.192 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 4.214017e-02 | 1.375 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 7.313194e-02 | 1.136 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 4.783645e-02 | 1.320 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 6.565367e-02 | 1.183 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 5.008564e-02 | 1.300 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 4.443597e-02 | 1.352 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 8.304539e-02 | 1.081 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 4.443597e-02 | 1.352 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 4.443597e-02 | 1.352 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 4.443597e-02 | 1.352 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 6.423876e-02 | 1.192 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 6.788193e-02 | 1.168 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 6.788193e-02 | 1.168 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 7.603032e-02 | 1.119 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 7.603032e-02 | 1.119 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 5.110745e-02 | 1.292 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 5.184830e-02 | 1.285 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 4.452671e-02 | 1.351 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 7.069245e-02 | 1.151 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 6.423876e-02 | 1.192 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 6.423876e-02 | 1.192 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 4.642373e-02 | 1.333 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 7.069245e-02 | 1.151 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 6.760208e-02 | 1.170 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 7.175875e-02 | 1.144 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 5.008564e-02 | 1.300 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 4.288914e-02 | 1.368 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 4.297504e-02 | 1.367 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 4.288914e-02 | 1.368 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 6.249932e-02 | 1.204 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 8.256794e-02 | 1.083 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 5.907358e-02 | 1.229 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 5.605305e-02 | 1.251 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 4.896163e-02 | 1.310 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 5.558481e-02 | 1.255 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 5.580891e-02 | 1.253 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 5.993919e-02 | 1.222 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 5.209963e-02 | 1.283 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 5.702715e-02 | 1.244 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 5.702715e-02 | 1.244 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 5.993919e-02 | 1.222 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 5.887591e-02 | 1.230 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 4.876345e-02 | 1.312 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 4.741510e-02 | 1.324 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 5.791083e-02 | 1.237 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 5.887211e-02 | 1.230 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 7.961101e-02 | 1.099 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 6.978541e-02 | 1.156 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 5.209963e-02 | 1.283 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 5.580891e-02 | 1.253 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 7.297020e-02 | 1.137 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 7.334533e-02 | 1.135 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 6.760208e-02 | 1.170 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 6.219553e-02 | 1.206 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 6.941463e-02 | 1.159 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 8.311195e-02 | 1.080 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 8.311195e-02 | 1.080 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 8.320049e-02 | 1.080 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 8.320049e-02 | 1.080 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 8.320049e-02 | 1.080 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 8.320049e-02 | 1.080 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 8.586202e-02 | 1.066 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 8.696519e-02 | 1.061 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 8.772516e-02 | 1.057 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 8.772516e-02 | 1.057 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 8.824200e-02 | 1.054 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 8.824200e-02 | 1.054 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 9.153648e-02 | 1.038 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 9.153648e-02 | 1.038 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 9.153648e-02 | 1.038 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 9.353301e-02 | 1.029 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 9.451694e-02 | 1.024 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 9.594767e-02 | 1.018 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 9.617148e-02 | 1.017 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 9.632028e-02 | 1.016 | 0 | 0 |
| Hypusine synthesis from eIF5A-lysine | R-HSA-204626 | 9.632028e-02 | 1.016 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 9.632028e-02 | 1.016 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 9.632028e-02 | 1.016 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 9.632028e-02 | 1.016 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 9.632028e-02 | 1.016 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 9.632028e-02 | 1.016 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 9.698059e-02 | 1.013 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 9.807453e-02 | 1.008 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 9.807453e-02 | 1.008 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 1.045885e-01 | 0.981 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 1.048238e-01 | 0.980 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 1.048238e-01 | 0.980 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 1.048238e-01 | 0.980 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 1.048238e-01 | 0.980 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 1.049343e-01 | 0.979 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.099776e-01 | 0.959 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 1.099776e-01 | 0.959 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 1.099776e-01 | 0.959 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 1.139975e-01 | 0.943 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 1.162571e-01 | 0.935 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 1.165981e-01 | 0.933 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 1.179112e-01 | 0.928 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.186156e-01 | 0.926 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 1.189321e-01 | 0.925 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 1.212053e-01 | 0.916 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 1.219485e-01 | 0.914 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 1.219485e-01 | 0.914 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 1.219485e-01 | 0.914 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 1.219485e-01 | 0.914 | 0 | 0 |
| Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 | R-HSA-5083628 | 1.219485e-01 | 0.914 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 1.219485e-01 | 0.914 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 1.219485e-01 | 0.914 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 1.219485e-01 | 0.914 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 1.219485e-01 | 0.914 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 1.219485e-01 | 0.914 | 0 | 0 |
| Defective PGM1 causes PGM1-CDG | R-HSA-5609974 | 1.219485e-01 | 0.914 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 1.219485e-01 | 0.914 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 1.219485e-01 | 0.914 | 0 | 0 |
| ARL13B-mediated ciliary trafficking of INPP5E | R-HSA-5624958 | 1.219485e-01 | 0.914 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 1.219485e-01 | 0.914 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 1.219485e-01 | 0.914 | 0 | 0 |
| NTRK3 as a dependence receptor | R-HSA-9603505 | 1.219485e-01 | 0.914 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.223138e-01 | 0.913 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 1.241033e-01 | 0.906 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 1.241033e-01 | 0.906 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 1.265728e-01 | 0.898 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 1.265728e-01 | 0.898 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 1.283983e-01 | 0.891 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 1.285913e-01 | 0.891 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 1.320538e-01 | 0.879 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 1.329592e-01 | 0.876 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 1.386334e-01 | 0.858 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 1.386334e-01 | 0.858 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 1.386334e-01 | 0.858 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 1.386334e-01 | 0.858 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 1.415209e-01 | 0.849 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 1.428243e-01 | 0.845 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.428243e-01 | 0.845 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 1.433475e-01 | 0.844 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 1.451811e-01 | 0.838 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 1.479428e-01 | 0.830 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 1.494030e-01 | 0.826 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 1.494030e-01 | 0.826 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 1.529234e-01 | 0.816 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 1.529234e-01 | 0.816 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.529234e-01 | 0.816 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 1.530091e-01 | 0.815 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 1.535081e-01 | 0.814 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 1.535081e-01 | 0.814 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 1.535081e-01 | 0.814 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 1.535081e-01 | 0.814 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 1.535081e-01 | 0.814 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 1.550678e-01 | 0.809 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 1.590166e-01 | 0.799 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 1.590166e-01 | 0.799 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 1.590166e-01 | 0.799 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 1.592033e-01 | 0.798 | 0 | 0 |
| Signaling by RAS GAP mutants | R-HSA-9753510 | 1.592033e-01 | 0.798 | 0 | 0 |
| Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 | R-HSA-5083629 | 1.592033e-01 | 0.798 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 1.592033e-01 | 0.798 | 0 | 0 |
| Defective AHCY causes HMAHCHD | R-HSA-5578997 | 1.592033e-01 | 0.798 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 1.592033e-01 | 0.798 | 0 | 0 |
| Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 | R-HSA-5083633 | 1.592033e-01 | 0.798 | 0 | 0 |
| Neurophilin interactions with VEGF and VEGFR | R-HSA-194306 | 1.592033e-01 | 0.798 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 1.592033e-01 | 0.798 | 0 | 0 |
| ATF6B (ATF6-beta) activates chaperones | R-HSA-8874177 | 1.592033e-01 | 0.798 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 1.615455e-01 | 0.792 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 1.656522e-01 | 0.781 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.686722e-01 | 0.773 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.686722e-01 | 0.773 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 1.686722e-01 | 0.773 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 1.686722e-01 | 0.773 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 1.686722e-01 | 0.773 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.689829e-01 | 0.772 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 1.693510e-01 | 0.771 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 1.734036e-01 | 0.761 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 1.737567e-01 | 0.760 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 1.737567e-01 | 0.760 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.756297e-01 | 0.755 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 1.828416e-01 | 0.738 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.828416e-01 | 0.738 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.840746e-01 | 0.735 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.840746e-01 | 0.735 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 1.840746e-01 | 0.735 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.840746e-01 | 0.735 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 1.844579e-01 | 0.734 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 1.844579e-01 | 0.734 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 1.860993e-01 | 0.730 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 1.888595e-01 | 0.724 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 1.901606e-01 | 0.721 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 1.911237e-01 | 0.719 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 1.948796e-01 | 0.710 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 1.948796e-01 | 0.710 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 1.948796e-01 | 0.710 | 0 | 0 |
| Intracellular oxygen transport | R-HSA-8981607 | 1.948796e-01 | 0.710 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 1.953271e-01 | 0.709 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 1.975823e-01 | 0.704 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 1.996677e-01 | 0.700 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.996677e-01 | 0.700 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 1.996677e-01 | 0.700 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 1.996677e-01 | 0.700 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.998758e-01 | 0.699 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 1.998758e-01 | 0.699 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 1.998758e-01 | 0.699 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 2.041607e-01 | 0.690 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 2.078147e-01 | 0.682 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 2.087458e-01 | 0.680 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 2.127147e-01 | 0.672 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.154078e-01 | 0.667 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 2.154078e-01 | 0.667 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 2.154078e-01 | 0.667 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 2.179822e-01 | 0.662 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 2.180181e-01 | 0.662 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 2.287849e-01 | 0.641 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 2.287849e-01 | 0.641 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 2.290442e-01 | 0.640 | 0 | 0 |
| Defective PNP disrupts phosphorolysis of (deoxy)guanosine and (deoxy)inosine | R-HSA-9735763 | 2.290442e-01 | 0.640 | 0 | 0 |
| Nucleotide catabolism defects | R-HSA-9735786 | 2.290442e-01 | 0.640 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 2.290442e-01 | 0.640 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 2.290442e-01 | 0.640 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 2.290442e-01 | 0.640 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 2.290442e-01 | 0.640 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 2.290442e-01 | 0.640 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 2.290442e-01 | 0.640 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 2.312544e-01 | 0.636 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 2.312544e-01 | 0.636 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 2.312544e-01 | 0.636 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 2.331317e-01 | 0.632 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 2.359837e-01 | 0.627 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 2.414233e-01 | 0.617 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 2.451595e-01 | 0.611 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 2.451595e-01 | 0.611 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 2.451595e-01 | 0.611 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 2.471702e-01 | 0.607 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 2.471702e-01 | 0.607 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 2.516469e-01 | 0.599 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 2.516469e-01 | 0.599 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 2.543362e-01 | 0.595 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 2.608195e-01 | 0.584 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.617610e-01 | 0.582 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 2.617610e-01 | 0.582 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.617610e-01 | 0.582 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 2.617610e-01 | 0.582 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 2.617610e-01 | 0.582 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 2.617610e-01 | 0.582 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 2.617610e-01 | 0.582 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 2.617610e-01 | 0.582 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 2.617610e-01 | 0.582 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 2.631208e-01 | 0.580 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 2.631208e-01 | 0.580 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 2.631208e-01 | 0.580 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 2.631208e-01 | 0.580 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 2.631208e-01 | 0.580 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 2.631208e-01 | 0.580 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 2.632013e-01 | 0.580 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 2.640006e-01 | 0.578 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 2.649263e-01 | 0.577 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 2.678385e-01 | 0.572 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 2.748196e-01 | 0.561 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 2.764040e-01 | 0.558 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 2.790748e-01 | 0.554 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 2.790748e-01 | 0.554 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 2.790748e-01 | 0.554 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 2.790748e-01 | 0.554 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 2.790748e-01 | 0.554 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 2.845855e-01 | 0.546 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 2.929252e-01 | 0.533 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 2.930914e-01 | 0.533 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 2.930914e-01 | 0.533 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 2.930914e-01 | 0.533 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 2.930914e-01 | 0.533 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 2.930914e-01 | 0.533 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 2.930914e-01 | 0.533 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 2.930914e-01 | 0.533 | 0 | 0 |
| VEGF binds to VEGFR leading to receptor dimerization | R-HSA-195399 | 2.930914e-01 | 0.533 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 2.930914e-01 | 0.533 | 0 | 0 |
| VEGF ligand-receptor interactions | R-HSA-194313 | 2.930914e-01 | 0.533 | 0 | 0 |
| Acetylcholine inhibits contraction of outer hair cells | R-HSA-9667769 | 2.930914e-01 | 0.533 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 2.930914e-01 | 0.533 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 2.930914e-01 | 0.533 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 2.950032e-01 | 0.530 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.950032e-01 | 0.530 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 2.950032e-01 | 0.530 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.950032e-01 | 0.530 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 3.067742e-01 | 0.513 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 3.096103e-01 | 0.509 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 3.099277e-01 | 0.509 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 3.108795e-01 | 0.507 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 3.108795e-01 | 0.507 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 3.108795e-01 | 0.507 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 3.108795e-01 | 0.507 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 3.180028e-01 | 0.498 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 3.216738e-01 | 0.493 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 3.230939e-01 | 0.491 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 3.230939e-01 | 0.491 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 3.230939e-01 | 0.491 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 3.230939e-01 | 0.491 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 3.230939e-01 | 0.491 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 3.230939e-01 | 0.491 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 3.230939e-01 | 0.491 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 3.230939e-01 | 0.491 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 3.230939e-01 | 0.491 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 3.230939e-01 | 0.491 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 3.266794e-01 | 0.486 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 3.266794e-01 | 0.486 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 3.287604e-01 | 0.483 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 3.287604e-01 | 0.483 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 3.312663e-01 | 0.480 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 3.315291e-01 | 0.479 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 3.409882e-01 | 0.467 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 3.409882e-01 | 0.467 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 3.409882e-01 | 0.467 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 3.409882e-01 | 0.467 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 3.409882e-01 | 0.467 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 3.409882e-01 | 0.467 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 3.423809e-01 | 0.465 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 3.423809e-01 | 0.465 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 3.463632e-01 | 0.460 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 3.508715e-01 | 0.455 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 3.518248e-01 | 0.454 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 3.518248e-01 | 0.454 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 3.518248e-01 | 0.454 | 0 | 0 |
| DAG1 core M1 glycosylations | R-HSA-8932506 | 3.518248e-01 | 0.454 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 3.518248e-01 | 0.454 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 3.518248e-01 | 0.454 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 3.518248e-01 | 0.454 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 3.518248e-01 | 0.454 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 3.518248e-01 | 0.454 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 3.518248e-01 | 0.454 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 3.518248e-01 | 0.454 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 3.518248e-01 | 0.454 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 3.518248e-01 | 0.454 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 3.518248e-01 | 0.454 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 3.579639e-01 | 0.446 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 3.579639e-01 | 0.446 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 3.579639e-01 | 0.446 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 3.584808e-01 | 0.446 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 3.602869e-01 | 0.443 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 3.685748e-01 | 0.433 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 3.685748e-01 | 0.433 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 3.695546e-01 | 0.432 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 3.734103e-01 | 0.428 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 3.734103e-01 | 0.428 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 3.793379e-01 | 0.421 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 3.793379e-01 | 0.421 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 3.793379e-01 | 0.421 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 3.793379e-01 | 0.421 | 0 | 0 |
| DAG1 core M2 glycosylations | R-HSA-8932504 | 3.793379e-01 | 0.421 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 3.793379e-01 | 0.421 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 3.793379e-01 | 0.421 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 3.793379e-01 | 0.421 | 0 | 0 |
| Fructose biosynthesis | R-HSA-5652227 | 3.793379e-01 | 0.421 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 3.793379e-01 | 0.421 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 3.793379e-01 | 0.421 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 3.793379e-01 | 0.421 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 3.793379e-01 | 0.421 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 3.793379e-01 | 0.421 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 3.802283e-01 | 0.420 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 3.813594e-01 | 0.419 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 3.857606e-01 | 0.414 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 3.865547e-01 | 0.413 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 3.887035e-01 | 0.410 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 3.887035e-01 | 0.410 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 3.887035e-01 | 0.410 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 3.887035e-01 | 0.410 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 3.887035e-01 | 0.410 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 3.887035e-01 | 0.410 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 3.887035e-01 | 0.410 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 3.907510e-01 | 0.408 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 3.918344e-01 | 0.407 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 4.038288e-01 | 0.394 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 4.038288e-01 | 0.394 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 4.038288e-01 | 0.394 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 4.038288e-01 | 0.394 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 4.042517e-01 | 0.393 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 4.056848e-01 | 0.392 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 4.056848e-01 | 0.392 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 4.056848e-01 | 0.392 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 4.056848e-01 | 0.392 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 4.056848e-01 | 0.392 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 4.056848e-01 | 0.392 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 4.056848e-01 | 0.392 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 4.056848e-01 | 0.392 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 4.056848e-01 | 0.392 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 4.056848e-01 | 0.392 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 4.056848e-01 | 0.392 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 4.056848e-01 | 0.392 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 4.056848e-01 | 0.392 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 4.089321e-01 | 0.388 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 4.089321e-01 | 0.388 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 4.148705e-01 | 0.382 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 4.148705e-01 | 0.382 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 4.187729e-01 | 0.378 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 4.187729e-01 | 0.378 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 4.187729e-01 | 0.378 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 4.187729e-01 | 0.378 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 4.187729e-01 | 0.378 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 4.194830e-01 | 0.377 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 4.194830e-01 | 0.377 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 4.256832e-01 | 0.371 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 4.262012e-01 | 0.370 | 0 | 0 |
| S Phase | R-HSA-69242 | 4.305292e-01 | 0.366 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 4.305292e-01 | 0.366 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 4.309148e-01 | 0.366 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 4.309148e-01 | 0.366 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 4.309148e-01 | 0.366 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 4.309148e-01 | 0.366 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 4.309148e-01 | 0.366 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 4.309148e-01 | 0.366 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 4.309148e-01 | 0.366 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 4.309148e-01 | 0.366 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 4.309148e-01 | 0.366 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 4.309148e-01 | 0.366 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 4.309148e-01 | 0.366 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 4.335240e-01 | 0.363 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 4.335240e-01 | 0.363 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 4.335240e-01 | 0.363 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 4.335240e-01 | 0.363 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 4.335240e-01 | 0.363 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 4.376201e-01 | 0.359 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 4.396055e-01 | 0.357 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 4.434635e-01 | 0.353 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 4.471817e-01 | 0.350 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 4.480715e-01 | 0.349 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 4.531498e-01 | 0.344 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 4.531498e-01 | 0.344 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 4.550752e-01 | 0.342 | 0 | 0 |
| DAG1 core M3 glycosylations | R-HSA-8932505 | 4.550752e-01 | 0.342 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 4.550752e-01 | 0.342 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 4.550752e-01 | 0.342 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 4.550752e-01 | 0.342 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 4.550752e-01 | 0.342 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 4.550752e-01 | 0.342 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 4.550752e-01 | 0.342 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 4.550752e-01 | 0.342 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 4.550752e-01 | 0.342 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 4.563557e-01 | 0.341 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 4.566290e-01 | 0.340 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 4.624062e-01 | 0.335 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 4.624062e-01 | 0.335 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 4.624062e-01 | 0.335 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 4.691932e-01 | 0.329 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 4.697223e-01 | 0.328 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 4.710864e-01 | 0.327 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 4.765199e-01 | 0.322 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 4.765199e-01 | 0.322 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 4.782112e-01 | 0.320 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 4.782112e-01 | 0.320 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 4.782112e-01 | 0.320 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 4.782112e-01 | 0.320 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 4.782112e-01 | 0.320 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 4.782112e-01 | 0.320 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 4.782112e-01 | 0.320 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 4.782112e-01 | 0.320 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 4.820420e-01 | 0.317 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 4.846265e-01 | 0.315 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 4.894140e-01 | 0.310 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 4.904055e-01 | 0.309 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 4.938313e-01 | 0.306 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 5.003663e-01 | 0.301 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 5.003663e-01 | 0.301 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 5.003663e-01 | 0.301 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 5.003663e-01 | 0.301 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 5.003663e-01 | 0.301 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 5.003663e-01 | 0.301 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 5.003663e-01 | 0.301 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 5.003663e-01 | 0.301 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 5.003663e-01 | 0.301 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 5.003663e-01 | 0.301 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 5.003663e-01 | 0.301 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 5.003663e-01 | 0.301 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 5.003663e-01 | 0.301 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 5.018392e-01 | 0.299 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 5.018392e-01 | 0.299 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 5.040570e-01 | 0.298 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 5.040570e-01 | 0.298 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 5.040570e-01 | 0.298 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 5.040570e-01 | 0.298 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 5.104056e-01 | 0.292 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 5.120285e-01 | 0.291 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 5.183929e-01 | 0.285 | 0 | 0 |
| PDH complex synthesizes acetyl-CoA from PYR | R-HSA-9861559 | 5.215821e-01 | 0.283 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 5.215821e-01 | 0.283 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 5.215821e-01 | 0.283 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 5.215821e-01 | 0.283 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 5.215821e-01 | 0.283 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 5.215821e-01 | 0.283 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 5.215821e-01 | 0.283 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 5.215821e-01 | 0.283 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 5.215821e-01 | 0.283 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 5.215821e-01 | 0.283 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 5.215821e-01 | 0.283 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 5.215821e-01 | 0.283 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 5.306380e-01 | 0.275 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 5.306380e-01 | 0.275 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 5.308060e-01 | 0.275 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 5.418981e-01 | 0.266 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 5.418981e-01 | 0.266 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 5.418981e-01 | 0.266 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 5.418981e-01 | 0.266 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 5.418981e-01 | 0.266 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 5.450260e-01 | 0.264 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 5.479355e-01 | 0.261 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 5.543365e-01 | 0.256 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 5.554388e-01 | 0.255 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 5.562315e-01 | 0.255 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 5.562315e-01 | 0.255 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 5.613527e-01 | 0.251 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 5.613527e-01 | 0.251 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 5.613527e-01 | 0.251 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 5.613527e-01 | 0.251 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 5.613527e-01 | 0.251 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 5.613527e-01 | 0.251 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 5.613527e-01 | 0.251 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 5.613527e-01 | 0.251 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 5.613527e-01 | 0.251 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 5.613527e-01 | 0.251 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 5.654082e-01 | 0.248 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 5.745140e-01 | 0.241 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 5.746854e-01 | 0.241 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 5.799821e-01 | 0.237 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 5.799821e-01 | 0.237 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 5.799821e-01 | 0.237 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 5.799821e-01 | 0.237 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 5.799821e-01 | 0.237 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 5.799821e-01 | 0.237 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 5.799821e-01 | 0.237 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 5.799821e-01 | 0.237 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 5.799821e-01 | 0.237 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 5.799821e-01 | 0.237 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 5.799821e-01 | 0.237 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 5.808180e-01 | 0.236 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 5.808180e-01 | 0.236 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 5.808180e-01 | 0.236 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 5.808180e-01 | 0.236 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 5.849311e-01 | 0.233 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 5.898382e-01 | 0.229 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 5.927304e-01 | 0.227 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 5.927304e-01 | 0.227 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 5.927304e-01 | 0.227 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 5.978215e-01 | 0.223 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 5.978215e-01 | 0.223 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 5.978215e-01 | 0.223 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 5.978215e-01 | 0.223 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 5.978215e-01 | 0.223 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 5.978215e-01 | 0.223 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 5.978215e-01 | 0.223 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 5.978215e-01 | 0.223 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 5.978215e-01 | 0.223 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 6.043881e-01 | 0.219 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 6.043881e-01 | 0.219 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 6.043881e-01 | 0.219 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 6.043881e-01 | 0.219 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 6.149042e-01 | 0.211 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 6.149042e-01 | 0.211 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 6.149042e-01 | 0.211 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 6.157914e-01 | 0.211 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 6.194814e-01 | 0.208 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 6.269408e-01 | 0.203 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 6.312623e-01 | 0.200 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 6.312623e-01 | 0.200 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 6.312623e-01 | 0.200 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 6.312623e-01 | 0.200 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 6.312623e-01 | 0.200 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 6.312623e-01 | 0.200 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 6.312623e-01 | 0.200 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 6.312623e-01 | 0.200 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 6.378373e-01 | 0.195 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 6.378373e-01 | 0.195 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 6.378373e-01 | 0.195 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 6.461997e-01 | 0.190 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 6.469265e-01 | 0.189 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 6.469265e-01 | 0.189 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 6.469265e-01 | 0.189 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 6.469265e-01 | 0.189 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 6.469265e-01 | 0.189 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 6.484823e-01 | 0.188 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 6.575525e-01 | 0.182 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 6.588775e-01 | 0.181 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 6.619262e-01 | 0.179 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 6.619262e-01 | 0.179 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 6.619262e-01 | 0.179 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 6.619262e-01 | 0.179 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 6.619262e-01 | 0.179 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 6.619262e-01 | 0.179 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 6.619262e-01 | 0.179 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 6.690248e-01 | 0.175 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 6.690248e-01 | 0.175 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 6.738183e-01 | 0.171 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 6.738183e-01 | 0.171 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 6.762895e-01 | 0.170 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 6.762895e-01 | 0.170 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 6.762895e-01 | 0.170 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 6.762895e-01 | 0.170 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 6.762895e-01 | 0.170 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 6.762895e-01 | 0.170 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 6.789266e-01 | 0.168 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 6.789266e-01 | 0.168 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 6.813308e-01 | 0.167 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 6.900435e-01 | 0.161 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 6.900435e-01 | 0.161 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 6.900435e-01 | 0.161 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 6.900435e-01 | 0.161 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 6.900435e-01 | 0.161 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 6.900435e-01 | 0.161 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 6.945263e-01 | 0.158 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 6.951015e-01 | 0.158 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 6.975799e-01 | 0.156 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 6.980040e-01 | 0.156 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 7.032138e-01 | 0.153 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 7.032138e-01 | 0.153 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 7.032138e-01 | 0.153 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 7.032138e-01 | 0.153 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 7.032138e-01 | 0.153 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 7.032138e-01 | 0.153 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 7.126781e-01 | 0.147 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 7.158253e-01 | 0.145 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 7.158253e-01 | 0.145 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 7.158253e-01 | 0.145 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 7.158253e-01 | 0.145 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 7.158253e-01 | 0.145 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 7.158253e-01 | 0.145 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 7.161325e-01 | 0.145 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 7.170275e-01 | 0.144 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 7.259640e-01 | 0.139 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 7.259640e-01 | 0.139 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 7.271885e-01 | 0.138 | 0 | 0 |
| CYP2E1 reactions | R-HSA-211999 | 7.279016e-01 | 0.138 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 7.279016e-01 | 0.138 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 7.279016e-01 | 0.138 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 7.279016e-01 | 0.138 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 7.279016e-01 | 0.138 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 7.279016e-01 | 0.138 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 7.279016e-01 | 0.138 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 7.279016e-01 | 0.138 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 7.301309e-01 | 0.137 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 7.333379e-01 | 0.135 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 7.394655e-01 | 0.131 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 7.394655e-01 | 0.131 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 7.394655e-01 | 0.131 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 7.394655e-01 | 0.131 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 7.394655e-01 | 0.131 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 7.394655e-01 | 0.131 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 7.411188e-01 | 0.130 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 7.416031e-01 | 0.130 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 7.416031e-01 | 0.130 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 7.416031e-01 | 0.130 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 7.505385e-01 | 0.125 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 7.505385e-01 | 0.125 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 7.505385e-01 | 0.125 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 7.505385e-01 | 0.125 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 7.611416e-01 | 0.119 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 7.611416e-01 | 0.119 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 7.611416e-01 | 0.119 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 7.611416e-01 | 0.119 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 7.611416e-01 | 0.119 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 7.611416e-01 | 0.119 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 7.614555e-01 | 0.118 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 7.712946e-01 | 0.113 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 7.725011e-01 | 0.112 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 7.797042e-01 | 0.108 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 7.810167e-01 | 0.107 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 7.810167e-01 | 0.107 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 7.810167e-01 | 0.107 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 7.903260e-01 | 0.102 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 7.903260e-01 | 0.102 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 7.903260e-01 | 0.102 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 7.903260e-01 | 0.102 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 7.903260e-01 | 0.102 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 7.903260e-01 | 0.102 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 7.903260e-01 | 0.102 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 7.935126e-01 | 0.100 | 0 | 0 |
| Aspartate and asparagine metabolism | R-HSA-8963693 | 7.992402e-01 | 0.097 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 7.992402e-01 | 0.097 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 7.999800e-01 | 0.097 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 8.001260e-01 | 0.097 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 8.001260e-01 | 0.097 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 8.065509e-01 | 0.093 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 8.065509e-01 | 0.093 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 8.077758e-01 | 0.093 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 8.077758e-01 | 0.093 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 8.077758e-01 | 0.093 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 8.077758e-01 | 0.093 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 8.120830e-01 | 0.090 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 8.127913e-01 | 0.090 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 8.159491e-01 | 0.088 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 8.159491e-01 | 0.088 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 8.159491e-01 | 0.088 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 8.188514e-01 | 0.087 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 8.188514e-01 | 0.087 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 8.233108e-01 | 0.084 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 8.237753e-01 | 0.084 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 8.237753e-01 | 0.084 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 8.237753e-01 | 0.084 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 8.237753e-01 | 0.084 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 8.237753e-01 | 0.084 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 8.247352e-01 | 0.084 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 8.304467e-01 | 0.081 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 8.312692e-01 | 0.080 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 8.312692e-01 | 0.080 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 8.312692e-01 | 0.080 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 8.384448e-01 | 0.077 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 8.384448e-01 | 0.077 | 0 | 0 |
| Metabolism of ingested SeMet, Sec, MeSec into H2Se | R-HSA-2408508 | 8.384448e-01 | 0.077 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 8.413688e-01 | 0.075 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 8.453157e-01 | 0.073 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 8.453157e-01 | 0.073 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 8.453157e-01 | 0.073 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 8.453157e-01 | 0.073 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 8.516494e-01 | 0.070 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 8.518948e-01 | 0.070 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 8.549336e-01 | 0.068 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 8.581945e-01 | 0.066 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 8.583028e-01 | 0.066 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 8.642265e-01 | 0.063 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 8.642265e-01 | 0.063 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 8.642265e-01 | 0.063 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 8.674100e-01 | 0.062 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 8.700024e-01 | 0.060 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 8.700024e-01 | 0.060 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 8.700024e-01 | 0.060 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 8.700024e-01 | 0.060 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 8.700024e-01 | 0.060 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 8.704095e-01 | 0.060 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 8.755328e-01 | 0.058 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 8.755328e-01 | 0.058 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 8.808283e-01 | 0.055 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 8.808283e-01 | 0.055 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 8.808283e-01 | 0.055 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 8.858988e-01 | 0.053 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 8.866473e-01 | 0.052 | 0 | 0 |
| Methylation | R-HSA-156581 | 8.954027e-01 | 0.048 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 8.954027e-01 | 0.048 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 8.954027e-01 | 0.048 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 8.998539e-01 | 0.046 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 8.998539e-01 | 0.046 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.042391e-01 | 0.044 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.044464e-01 | 0.044 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.049045e-01 | 0.043 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 9.121043e-01 | 0.040 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.121043e-01 | 0.040 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.121043e-01 | 0.040 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.143633e-01 | 0.039 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.158457e-01 | 0.038 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.173020e-01 | 0.037 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 9.194280e-01 | 0.036 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.194280e-01 | 0.036 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.194280e-01 | 0.036 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.228581e-01 | 0.035 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 9.261423e-01 | 0.033 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.268635e-01 | 0.033 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.281688e-01 | 0.032 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.292869e-01 | 0.032 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.351807e-01 | 0.029 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.354188e-01 | 0.029 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.376774e-01 | 0.028 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.398610e-01 | 0.027 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.405838e-01 | 0.027 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.431144e-01 | 0.025 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.435819e-01 | 0.025 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.455372e-01 | 0.024 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.455372e-01 | 0.024 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.478571e-01 | 0.023 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.478571e-01 | 0.023 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.500782e-01 | 0.022 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.500782e-01 | 0.022 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.542410e-01 | 0.020 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.561906e-01 | 0.019 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.615556e-01 | 0.017 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.615556e-01 | 0.017 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.631939e-01 | 0.016 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.662643e-01 | 0.015 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.665138e-01 | 0.015 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.677023e-01 | 0.014 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.677023e-01 | 0.014 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.677023e-01 | 0.014 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.690790e-01 | 0.014 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.703971e-01 | 0.013 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 9.716591e-01 | 0.012 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.741104e-01 | 0.011 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.758028e-01 | 0.011 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 9.761922e-01 | 0.010 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.772075e-01 | 0.010 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.772075e-01 | 0.010 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.775334e-01 | 0.010 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.791101e-01 | 0.009 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 9.824528e-01 | 0.008 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.832497e-01 | 0.007 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 9.839181e-01 | 0.007 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.864923e-01 | 0.006 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.904718e-01 | 0.004 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 9.904718e-01 | 0.004 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.917480e-01 | 0.004 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.921345e-01 | 0.003 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.934090e-01 | 0.003 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.935831e-01 | 0.003 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.948776e-01 | 0.002 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.952614e-01 | 0.002 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.958819e-01 | 0.002 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.972022e-01 | 0.001 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.981076e-01 | 0.001 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 9.983403e-01 | 0.001 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.984113e-01 | 0.001 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.985862e-01 | 0.001 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.987782e-01 | 0.001 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.989580e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.990093e-01 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 9.991006e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.991621e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.993381e-01 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 9.996858e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.998853e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999339e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999819e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.999850e-01 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.999878e-01 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.999986e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999991e-01 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 9.999993e-01 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.999997e-01 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 9.999999e-01 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |